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Abstract
Transcription factors (TFs) forage the genome to instruct cell plasticity, identity, and differentiation. These
developmental processes are elicited through TF engagement with chromatin. Yet, how and which TFs
can engage with chromatin and thus, nucleosomes, remains largely unexplored. Pioneer TFs are TF that
display a high affinity for nucleosomes. Extensive genetic and biochemical studies on the pioneer TF
FOXA, a driver of fibroblast to hepatocyte reprogramming, revealed its nucleosome binding ability and
chromatin targeting lead to chromatin accessibility and subsequent cooperative binding of TFs. Similarly,
a number of reprogramming TFs have been suggested to have pioneering activity due to their ability to
target compact chromatin and increase accessibility and enhancer formation in vivo. But whether these
factors directly interact with nucleosomes remains to be assessed. Here we test the nucleosome binding
ability of the cell reprogramming TFs, Oct4, Sox2, Klf4 and cMyc, that are required for the generation of
induced pluripotent stem cells. In addition, we also test neuronal and macrophage reprogramming TFs.
Our study shows that reprogramming TFs bind nucleosomes with a range of nucleosome binding
affinities, indicating that although specific cocktails of TFs are required for reprogramming,
mechanistically these TFs show differential nucleosome interacting behaviors. These results allowed us
to assess differential features between TFs nucleosome binding ability and to correlate their binding with
reprogramming potential.
To determine how general is nucleosome binding we extended our analysis to screen 593 of the 2,000
predicted human TFs in the genome for potential nucleosome binding and validated their binding in
solution. Based on 3D structural analysis, we proposed that strong nucleosome binders anchor DNA
through short -helixes and have a flexible and adaptable DNA binding domain while weak nucleosome
binders use -sheets or unstructured regions and have a higher rigidity within their DNA binding domain.
Through the experiments presented in this dissertation we present the first study revealing the shared
structural features contributing to nucleosome binding potential of pioneer TFs and thus allow for
predication of novel pioneer TFs with cell reprogramming potential.
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ABSTRACT
MECHANISM OF NUCLEOSOME TARGETING BY PIONEER
TRANSCRIPTION FACTORS
Meilín M. Fernández García
Kenneth S. Zaret

Transcription factors (TFs) forage the genome to instruct cell plasticity,
identity, and differentiation. These developmental processes are elicited through
TF engagement with chromatin. Yet, how and which TFs can engage with
chromatin and thus, nucleosomes, remains largely unexplored. Pioneer TFs are
TF that display a high affinity for nucleosomes. Extensive genetic and
biochemical studies on the pioneer TF FOXA, a driver of fibroblast to hepatocyte
reprogramming, revealed its nucleosome binding ability and chromatin targeting
lead to chromatin accessibility and subsequent cooperative binding of TFs.
Similarly, a number of reprogramming TFs have been suggested to have
pioneering activity due to their ability to target compact chromatin and increase
accessibility and enhancer formation in vivo. But whether these factors directly
interact with nucleosomes remains to be assessed. Here we test the nucleosome
binding ability of the cell reprogramming TFs, Oct4, Sox2, Klf4 and cMyc, that are
required for the generation of induced pluripotent stem cells. In addition, we also
test neuronal and macrophage reprogramming TFs. Our study shows that
reprogramming TFs bind nucleosomes with a range of nucleosome binding
vi

affinities, indicating that although specific cocktails of TFs are required for
reprogramming, mechanistically these TFs show differential nucleosome
interacting behaviors. These results allowed us to assess differential features
between TFs nucleosome binding ability and to correlate their binding with
reprogramming potential.
To determine how general is nucleosome binding we extended our
analysis to screen 593 of the 2,000 predicted human TFs in the genome for
potential nucleosome binding and validated their binding in solution. Based on
3D structural analysis, we proposed that strong nucleosome binders anchor DNA
through short a-helixes and have a flexible and adaptable DNA binding domain
while weak nucleosome binders use b-sheets or unstructured regions and have a
higher rigidity within their DNA binding domain. Through the experiments
presented in this dissertation we present the first study revealing the shared
structural features contributing to nucleosome binding potential of pioneer TFs
and thus allow for predication of novel pioneer TFs with cell reprogramming
potential.
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CHAPTER 1: INTRODUCTION
1.1 Transcription Factor Medicated Cell Reprogramming : A Low Efficiency
Process
During development, cells commit to a resolved identity that dictates their
specialized functions. A stable and specialized cellular identity is determined
by the epigenetic and transcriptional states and the genome configuration that a
cell acquires during differentiation stages. Differentiation stages are orchestrated
by the hierarchical expression of transcription factors (TFs), key proteins that
decode the information in our DNA to regulate expression and repression of
genes. Pioneering work by John Gurdon first demonstrated that when Xenoupus
nuclei from a specialized cell are transferred into an enucleated oocyte it results
in the full development of a frog. These studies showed that specialized cells still
contain the developmental capacity to drive Xenoupus oocytes, through
embryonic development (Gurdon, 1962). Later work by Shinya Yamanaka
demonstrated that the identity of a specialized cell can be reverted back to a
pluripotency state by forced expression of specific TFs, a process known as cell
reprogramming, which results in induced pluripotent stem cells (Figure 1.1)
(Nakagawa et al., 2008; Takahashi and Yamanaka, 2006). These breakthrough
experiments revolutionized the field of stem cell biology and defined TFs as the
master regulators of cell identity conversion and plasticity.

1

Stem cells and in vitro reprogrammed cells have greatly advanced the
field of regenerative medicine, as these cells may be used for cell replacement
therapies in cases of tissue damage. For example, heart regeneration may be
achieved by induced cardiomyocyte replacement, and liver damaged can be
repaired by transplantation of induced hepatocytes (Huang et al., 2011; Ieda,
2013; Park et al., 2019; Song et al., 2012). In addition, reprogrammed cells
provide the unique opportunity for disease-modeling with patient-specific cells in
cases where the relevant cell types are otherwise unattainable, such as
neurodegenerative disorders of the brain (Wang et al., 2019).
Over the last decade much work has been done to understand the
pathways underlying cell reprogramming of somatic cells to pluripotency.
Integration of population and single cell genome-wide technologies have allowed
the description of a comprehensive road map of cells progression through fate
change. These studies included the identity of surface markers crucial for iPSC
isolation, single cell transcriptome analysis, chromatin landscape transitions, 3D
chromatin organization, and TF dynamics during reprogramming (Beagan et al.,
2016; Buganim et al., 2012a; Cacchiarelli et al., 2015; Chronis et al., 2017;
Hansson et al., 2012; Hussein et al., 2014; Li et al., 2017; Paik et al., 2018; Polo
et al., 2012; Soufi et al., 2012; White et al., 2016). Still, generation of mature
reprogrammed cell populations remains a problematic, highly variable, and
inefficient process with reported reprogramming efficiencies ranging from
0.00002 – 1 % (Malik and Rao, 2013; Omole and Fakoya, 2018). Therefore,
2

considerable barriers need to be overcome in order to facilitate clinical translation
of cell reprogramming technologies. These challenges stress the need to better
understand the unique characteristics that allow reprogramming TFs to induce
such drastic changes in cell fate.

1.2 Cell Reprogramming Transcription Factors
MyoD, a skeletal muscle-specific TF required for myogenesis, was the first
reported TF to induce direct cell reprogramming of fibroblasts to myoblasts, a
process where cells undergo reprogramming without transitioning through a
pluripotent state (Davis et al., 1987). Two decades later Oct4, Sox2, Klf4 and
cMyc (OSKM) were identified as the embryonic stem cell (ESCs)-specific TFs
cocktail, from a 24 gene pool, required for the reprogramming of fibroblasts to
induced pluripotent stem cells (Figure 1.1) (Takahashi and Yamanaka, 2006).
These cells had ESC-like phenotype and were therefore name induced
pluripotent stem cells (iPSCs).
These early examples of TF-mediated reprogramming triggered numerous
screens to identify cell lineage-specific TFs that could induce direct cell
reprogramming of somatic cells into distantly related cell types from all three
germ layers (Figure 1.1) (Huang et al., 2011; Laiosa et al., 2006; Song et al.,
2012; Vierbuchen et al., 2010). These screens used cDNA pools of cell typespecific TFs followed by single TF cDNA subtraction to narrow down genes
required for direct cell reprogramming. Results from these experiments revealed
3

that only a subset of the tested TFs were capable of inducing direct cell
reprogramming from fibroblasts, including: PU1, C/EBPα, and GATA1 for
hematopoietic reprogramming (Feng et al., 2008; Laiosa et al., 2006); Foxa,
Gata4, and Hnf1α for hepatocyte reprogramming (Figure 1.1) (Huang et al.,
2011; Huang et al., 2014; Sekiya and Suzuki, 2011; Yu et al., 2013); and Ascl1,
Myt1l, and Brn2 for neuronal cell reprogramming (Vierbuchen et al., 2010).
These experiments revealed the existence of lineage-specific TF combinations
capable of erasing mature cell identity and driving acquisition of a new identity.
However, how these reprogramming TFs initially interact with repressed
chromatin to reactivate a developmentally silenced program was not understood.
Pervasiveness of a select group of TFs required for cell reprogramming
opened the question as to what makes these TFs unique and what features
enable TFs with the ability to reprogram cells. It has been suggested that within
this subset of factors there is a hierarchy of reprogramming dominance. Although
multiple studies have identified alternative TF combinations to OSKM for iPSCs
reprogramming, Oct4 and Sox2 remained constant within most TFs combinations
(Feng et al., 2009; Nakagawa et al., 2008; Yu et al., 2007). Furthermore,
expression of Oct4 alone is sufficient to generate iPSCs from mouse neuronal
stem cells (Kim et al., 2009). In contrast, Klf4 can be replaced by Esrrb while
cMyc can be omitted for reprogramming and is thus dispensable for this process
(Feng et al., 2009; Nakagawa et al., 2008; Yu et al., 2007). However, in most
circumstances S, K, and M are also needed for efficient reprogramming to
4

iPSCs(Takahashi and Yamanaka, 2006).
In neuronal cell reprogramming Ascl1 is dominant over Myt1l and
Brn2(Wapinski et al., 2013). Similar to Oct4, expression of Ascl1 alone in
fibroblast is sufficient to drive neuronal cell reprogramming (Wapinski et al.,
2013). Still, Brn2 and Myt1l were required to enhance reprogramming efficiency.
Additionally, in hepatocyte reprogramming from fibroblasts, three different studies
identified TFs that could promote hepatocyte conversion, but among them only
FoxA was a common TF (Huang et al., 2014; Sekiya and Suzuki, 2011; Yu et al.,
2013). Removal of FoxA2 or FOXA3 from hepatocyte reprogramming protocols
inhibited the formation of epithelial colonies, but expression of Hnf4α was not
required. These findings support the hypothesis that within a subset of
reprogramming factors, there is a hierarchy in reprogramming ability. Early work
on one of the reprogramming TFs FOXA, provided clues about the molecular
features of strong reprogramming TFs and hierarchy of reprogramming ability.

1.3 Pioneer Transcription Factors in Cellullar Reprogramming and
Development
Dominant reprogramming TFs play a crucial role in cell development.
FoxA, the dominant reprogramming factor required for fibroblast to hepatocyte
conversion (Du et al., 2014; Huang et al., 2011; Huang et al., 2014; Yu et al.,
2013) is also required for hepatic specification of the gut endoderm (Gualdi et al.,
1996). During liver development, FoxA directly accesses the albumin enhancer
5

when it is packaged in nucleosomal DNA within transcriptionally silent, closed
chromatin. This binding promotes accessibility of the enhancer and subsequent
activation of albumin, a highly liver-specific gene (Chaya et al., 2001; Cirillo et al.,
2002; Cirillo and Zaret, 1999a; Gualdi et al., 1996). In vitro, FoxA can remodel
the compacted albumin enhancer into a local open state by displacing linker
histone in the absence of ATP-chromatin remodelers (Cirillo et al., 2002). Unlike
FoxA, ATP-dependent chromatin remodelers are sensitive to linker histonebound nucleosomes (Hill and Imbalzano, 2000; Ramachandran et al., 2003).
FoxA1-mediated DNA accessibility, as determined by an increase in DNAse
hypersensitivity, leads to cooperative binding of subsequent TFs (Figure 2)
(Cirillo et al., 2002; Cirillo et al., 1998; Cirillo and Zaret, 1999a; Iwafuchi-Doi et
al., 2016). Therefore, unlike most TFs, FoxA binding to DNA is not inhibited by
nucleosome structure. These distinguishing features of FoxA led to its
identification as a “pioneer factor”– a novel class of developmental regulators
with nucleosome binding activity and ATP-independent local chromatin
remodeling activity (Figure 1.2).
As cells undergo mitosis, chromosomes condense and transcriptional
levels decrease (Naumova et al., 2013; Palozola et al., 2017). Still, FoxA is
retained in mitotic chromatin due to its high nucleosome binding affinity.
Furthermore, genomic sites that retain FoxA binding through mitosis correlate
with higher than predicted nucleosome occupancy (Caravaca et al., 2013;
Kadauke et al., 2012; Sekiya et al., 2009). Therefore, FoxA1 was shown to play a
6

role in the maintenance of cellular memory through mitosis. This work highlighted
the importance of TFs interactions with silenced chromatin for the initiation of
chromatin accessibility and progression through cell differentiation and
reprogramming.
Similar to FoxA1, dominant reprogramming TFs have been suggested to
have pioneering activity through their engagement with target sites within
compacted chromatin and the resulting chromatin changes that initiate cell
reprogramming. Work from the Zaret lab used genome-wide nucleosome
occupancy data to reveal that the iPSC TFs OSK, but not cMyc, co-occupy
closed chromatin regions that contain key pluripotency genes only 48 hr into
reprogramming (Soufi et al., 2012). Furthermore, cooperative binding of OSK is
crucial for the initiation of proper enhancer selection and thus for fibroblast
identify silencing. However, the addition of cMYC strongly biased OSKM to
promoters poised for activation (Chronis et al., 2017).
Genome-wide mapping of Ascl1, Brn2, and Myt1L during neuronal
reprogramming showed that Ascl1 preferentially localizes to closed chromatin
and is targeted to neuronal-specific enhancers (Wapinski et al., 2013). In
contrast, Brn2 and Myt1L cannot access closed chromatin, preferentially target
open chromatin and thus have a less dominate role in at the initial stages of
neuronal reprogramming (Wapinski et al., 2013). Expression of Ascl1 alone
followed by single-cell transcriptome analysis in fibroblast showed that Ascl1 is
sufficient to robustly induce reactivation of neuronal genes, downregulation of cell
7

cycle genes, and initiate neuronal reprogramming (Chanda et al., 2014; Treutlein
et al., 2016). In contrast, Myt1L localizes to open and accessible promoters to
execute transcriptional repression and downregulate non-neuronal genes (Mall et
al., 2017). These findings show that neuronal reprogramming is dependent on
the precise match between dominant TFs and chromatin context for the onset of
neuronal identity acquisition followed by the repression of alternative identities.
Hematopoietic TFs PU1, CEBPa and CEBPb have been demonstrated to
reprogram fibroblast to macrophage like cells with PU1, CEBPa and CEBPb
suggested to act as pioneer factors in different contexts; PU1 in macrophage
conversion, CEBPa in B Cell conversion and CEBPb in adipose cells (Feng et
al., 2008; Heinz et al., 2010; Pundhir et al., 2018; Siersbaek et al., 2011; Tagore
et al., 2015; van Oevelen et al., 2015). PU.1 and CEBPa TFs suggested to have
pioneering roles during B cell to macrophage reprogramming by distinct
mechanisms of chromatin targeting. In vivo genomic and chromatin state
analysis by MNase-seq of PU.1 and CEBPa during B cells to macrophages
reprogramming revealed that PU1 target nucleosome-enriched chromatin and
induces chromatin accessibility, while CEBPa binding to nucleosome-enriched
regions is strongly dependent on PU.1 and EBF1 (Barozzi et al., 2014; Boller et
al., 2016; Li et al., 2018; van Oevelen et al., 2015). EBF1 has also been shown to
bind compacted chromatin and induce lineage-specific chromatin accessibility
(Boller et al., 2016; Li et al., 2018). Moreover, knock down of PU.1 in B cells
compromises CEBPa binding to nucleosome-enriched enhancers (Heinz et al.,
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2010; Tagore et al., 2015). This leaves the open question of whether CEBPa
truly targets nucleosomes and thus acts as a pioneer.
While significant research has been done to parse the epigenetic
mechanism of TFs driving direct cell reprogramming toward neuronal and
hematopoietic cell types (Vignoles et al., 2019), the epigenetic mechanism of
direct cell reprogramming toward cardiac, pacemaker cells, keratinocytes
suggesting novel pioneer TFs such as Isl1, Hand2, and TFAP2C/p63
respectively are just beginning to be explored (Fernandez-Perez et al., 2019;
Gao et al., 2019; Li et al., 2019). Moreover, direct cellular reprogramming toward
peripheral red bloods cells remains difficult and TFs cocktails have not yet been
identified. Therefore, characterization of the unique features of pioneer
transcription factors will allow the prediction of TFs with pioneering and
reprogramming potential.
Studies correlating TF binding co-occurrence with chromatin accessibility
in vivo suggest a hierarchical model of TF-mediate reprogramming. In this model,
factors sufficient for reprogramming access compacted chromatin, leading to the
recruitment of additional factors. Finally, supporting TFs target open chromatin
and repress the host identity (Mall et al., 2017; Wapinski et al., 2013). The
hierarchical model place TF nucleosome binding ability as a determinant of
reprogramming potential. Nonetheless models based on genetic correlations
alone are insufficient to distinguish between intrinsic nucleosome targeting ability
and chromatin engagement through cooperative interactions. Moreover, whether
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these factors have the inherent biochemical ability to bind nucleosomes remains
to be assessed. Thus, the requirement for nucleosome binding by these factors
as a seminal event in the initiation steps of reprogramming has not been
determined.

1.4 Chromatin Barriers to Transcription Factor DNA Accessibility
TFs work in the context of chromatin where DNA is hierarchically
packaged into a 3D genome conformation that controls the diverse regulatory
mechanisms of gene activation and repression (Figure 1.3 ) (Luger, 2003; Luger
et al., 1997). Regulation of the 3D genome organization and its dynamics across
time and space results in a 4D nucleome network that controls cellular
differentiation into specialized cells (Figure 1.1 ) (Dekker et al., 2017; Mirny et al.,
2019; Zheng and Xie, 2019).
Nucleosomes are the principal packing elements of DNA and therefore,
the fundamental determinants of DNA accessibility for essentially all DNAtemplated processes. They are formed by the association of 146 bp of DNA
wrapped around two histone dimers of H2A-H2B and a H3-H4 tetramer (Figure
1.4 )(Luger, 2003; Luger et al., 1997). The histone octamer forms histone-DNA
contacts at the interior minor groove of DNA, serving as the first level of DNA
constraint modulating the binding of TFs to DNA and chromatin regulators
(Luger, 2003; McGinty and Tan, 2015). The tight packing of DNA by histones
impedes accessibility of TFs to DNA and inhibits TF transcriptional activity
10

(Blomquist et al., 1996; Schild-Poulter et al., 1996; Taylor et al., 1991). Moreover,
rotational phasing of the TF DNA binding sites within the nucleosome has been
shown to limit TF binding (Liu and Kraus, 2017; Sekiya et al., 2009).
As described above, pioneer TFs can overcome such constraints.
Nucleosomes can also allow binding of diverse proteins such as pioneer TFs,
epigenetic modifiers and chromatin remodelers that alter the nucleosome
structure, positioning and compaction (Hughes and Rando, 2014; McGinty and
Tan, 2015). The nucleosome’s acidic patch, a negatively charged region on the
nucleosome surface, serves as the landing pad for nucleosome binding proteins
including regulator of chromosome condensation RCC1, polycomb repressive
complex PRC1, centromere protein, CENPC, among others (Figure 1.4) (Allu et
al., 2019; Kato et al., 2013; Makde et al., 2010; McGinty et al., 2014; Wang et al.,
2013). However, these nucleosome binding proteins interact with chromatin
through non-specific interactions, which does not allow the targeting to cell type
specific genes. On the other hand, TFs recognize unique sequences within DNA.
Therefore, pioneer TFs play a crucial role in the gene specific targeting and
recruitment of chromatin regulators and allow access of nucleosome-inhibited
binding of TFs to target sites in closed chromatin to direct competence for a
specific cell lineage.
TFs display sensitivity to the multiple states of chromatin compaction
where nucleosome presence is inhibitory for the binding of most TFs. Our lab has
identified heterochromatic domains which are refractory to OSKM binding during
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iPSCs reprogramming (Soufi et al., 2012). Differentially bound regions (DBRs)
were initially described as histone 3 lysine 9 trimethylation (H3K9me3)- enriched
mega-base scale domains (Figure 1.3) (Soufi et al., 2012). These DBRs contain
pluripotency genes with restricted expression to few cells in the late stages of
iPSCs reprogramming stages (Buganim et al., 2012b). More recently our lab
showed that H3K9me3 heterochromatin domains are biophysically distinct
domains that are sonication resistant therefore revealing structural subtypes of
heterochromatin (Becker et al., 2017). Additionally, liver specific genes located
with these sonication resistant domain failed to activate during direct cell
reprogramming of fibroblast to hepatocytes therefore, impeding efficient
reprogramming (Becker et al., 2017). These studies, highlighted the role of TFs
chromatin state sensitivity in restricting manipulation of cell fate. Continued
research on the impediment of TF chromatin restriction will allow the design of
better reprogramming protocols and facilitate cell reprogramming translation for
therapeutic technologies.

1.5 Transcription Factor Screens: DNA and Chromatin Interacting
Behaviors
Proteins that recognize the nucleosome as a substrate cannot be reliably
predicted by genomic analysis and while there are over 2,000 predicted human
TFs in the genome (Kummerfeld and Teichmann, 2006; Lander ES, 2001;
Messina et al., 2004; Vaquerizas et al., 2009; Venter JC, 2001), only a minority of
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sequence-specific DNA chromatin binding proteins have been assayed for
nucleosome interaction (Blomquist et al., 1996; Haswell and O'Shea, 1999; Liu
and Kraus, 2017; Perlmann, 1988; Schild-Poulter et al., 1996).
Multiple high throughput studies have described the profile of TFs
sequence-specific DNA interactome and their sensitivity for DNA methylation by
systematic evolution of ligands by exponential enrichment (SELEX) and ChIPseq (Hu et al., 2009; Jolma et al., 2013; Yin et al., 2017). More recently the
development of combinatorial technologies that allow parallel analysis of DNA
accessibility and gene expression have allowed the discovery of associations
between chromatin state, TF motif enrichment and gene expression (Cao et al.,
2018; Clark et al., 2018; Cusanovich et al., 2015). But these technologies had
been unable to incorporate TF-chromatin interaction profiles into the analysis due
to limitations in the high number of cells required for these assays and the
requisite of DNA-sequence specificity of TFs. These constraints limit the
identification of TFs with nucleosome binding potential and make it challenging
for computational tools to predict the general rules underlying nucleosome
binding and pioneer activity.
To elucidate the molecular mechanisms that mediate TF access to
nucleosomal sites and the nucleosome-interacting behaviors of such TFs, two
recent publications developed novel approaches (Yan et al., 2018; Zhu et al.,
2018). Yan et. al. systematically compared the properties of yeast nucleosomedisplacing factors (NDFs). Similar to pioneer TFs, NDFs access embedded sites
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within compacted DNA, but unlike pioneer TFs, NDFs induce depletion of
nucleosomes (Yan et al., 2018). This study identified TFs with strong and weak
nucleosome displacing activity. Furthermore, this study showed that strong NDFs
antagonize

nucleosome

formation

through

DNA

replication

dependent

mechanisms in yeast (Yan et al., 2018).
Research by Zhu et al from Taipale’s group developed nucleosome
consecutive affinity purification –SELEX to test nucleosome binding of over 200
TFs. CAP-SELEX consists of pull down assays with recombinant nucleosomes
assembled with 147 bp and 200 bp DNA libraries followed by analysis of TF
sequence-specific enrichment (Zhu et al., 2018). In agreement with previous
findings, nucleosomes inhibited the binding of most TFs but also revealed
position-specific binding such as, periodic and dyad binding to nucleosomal DNA.
In conclusion these publications revealed the interaction landscape between TFs
and the nucleosome (Yan et al., 2018; Zhu et al., 2018). Nonetheless the
molecular features of TFs that permit or preclude binding to nucleosomal DNA
and the chromatin perturbations that immediately succeed binding, to promote
cooperative interactions with other factors, remain to be understood.

1.6 Conclusions
Based on the shared occupancy at silent chromatin of FoxA and
reprogramming TFs, I sought to investigate the nucleosome binding abilities of
reprogramming TF as a required step for the initiation of reprogramming.
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Although it has been proposed that TF-mediated chromatin opening is a
generalized mechanism to access regulatory regions as an initial step in
reprogramming and differentiation, these models have been based on genomewide ChIP-seq data, which cannot differentiate between direct interaction with
chromatin or close proximity mediated by intermediate proteins. Therefore, my
thesis work tests the ability of reprogramming factors to directly engage with
nucleosomes (chapter 2) and systematically assess the ability of the direct
reprogramming TFs toward multiple cell types to bind reconstituted nucleosomes
(chapter 3). Additionally, by TF screening methods I was able to identify TFs with
previously unreported pioneering activity (Chapter 3). Indeed, revealing that
nucleosome binding is a characteristic of strong reprogramming TFs and further
predicting TFs for unreported reprogramming protocols such as erythrocyte direct
cell reprogramming (Figure 1.1). My thesis work describes the unique structural
features of reprogramming TFs and provides insights into the initial step in the
mechanisms of cell reprogramming.
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1.7 Figures

Figure 1.1 | Transcription Factor Mediated Cell Reprogramming
Transcription factors (TFs) that mediate reprogramming of fibroblast toward
induced pluripotent stem cells or the direct cell reprogramming towards induced
neurons, induced hepatocytes, induced macrophages and other hematopoietic
lineages.
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Figure 1.2 | Mechanisms of Chromatin Organization
DNA is packaged into nucleosomes by histone octamers composed of H2A,
H2B, H3 and H4. These are positively-charged and adhere strongly to
negatively-charged DNA. Nucleosomes then fold into heterogeneous groups of
nucleosomes clutches (Ricci et al., 2015). These clutches are compressed and
folded in interphase into loops by architectural proteins like CTCF and cohesion.
DNA loops are then arranged into compartments by transcriptional state
into heterochromatin and euchromatin (Mirny et al., 2019). DNA compartments
and DNA loops are then studied through time to build spatial models of the
dynamic spatiotemporal regulation of chromatin (Dekker et al., 2017). Figure
adapted from (Dekker et al., 2017; Mirny et al., 2019).
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Figure 1.3 | Chromatin Binding by Pioneer Transcription Factors
Before gene activation DNA is highly compacted into low signal or repressed
heterochromatin inhibiting binding of most TFs. Pioneer TFs scan low signal
chromatin and access target sites within silent chromatin but this binding is
inhibited at differentially bound regions (DBRs) enriched for H3K9me3. Upon
binding pioneer TFs then induce local chromatin accessibility and through
cooperative interactions allow subsequent binding of TFs and chromatin
modifiers to induce cell type specific gene activation.
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Figure 1.4 | Surface topology and charge of the nucleosome core particle.
(A) Surface of nucleosome core particle viewed down the DNA superhelical axis
in space-filling representation.
(B) Surface electrostatic potential of nucleosome core particle contoured from −5
to +5 kT/e calculated with ABPS.164 Location of acidic patch is indicated (Figure
from (McGinty and Tan, 2015)
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CHAPTER 2: PIONEER TRANSCRIPTION FACTORS TARGET
PARTIAL DNA MOTIFS ON NUCLEOSOMES TO INITIATE
REPROGRAMMING
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2.2 Respective Contributions
Dr. Abdenour Soufi and Dr. Kenneth S. Zaret. conceived the study. Under
the guidance of Dr. Soufi and Dr. Zaret I carried out plasmid cloning, DNA
purifications, histones purifications, nucleosome reconstitutions, EMSAs and
competition experiments as well as dissociation constant analyses resulting in
Figure 2.1D, Table 1, Figure 2.2A and supplemental Figures 2.S1, 2.S2
presented. Dr. Soufi, Arthur Jaroszewicz, and Dr. Mateo Pellegrini performed
genome sequencing experiments and analysis including MNase-seq data
analysis. With the guidance or Dr. Soufi, Nebiyu Osman carried out
the recombinant protein purifications of transcription factors. Dr. Soufi performed
DNAse footprinting experiments with samples that I prepared. Dr. Soufi also
carried out the motif and 3D structure analysis. Dr. Soufi and Zaret contributed to
supervision of personnel, data interpretation, and writing the manuscript. While I
contributed to the manuscript revision and discussions that led to the final
proposed model of transcription factors flexibility within the DNA binding domain.
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2.3 Abstract
Pioneer transcription factors (TFs) access silent chromatin and initiate
cell-fate changes, using diverse types of DNA binding domains (DBDs). FoxA,
the paradigm pioneer TF, has a winged helix DBD that resembles linker histone
and thereby binds its target sites on nucleosomes and in compacted chromatin.
Herein, we compare the nucleosome and chromatin targeting activities of Oct4
(POU DBD), Sox2 (HMG box DBD), Klf4 (zinc finger DBD), and c-Myc (bHLH
DBD), which together reprogram somatic cells to pluripotency. Purified Oct4,
Sox2, and Klf4 proteins can bind nucleosomes in vitro, and in vivo they
preferentially target silent sites enriched for nucleosomes. Pioneer activity relates
simply to the ability of a given DBD to target partial motifs displayed on the
nucleosome surface. Such partial motif recognition can occur by coordinate
binding between factors. Our findings provide insight into how pioneer factors
can target naive chromatin sites.
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2.4 Introduction
Silent chromatin is packed with nucleosomes, acting as a barrier to
targeting by most transcription factors (TFs) (Adams and Workman, 1995; Mirny,
2010). However, a select group of transcription factors (TFs) known as pioneer
factors have the combined ability to access their target sites in silent chromatin
and initiate cell-fate changes (Iwafuchi-Doi and Zaret, 2014; Zaret and Carroll,
2011). The winged-helix DNA binding domain (DBD) of the pioneer factor FoxA
(Clark, 1993), which is similar to that of linker histone(Ramakrishnan et al.,
1993), allows the protein to bind its DNA motif exposed on a nucleosome and
access to silent chromatin (Cirillo et al., 2002; Cirillo et al., 1998; Cirillo and
Zaret, 1999a). Such activity is necessary for liver induction (Lee et al., 2005).
Other TFs involved in cell reprogramming can target their sites in silent chromatin
(Montserrat et al., 2013; Soufi et al., 2012; Takahashi and Yamanaka, 2006;
Wapinski et al., 2013), but they possess DBDs that differ from that of FoxA.
Whether such reprogramming factors directly bind nucleosomes and how the
structures of their respective DBDs relate to nucleosome binding, and hence
pioneer activity, has not been assessed.
Transcription factors containing major structural classes of DBDs,
including Pit-Oct-Unc (POU), Sry-related High Mobility Group (HMG), Zinc
Fingers (ZF), and basic-helix-loop-helix (bHLH), represented by O, S, K, and M,
respectively, have been used in the most dramatic example of cellular
reprogramming: the conversion of differentiated cells into induced pluripotent
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stem cells (Takahashi and Yamanaka, 2006). We previously compared genomic
chromatin features of human fibroblasts, prior to the ectopic expression of
OSKM, to where the factors first bind the genome during their initial expression
(Soufi et al., 2012). This allowed us to assess how OSKM target pre-existing
states in chromatin, as opposed to assessing chromatin states after the factors
are bound. The data showed that Oct4, Sox2, and Klf4, but not c-Myc, could
function as pioneers during reprogramming by virtue of their ability to mostly
target “closed” chromatin sites that are DNase I resistant and “naive” by virtue of
lacking evident active histone modifications (Soufi et al., 2012). Recently, singlemolecule imaging analysis using fluorescently tagged proteins monitored in living
cells proposed that Sox2 guides Oct4 to its target sites (Chen et al., 2014); the
chromatin status of the sites was unknown. However, we previously found that
the ectopic Oct4 and Sox2 bind most extensively to separate sites in chromatin
(Soufi et al., 2012), leaving open how the bulk of chromatin targeting is achieved.
While many of initial binding events were promiscuous and not retained in
pluripotent cells, many others occurred at target genes that are required for
conversion to pluripotency.
Ascl1, Pax7, and Pu.1 have emerged as pioneer transcription factors
based on targeting closed chromatin and their ability to reprogram cells, though
assessments of direct interaction with nucleosomes has been lacking (Barozzi et
al., 2014; Budry et al., 2012; Wapinski et al., 2013). In light of the bHLH factor cMyc being unable to bind closed chromatin on its own (Soufi et al., 2012), it was
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surprising that Ascl1, another bHLH factor, can bind closed chromatin during
reprogramming fibroblasts to neuron-like cells (Wapinski et al., 2013). Studies
that have examined the correlation between co-existing TF binding and
nucleosome occupancy, without characterizing the “pre-bound” chromatin state,
could not address questions about initial chromatin access.
Generating induced pluripotent stem (iPS) cells, using the OSKM factors,
has proved to be highly valuable for research, with great potential for
regenerative medicine (Robinton and Daley, 2012). In an attempt to increase the
efficiency of reprogramming, efforts have focused on explaining how somatic
cells respond to the ectopic expression of OSKM (Buganim et al., 2012b; Papp
and Plath, 2013; Soufi, 2014). To gain insights into the molecular mechanisms
that impart OSKM access to closed chromatin, we measured the fundamental
interaction between the factors and nucleosomes, in vivo and in vitro, by three
mutually supportive approaches: biochemical assays, genomics, and structural
analysis. We find that the inherent ability of DBDs to recognize one face of DNA
on nucleosome, as seen by targeting a part of their canonical motif on
nucleosome-enriched sequences in chromatin, is the primary determinant of
pioneer factor activity. These findings can explain the pioneer activity of a diverse
set of reprogramming factors containing different structural classes of DBDs as
well as the synergistic behavior of pioneer and non-pioneer factors.
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2.5 Results
Oct4, Sox2, Klf4, and c-Myc Show a Range of Nucleosome Binding In Vitro
The interaction of full-length O, S, K, and M, as used in reprogramming,
with nucleosomes is not known. Therefore, we purified and refolded the fulllength O, S, and K factors, along with c-Myc and its obligate heterodimerization
partner Max from bacterial cells, representing post-translational unmodified
proteins (Figure 2.1A; Figure 2.S1A). We also obtained the full-length O, S, K,
and M expressed in human HEK293 cells and purified under native conditions,
representing post-translational modified versions of the proteins (Figure 2.1A). To
quantify the DNA binding activities of the proteins, the apparent equilibrium
dissociation constants (KD) were determined using two different methods: from
the decrement in the amount of free DNA (total KD) and from the appearance of
the first DNA-bound complex (specific KD), in electrophoretic mobility shift
assays (EMSA). As expected, the bacterial (bact.) and the mammalian (mamm.)
expressed, recombinant O, S, K, and M proteins bound to DNA probes
containing canonical motifs, as previously reported for the purified DBDs (Farina
et al., 2004; Nakatake et al., 2006; Rodda et al., 2005) (Figure 2.S1B; Table 2.1),
and bound with much lower affinity to non-specific DNA sequences of the same
length (Figure 2.S1C). The bact. reconstituted Myc:Max heterodimers formed a
complex that migrated more slowly than Max homodimers, and no protein-DNA
complexes with similar mobility to Max homodimers were observed even at the
highest concentrations, confirming that the c-Myc:Max preparation did not
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contain Max homodimers (Figure 2.S1B). The mamm. c-Myc did not show any
specific DNA binding activity in the absence of its partner Max, as seen
previously (Wechsler et al., 1994). These data demonstrate that the recombinant
full-length OSKM proteins were highly active in specific DNA binding.
To measure the direct interactions between OSKM and nucleosomes, we
identified a nucleosome-enriched site in the fibroblast genome that is efficiently
targeted by OSKM (Soufi et al., 2012), focusing on the LIN28B locus that is
important for reprogramming and pluripotency (Shyh-Chang et al., 2013; Yu et
al., 2007) RNA sequencing (RNA-seq) data showed that LIN28B is silent in
human fibroblasts and remains silent after 48 hr OSKM induction, revealing that
OSKM binding precedes LIN28B gene activation (data not shown). We selected
a region downstream of the LIN28B poly(A) site that is strongly enriched for a
nucleosome in pre-induced human fibroblasts, as measured by MNase
sequencing (MNase-seq) (Kelly et al., 2012) and was targeted by all four factors
at 48 hr post-induction (Figure 2.1B). We used PCR on human fibroblast DNA to
generate a 162-bp, Cy5-labeled LIN28B-DNA, which was assembled into
nucleosomes (LIN28B-nuc) by salt gradient dilution with purified recombinant
human histones (Figure 2.S1D). The nucleosomes exhibited protection from low
concentrations of DNase I except at the ends of the LIN28B fragment, compared
to free DNA, indicating translational positioning around the center of the 162-bp
LIN28B sequence (Figure 2.1C, top two boxes), similar to the observed position
of the center of the MNase-seq peak (Figures 2.1B and 2.1C). Ten-fold higher
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concentrations of DNase generated an approximately 10-bp DNase-cleavage
repeat pattern on LIN28B-nuc, reflecting rotational positioning of nucleosomes
within the population (Figure 2.1C, bottom).
It is generally accepted that nucleosomes act as a barrier to DNA binding
by TFs (see Introduction), though exceptions have been noted (Perlmann, 1988).
Interestingly, Oct4, Sox2, and Klf4, but not c-Myc:Max, showed binding to the
LIN28B-nuc (Figure 2.1D). Remarkably,both mamm. and bact. Oct4 and Sox2
showed similar or lower apparent KD values for LIN28B-nuc compared to
LIN28B-DNA, indicating similar or higher affinity to nucleosome than to free DNA
(Figure 2.1D; Table 2.1). On the other hand, Klf4 was able to bind LIN28B-nuc
with a higher apparent KD value compared to free DNA, indicating substantial
nucleosome binding, but at a lower affinity than to free DNA (Figure 2.1D; Table
2.1). c-Myc:Max did not yield saturated binding to LIN28B-nuc, even at the
highest concentrations of protein used, and thus the apparent KD must be in the
μM range (Figure 2.1D; Table 2.1). In conclusion, both mammalian and bacterial
expressed O, S, K, and M exhibit the same relative range of affinities to LIN28Bnuc, and O, S, and K have an independent nucleosome binding activity.

Specific and Non-Specific DNA Interactions Contribute to Nucleosome
Binding
It is well recognized that TFs show both sequence-specific and nonspecific interactions with their DNA targets
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(Biggin, 2011). To measure the

contribution of specificity on OSK binding to LIN28B nucleosomes, we carried out
EMSA in the presence of increasing amounts of specific and non-specific DNA
sequences that we had already characterized as competitors (Figures 2.S1B and
2.S1C; Table 2.1). EMSA competition experiments show that a 40-fold molar
excess of non-labeled DNA probes containing specific binding sites, but not
probes containing non-specific sequences, can displace LIN28B-DNA complexes
with each of the OSKM proteins, indicating specific interaction with LIN28B-DNA
(Figure 2.2A, left panel), similar to OSKM interaction with their canonical sites
(Figure 2.S2A). As expected, bact. and mamm. O, S, or K in complexes with
LIN28B-nuc were displaced in the presence of a 40× molar excess of unlabeled,
specific competitors (Figure 2.2A, lanes 16, 19, and 22). A 40× or lower (range
from 5× to 20×) molar excess of non-specific DNA failed to displace bact. and
mamm. Oct4 from the LIN28B-nuc (Figures 2.2A, lane 17, and 2.S2B, lanes 14–
16), demonstrating specific binding by Oct4 to the nucleosomes in vitro.
By contrast, a 40× excess of non-specific DNA competed almost all of
Sox2 and Klf4 from binding to LIN28B-nuc (Figure 2.2A, lanes 20 and 23).
Importantly, lower levels of non-specific competitor, from 5× to 20×, did not
compete to the same extent as specific competitor with LIN28B-nuc for binding
either Sox2 or Klf4 (Figures 2.S2C and 2.S2D, compare lanes 10 to 11–13
versus 14–16). Thus, both specific and non-specific interactions contribute to
Sox2 and Klf4 binding to nucleosomes in vitro.
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DNase footprinting showed that each of the O, S, K, and M factors protect
sequences on LIN28B-free DNA that resemble their canonical motifs (Figures
2.2B and 2.2C, dash boxes). In addition, at the concentrations used for
footprinting, Sox2, Klf4, and c-Myc also show non-specific protection of the
LIN28B-free DNA (Figure 2.2B, peaks labeled by asterisks). DNase footprinting
of LIN28B-nuc bound to Oct4 and Sox2 show that the factors protect part of their
canonical motifs, agreeing with the specific binding to nucleosomes seen with
EMSA competition experiments (Figures 2.2B and 2.2C). However, Sox2 and
Klf4 protect both specific and non-specific nucleotides on LIN28B-nuc, supporting
the non-specific contribution of Sox2 and Klf4 to nucleosomes as seen in EMSA
competition experiments (Figure 2.2B). The Klf4 binding site is close to the
predicted nucleosome dyad axis, where DNase cleavage is minimal, thus
precluding an accurate assessment of specific footprinting. Expectedly, c-Myc
showed minimal protection of LIN28B-nuc, confirming the weak affinity to
nucleosomes. Altogether, the O, S, and K reprogramming factors employ specific
and nonspecific nucleosome interactions to different extents.

Range of Nucleosome Binding In Vitro Is Observed in Genome Targeting In
Vivo
We assessed whether OSKM, 48 hr post-induction, targeted sites with
pre-existing nucleosome enrichment in fibroblast chromatin. Pooling seven
replicates from the MNase-seq data set (GSM543311) allowed a high-resolution
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map of nucleosomes with 6.6-fold genome coverage. First, we curated the sites
where O, S, K, or M targeted alone, by identifying O, S, K, or M peaks that are
500 bp or more apart from each other. The sites were arranged in rank order by
the number of chromatin immunoprecipitation sequencing (ChIP-seq) tags in the
central 200 bp, from high- to low-affinity sites. This analysis confirms that each of
the O, S, K, and M factors is highly enriched at the central 200 bp within a 2-kb
region (Figure 2.3A, blue boxes). Interestingly, Sox2 bound most frequently alone
(n = 41,107) compared to Oct4 (n = 22,495), Klf4 (n = 28,212), and c-Myc (n =
23,885). Subsequently, MNase tags across the respective 2-kb regions were
counted, reflecting local nucleosome enrichment. Read-density heatmaps
showed a range of nucleosome enrichment at the central 200-bp regions that
were targeted by O, S, K, or M factors alone (Figure 2.3A, red boxes). Notably,
Oct4 targets were the most highly enriched for nucleosomes, followed by Sox2,
and then Klf4 throughout the respective TF rank-ordered binding profiles. By
contrast, MNase tags in the c-Myc targeted sites were diminished. Also, we did
not observe pre-phased arrays of nucleosomes at OSKM target sites, indicating
that the initial association with nucleosomes proceeds repositioning, if any.
Remarkably, the extent of nucleosome targeting of O, S, K, and M in vivo
correlates with the relative abilities of the factors to bind nucleosomes in vitro
(Figure 2.1D; Table 2.1).
To assess the contribution of non-specific binding in vivo, we counted the
number of O, S, K, and M peaks at 48 hr post-induction as function of false
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discovery rate (FDR) threshold. Remarkably, while O, K, and M peak numbers
begin to stabilize above an FDR of 0.5% (used in our study) (slopes of 1.6, 1.5,
and 1.3 respectively), the number of Sox2 peaks continues to increase (slope of
2.1) with higher FDR (Figure 2.S3A). Thus, it appears that Sox2 employs a
measure of non-specific targeting in vivo, as we observed in vitro.

O, S, K, and/or M Synergistic Targeting of Nucleosomes In Vivo and In Vitro
It has been previously suggested that transcription factors can access
nucleosomal DNA by cooperative binding in order to compete with histones
(Polach and Widom, 1996). To investigate the contribution of synergy between
O, S, K, and/or M to nucleosome targeting, we studied sites that were cotargeted by multiple factors within a range of 100 bp or less from each other, i.e.,
within one nucleosome. In general, we observed that all possible O, S, K, and/or
M combinations targets were enriched for nucleosomes except for KM targets,
and the co-bound sites, on average, were more enriched for nucleosomes than
singly bound sites (Figures 2.3B and 2.S3B). Notably, there were more S, K,
and/or M combinations that included Oct4 and showed higher nucleosome
enrichment at initially targeted sites, compared to binding combinations lacking
Oct4 (Figures 2.3B and 2.S3, compare C–I to J–M). For example, c-Myc showed
the most nucleosome targeting when co-bound with Oct4, followed by with Sox2,
while c-Myc showed weak targeting to nucleosomes with Klf4 (Figure 2.S3,
compare E to K and M). Interestingly, the KM combination was the most frequent
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at nucleosome-depleted promoters, similar to KM targeting DNase hypersensitive
regions (Soufi et al., 2012) (Figure 2.S3M, red plot). Nevertheless, KM still
targeted nucleosome-enriched sites at TSS-distal regions (Figure 2.S3M, blue
plot).
To further investigate synergistic targeting with Oct4, we assessed binding
by each of the bact. Sox2, Klf4, and c-Myc:Max (1 nM) to the reconstituted
LIN28B-nuc (2 nM) in the presence of low amounts of Oct4 (0.3 nM). EMSA
showed that all the three recombinant proteins are able to bind with Oct4 to
nucleosomal DNA in vitro, forming higher order complexes (Figure 2.3C).
Notably, c-Myc:Max binding to LIN28B-nuc was enabled in the presence of Oct4
(Figure 2.3C, right panel). To assess the presence of histones in the LIN28B-nuc
in the complexes, we transferred the proteins from an EMSA gel to a
polyvinylidene fluoride (PVDF) membrane and blotted for H3 and H2B (Figure
2.S4). Though the c-Myc antibody was the weakest, all LIN28B-nuc-bound
complexes showed detectable amounts of H3, and to a lesser extent H2B,
indicating the factors bind together to nucleosomes. In summary, Oct4, Sox2,
and Klf4 enable c-Myc to target nucleosomal sites both in vivo and in vitro.

O, S, and K Separately Recognize Partial Motifs on Nucleosomes
To identify DNA motifs that are associated with O, S, and K alone
targeting to nucleosomes in vivo, the respective targeted sites were rank ordered
according to nucleosome enrichment in the central 200 bp. This allowed us to
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separate nucleosome-enriched from nucleosome-depleted regions that were
individually targeted by O, S, or K. By these criteria, 85%, 80%, and 65% of the
genomic sites initially targeted by Oct4, Sox2, and Klf4, respectively, were
enriched for nucleosomes (Figures 2.4A–2.4C, red boxes). We used de novo
motif analysis, separately analyzing the targets that were enriched for
nucleosomes (Figures 2.4A–2.4C, red boxes, upper portion) from those that were
depleted of nucleosomes, i.e., free DNA targets (Figures 2.4A–2.4C, red boxes,
lower portion). While O, S, and K primarily targeted sequences similar to their
canonical motifs at nucleosome-depleted and nucleosome-enriched sites, motifs
occurring at nucleosome-enriched sites showed distinctive features (Figures
2.4D–2.4F).
Strikingly, while Oct4 targeted its canonical octamer sequence at
nucleosome-depleted sites (∼49% of n = 3,375), Oct4 targeted hexameric motifs
resembling one or another half of the octamer motif at nucleosome-enriched sites
(42% and 28%, respectively, of n = 19,120) (Figure 2.4D). Sox2 targeted its
canonical HMG box motif at nucleosome-depleted sites (64% of n = 8,221), while
targeting a more degenerate motif lacking the sixth “G” nucleotide in the
nucleosomal motif (∼74% out of n = 32,886) (Figure 2.4E, arrowhead). Finally,
Klf4 alone targeted its nonameric motif at nucleosome-depleted sites (94% of n =
9,874), whereas Klf4 targeted a hexameric motif that was missing the three
terminal nucleotides at nucleosome-enriched sites (90% of n = 18,338) (Figure
2.4F, see dashed lines).
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These findings agree with the above DNase footprinting of LIN28B-nuc
bound to the factors (Figure 2.2B, right panels), with Oct4 and Sox2 protecting a
part of their canonical motifs on one side of the LIN28B-nuc DNA (Figures 2.2B
and 2.2C; right). On free DNA, Klf4 protected the first three nucleotides of its
motif on the upper strand while protecting the remaining six nucleotides of its
motif on the bottom strand (Figure 2.S5A). However, Klf4 did not protect the first
three nucleotides on the upper strand of LIN28B-nuc, as they were not exposed
to DNase I digestion, indicating that Klf4 may be interacting with part of its motif
exposed on the other strand (Figures 2.2B and 2.2C).
These data show that the O, S, and K factors can independently target
nucleosomes using partial or degenerate motifs, and that each of the factors
targets their full canonical motif in the absence of nucleosomes at a target site.
Targeting of partial motifs at nucleosomal sites by OS or OK together also
reveals partial motifs for each of the factors (data not shown).

The Molecular Basis for O, S, and K Nucleosomal Targeting
In order to define the molecular basis that govern O, S, and K interactions
with nucleosomal DNA, we interrogated the three dimensional structures of O, S,
and K DBDs in complexes with their canonical motifs that were deposited in the
RCSB Protein Data Bank. Oct4 contains a bipartite POU domain, composed of
an N-terminal POU-specific (POUS) and a C-terminal POU-homeodomain
(POUHD), separated by a linker region. The X-ray structure of Oct4-POU-DNA
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complex confirms that the POUS and POUHD each bind one-half of the
octameric motif on DNA (Esch et al., 2013) (Figure 2.4G, lower panels). The
truncated POUS and POUHD can bind their respective half motif DNA probes in
vitro, independently from each other (Verrijzer et al., 1992). Interestingly, the
isolated DNA-bound state of either POUS or POUHD accommodates less than
half of the DNA surface across the circumference of the double helix (DNA
surface occupied 606 and 718 Å2, respectively), leaving the opposite DNA
surface solvent-exposed and potentially free to interact with histones in a
nucleosome conformation (Figure 2.4G, red dashed arrows in upper panels).
However, once both POUS and POUHD are bound to the full motif (1,321 Å2),
less than a quarter of the DNA circumference is solvent-exposed and hence
would be incompatible with nucleosome binding, due to steric hindrance (Figure
2.4G, red dashed arrow in lower panel). Thus, the two POU domains do not
target directly adjacent half sites on nucleosomes, as seen in free DNA, but the
exposure of the separate half sites on nucleosomes is enough for Oct4 initial
targeting.
Sox2 binds DNA through its HMG box, inducing a sharp bend and
widening of the minor groove (Remenyi et al., 2003) (Figure 2.4H, lower-left
panel). Our motif analysis showed that Sox2 targets a degenerate motif within
nucleosomes, missing one “G” nucleotide at the sixth position (Figure 2.4E). This
“G” nucleotide is positioned at the angle of the induced bend and makes direct
contacts with the N46 residue at the N-terminal tail of Sox2-HMG (Remenyi et al.,
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2003) (Figures 2.4E and 2.4H, arrowhead). Remarkably, mutation of this one
amino acid (N46Q) within Sox2-HMG results in a significant decrease in DNAbending ability without affecting DNA binding (Scaffidi and Bianchi, 2001). In
transient

transfection

assays,

the

Sox2-N46Q

mutant

displays

higher

transactivation activity from the Fgf4 enhancer compared to Sox2 wild-type
(Scaffidi and Bianchi, 2001). Furthermore, mutation of the “G” nucleotide in the
sixth position of the motif has the unique ability, among all mutations tested, to
abolish DNA bending by wild-type Sox2 (Scaffidi and Bianchi, 2001). Together
these data indicate that Sox2 would not induce extensive DNA-distortion when
targeting the nucleosomal motif, since that motif lacks the “G” nucleotide. To
further support these observations, we superimposed the 3D structure of DNA
bound by wild-type Sox2 and Sox2-N46Q mutant on nucleosomal DNA and after
1,000 cycles refinement we calculated the root-mean-square deviation (RMSD)
as a measure of the average distance between the phosphate backbone for the
best fit. These analysis reveal that the less distorted DNA is more compatible
with nucleosomal DNA (RMSD = 0.86 Å) compared to the extensively distorted
DNA (RMSD = 6.83 Å) (Figure 2.4H, right panel). In conclusion, our data indicate
that Sox2 engages nucleosomes by recognizing a degenerate motif that involves
less DNA distortion, better filling the curvature and widened minor groove of DNA
around the histone octamer.
Klf4 recognizes the nonameric DNA motif using all three C2H2-type ZFs
(three nucleotides per ZF) located at the C terminus (Schuetz et al., 2011)
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(Figure 2.4F). However, we identified a hexameric motif, lacking the last three
nucleotides, enriched within nucleosomal targets (Figure 2.4F, 90%). Mutagenic
studies have shown that the hexameric motif represents the minimal essential
binding site for Klf4 (Shields and Yang, 1998). Recently, X-ray crystallography
has revealed the structures of Klf4 bound to the hexameric and nonameric sites
(Schuetz et al., 2011) (Figure 2.4I). Klf4 uses its two most C-terminal ZFs, out of
the three, to recognize the hexameric motif, occupying one side of the DNA
double helix (595 Å2) and leaving more than half of the opposite surface
potentially free to interact with histones in a nucleosome (Figure 2.4I, red dashed
arrow in upper-right panel). Klf4 bound to the nonameric motif, with all three ZFs,
fills up more than half of the DNA surface (847 Å2) and would hinder binding to
nucleosomes (Figure 2.4I, red dashed arrow in lower-right panel). This analysis
suggests that Klf4 employs two of its three ZFs to engage nucleosomes.
Interestingly, the observed adaptability of O, S, and K to recognize partial motifs
correlates with the apparent flexibility of their respective DBDs that we modeled
during their transition from the DNA-free to the DNA-bound states (Figures
2.S5B–2.S5G).

c-Myc Recognizes a Partial Motif Enriched on Nucleosomes through CoBinding with Other Factors
Using the partitioning method in Figures 2.4A–2.4C, a subset of c-Myc
targeted sites (33%, n = 5,494) were enriched for nucleosomal DNA, while the
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majority of sites (77%, n = 18,391) did not exhibit enrichment (Figure 2.5A). Motif
analysis revealed that c-Myc nucleosomal targets were enriched for an E-box
motif that is missing the two central nucleotides (CANNTG) compared to the
canonical E-box (CACGTG) (Figure 2.5B, double arrowheads in top panel).
However, nucleosome-depleted targets were enriched for a less degenerate Ebox motif that we and others have previously reported to be associated with cMyc binding at enhancers (Lin et al., 2012; Nie et al., 2012; Soufi et al., 2012)
(Figure 2.5B, single arrowhead in bottom panel). Interestingly, c-Myc-alone (i.e.,
without OSK) nucleosomal targets were additionally enriched for a homeobox
(73%) motif that is highly similar to the POUHD motif, compared to nucleosomedepleted sites (48%) (Figure 2.5C). Likewise, the majority of c-Myc sites that cotargeted with Oct4 (76%, n = 2,219) that are enriched for nucleosomes contain
centrally a degenerate E-box motif similar to that identified in nucleosomal c-Mycalone targets (Figures 2.5D and 2.5E). The separate halves of the POU motif
were also enriched at the OM targeted sites, indicating that Oct4 uses one or the
other DBD while co-binding with c-Myc (Figure 2.5F). In conclusion, c-Myc
targets nucleosomal sites either with O, S, K, or with endogenous homeodomain
factors, recognizing a centrally degenerate E-box motif.
The basic region of bHLH domain, not bound to DNA, appears to be
unfolded in solution (Sauve et al., 2004) (Figure 2.6A; Figure 2.S6A). Upon DNA
binding, the basic region folds as an extension of helix-1 and will be referred to
as basic-helix-1 (bH) (Nair and Burley, 2003) (Figures 2.6D and 2.S6B, blue
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helices). Notably, the most conserved four nucleotides of the E-box (CANNTG)
face toward the interaction interface between bHLH and DNA, while the
degenerate central two nucleotides (CANNTG) face the exterior part of the DNA
helix (Figure 2.6B, see cyan and magenta arrowheads). The transition between
DNA free and DNA bound by molecular morphing indicates that the bH follows a
gradual folding trajectory across the major groove of DNA (Figures 2.6A–2.6D
and 2.S6B). The interaction between a partially folded bHLH and the CANNTG
drives the initial recognition of the E-box without making contacts with the central
nucleotides (NN), resulting in the centrally degenerate E-box motif that we
observed for c-Myc at the nucleosome-enriched sites (Figure 2.6B).
Importantly, the partially folded c-Myc only occupies one-half the DNA
helix surface, leaving the other half solvent-exposed and potentially nucleosome
compatible (Figure 2.6B, red dashed arrow). Apparently, the partially folded cMyc-DNA complex requires further assistance from other factors such as Oct4 or
other homeodomain-containing proteins to remain associated with DNA. The
interaction between a partially folded bHLH and a centrally degenerate E-Box
motif has been observed by X-ray crystallography for Mitf, which shares 86%
sequence homology across the basic region with c-Myc (Figure 2.S6C)
(Pogenberg et al., 2012). Once fully folded, the c-Myc bHLH adopts a rigid
structure, stabilizing DNA binding and resulting in less-degenerate E-box motif,
which would be incompatible with nucleosomes (Figure 2.6D). We conclude that
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partially unfolded c-Myc targets a centrally degenerate E-box motif, thereby
adapting to a nucleosome template when assisted by other factors.

Predicting

Pioneer

Activity

among

Different

bHLH

Factors

in

Reprogramming
To gain insights on how bHLH proteins may differentially target
nucleosomes in reprogramming, we examined the 3D structures of a range of
bHLH-DNA complexes that have been used in reprogramming experiments (El
Omari et al., 2013; Longo et al., 2008; Ma et al., 1994). Interestingly, the basic
helix-1 from the different bHLH domains extends across the DNA helix to variable
extents (Figures 2.6E–2.6I). Motif analysis was also carried out on genomic sites
bound by these factors from available ChIP-seq data. Notably, in conjunction with
our findings on c-Myc, the length of the bH α helix negatively correlates with the
degeneracy of the central nucleotides (CANNTG) of the de novo motifs that we
identified for each factor (Figures 2.6E–2.6I).
To further test this correlation, we examined the recent findings that the
bHLH factor Ascl1 can act as a pioneer factor during reprogramming fibroblasts
to neurons(Wapinski et al., 2013). We measured nucleosome enrichment in preinduced mouse embryonic fibroblasts (MEF) within Ascl1 initial targets in MEFs
after 48 hr induction (Teif et al., 2012; Wapinski et al., 2013). Unlike c-Myc, the
majority of Ascl1 sites (73%, n = 3,019) were enriched for nucleosomes (Figure
2.S6D). Importantly, the basic helix-1 of Ascl1 is considerably shorter compared
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to that of c-Myc, leaving more of the DNA surface solvent exposed (Figure 2.6E).
Similar to c-Myc, Ascl1 target nucleosomes were enriched (99.3%) for an E-box
motif with degenerate central two nucleotides (CANNTG) compared to the E-box
seen in 98.7% of sites depleted from nucleosomes (Figure 2.S6E). Ascl1
nucleosomal targets contain an extra “G” nucleotide at the 3′-end of the E-box
motif, which is missing in the nucleosome-depleted sites, resulting in more
specific targeting of nucleosomes despite the centrally degenerate E-box
(Figures 2.6E and 2.S6E).
Ascl1 and Olig2 exhibited the shortest bH regions, by molecular modeling,
compared to X-ray crystals of NeuroD, MyoD, and Tal1, with longer bHs. To
verify that the observed bH lengths were not due to the methodology, we
examined the amino-acid composition of the basic regions in all bHLH factors
(Figure 2.6J). The bH-DNA interaction is mainly driven by positively charged
residues (and hence the name basic). Interestingly, the Ascl1 bH ends at the last
(N-terminal end) basic residue (arginine), which is positioned further upstream
(toward the C terminus) compared to the other factors (Figures 2.6J and 2.6R,
residues in blue boxes). The last basic residue of Olig2-bH falls in between Ascl1
and the rest of the factors. In conclusion, the basic helix-1 of pioneer bHLH
factors such as Ascl1 is intrinsically shorter, allowing the factors to bind
nucleosomes more efficiently.
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2.6 Discussion
The introduction of a defined set of TFs, such as OSKM, into differentiated
cells can result in cell-fate conversion (Takahashi and Yamanaka, 2006), and yet
it has been clear that the different factors have different contributions or
“strengths” in cell-type conversion. This provided the basis for our effort to tackle
the long-standing problem of how TFs initially target their sites in closed
chromatin. The pioneer factor theory partly answers this question by suggesting
that a select group of TFs, such as FoxA, access closed chromatin by a direct
interaction with nucleosomal DNA through a DBD that resembles the structure of
a linker histone (Iwafuchi-Doi and Zaret, 2014; Zaret and Carroll, 2011). We
previously found that the diverse set of DBDs exhibited by O, S, K, and M, which
are structurally different from a linker histone, have differential abilities to access
closed chromatin (Soufi et al., 2012). Here, we revealed that the relative
tendencies of O, S, K, and M to initially target nucleosomal sites in
reprogramming reflect their inherent ability to bind nucleosomes in vitro and their
ability to recognize partial motifs on nucleosomes in vivo. This is different from
what was observed for FoxA1, which recognizes the same motif on free DNA and
nucleosomes (Cirillo et al., 1998; Li et al., 2011). Factors that cannot bind
nucleosomes on their own, such as c-Myc, associate with other factors to target
degenerate E-boxes on nucleosomes. Our new approach is in contrast to the
previous predictions of pioneer factors by fitting fully folded DBDs, in their naked
DNA-bound state, on nucleosomes through a docking mechanism.
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We found that the bipartite POU domain of Oct4 can target partial motifs
exposed on nucleosomes using separate PouS or PouHD domains. The single
motif targeted by each domain is longer than each half of the octamer motif, thus
providing greater binding specificity than a half motif. In addition, mass
spectroscopy analysis has identified histones as interacting partners of Oct4 in
mouse ES cells (Pardo et al., 2010), indicating an additional affinity contribution
by protein-histone interactions. The bipartite domain-Pax family of TFs can bind
DNA using both domains and still occupy half of the DNA surface and would
therefore be compatible with nucleosome binding (Garvie et al., 2001; Xu et al.,
1999) (Figure 2.S7, right, compared to POU TFs). This agrees with the finding
that Pax7 is a pioneer factor that uses full motif recognition during initial targeting
(Budry et al., 2012). Thus, bipartite TFs have to either employ one DBD or
position both DBDs on the same surface of DNA in order to interact with
nucleosomes. Notably, the pioneer activity of a Zebrafish homolog of an Oct
protein was observed during the maternal-to-zygote transition (Lee et al., 2013;
Leichsenring et al., 2013), suggesting that targeting nucleosomal sites may be a
general method for de novo programming of the genome.
The high affinity of Sox2 for nucleosomes may be due to the pre-bent
conformation of DNA, which widens the DNA minor groove and favors initial
minor groove sensing. While bending naked DNA by Sox2 requires minimal work
(Privalov, 2009), the energy cost would impede Sox2 to further bend DNA on
nucleosomes. We find that Sox2 would not further bend nucleosomal DNA
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because it recognizes a partial motif that diminishes the extreme bending of the
full motif. Sox family members share the recognition of the core motif but display
diverse preferences outside the core in naked DNA (Badis et al., 2009). Our
findings reveal greater flexibility with regard to Sox2 core motif preferences on
nucleosomes than was previously recognized. In addition, we showed evidence
for both specific and nonspecific binding by Sox2 in vitro and in vivo. The stable,
motif-driven targeting by Sox2 on nucleosomes in the ChIP-seq data show much
lower co-binding with Oct4 (Soufi et al., 2012) than seen in live imaging (Chen et
al., 2014), leaving open whether the latter approach depicts nucleosomal or free
DNA binding during genome scanning.
Klf4 showed higher affinity to free DNA compared to nucleosomes in vitro,
and its initial targets in vivo were enriched for nucleosomes, though less so than
compared to Oct4 and Sox2. Klf4 targets nucleosomes in vivo using two out of its
three zinc fingers, recognizing a hexameric motif. This explains how the affinity of
Klf4 to nucleosomes is lower than that to free DNA. The pioneer factor GATA4
binds nucleosomes modestly in vitro (Cirillo and Zaret, 1999a) and targets a
hexameric motif in vivo (Zheng et al., 2013). Notably, GATA4 only contains two
zinc fingers. The Gils zinc finger family 1 (Gli1) greatly enhances reprogramming
when co-expressed with OSK (Maekawa et al., 2011). Interestingly, despite
containing five ZFs, Glis1 only employs two ZFs (number four and five) to
recognize its targets (Pavletich and Pabo, 1993). The repressor ZFP57/Kap1,
which is known to be associated with closed chromatin, also recognizes a
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hexameric motif despite containing an array of seven zinc fingers (Quenneville et
al., 2011). This suggests that zinc finger proteins in general may use two zinc
fingers to initially target hexameric motifs exposed on nucleosomes. Klf4 also
showed non-specific interactions with nucleosomes, suggesting a similar genome
searching mechanism as Sox2.
Various examples have been reported on the overexpression of bHLH
factors in cancer, including c-Myc, Tal1, and Olig2 (Lin et al., 2012; Nie et al.,
2012; Palii et al., 2011; Sanda et al., 2012; Suva et al., 2014). In all of these
cases, the bHLH factors have been associated with degenerate E-box motifs and
co-binding with other factors. We propose that the extent to which basic helix-1
lays on DNA and co-binds with pioneer factors is reflected in the recognized
motif, predicting bHLH ability to bind nucleosomes and access closed chromatin.
Interestingly, the mutation of two amino acids within the basic helix-1 that
interacts with central E-box makes the non-myogenic bHLH factor E12 able to
convert fibroblasts to muscle cells (Davis and Weintraub, 1992). The
homeodomain factor PBX primes MyoD targets to induce myogenic potential
(Maves et al., 2007). Furthermore, the hematopoietic TAL1-E45 heterodimer
employs one of the two bHLH domains using LMO2 as an adaptor to interact with
GATA1 (El Omari et al., 2013). Hence, in addition to their intrinsic structures,
bHLH factors co-binding with DNA-binding and non-DNA binding proteins appear
to be involved in stabilizing the interaction of the partially folded bHLH factors to
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nucleosomes. These features are relevant to the multitude of bHLH factors
functioning in development, cancer, and reprogramming experiments.
The differential ability of TFs to recognize their target sites on
nucleosomes supports a hierarchical model where pioneer factors are the first to
gain access to their targets in silent chromatin. We also observe that the initial
targeting can occur for non-pioneer proteins when they bind in conjunction with
pioneer factors that allow the former to recognize their DBDs to a reduced motif
that is compatible with nucleosome binding. Further studies are needed to
understand the secondary events that lead to subsequent changes in local
chromatin structure and the formation of large complexes at gene regulatory
sequences. By understanding the mechanistic basis by which certain
transcription factors are especially capable of initiating cell-fate changes, we
hope to modulate the process and ultimately control cell fates at will.
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2.7 Main Figures

Figure 2.1 | Oct4, Sox2, Klf4, and c-Myc Display Differential Affinity to
Nucleosomes In Vitro
(A) Recombinant purified mammalian and bacterial O, S, K, M, and bacterial Max
(X) proteins analyzed by SDS-PAGE and Coomassie staining. The respective
OSKMX bands run at the expected sizes when compared to the sizes of protein
standards. The OSKM DNA binding activity and specificity are shown in Figures
2.S1A–2.S1C.
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(B) O, S, K, and M ChIP-seq profiles (blue, red, orange, and green, respectively)
48 hr post-induction and MNase-seq profile (black) in fibroblasts across the
LIN28B locus within the displayed genomic location.
(C) DNase I footprinting showing the protection of LIN28B-DNA before and after
nucleosome reconstitution in vitro. Electropherograms of 5′-6FAM end-labeled
LIN28B (top strand) oligonucleotides generated by digesting free DNA (blue) and
nucleosomal DNA (red) with DNase I. The amount of DNase I used is indicated
on top of each panel. Shaded boxes represent the DNase-I-protected regions
within LIN28B-nuc in the expected ∼10-bp pattern. See Figure 2.S1D for details
about nucleosome reconstitution.
(D) Representative EMSA showing the affinity of increasing amounts of
recombinant O, S, K, and M proteins (bact. top panels and mamm. bottom
panels) to Cy5-labeled LIN28B-DNA (left panels) and LIN28B-nucleosome (right
panels). EMSA of O, S, K, and M to DNA probes containing specific and nonspecific targets are shown in Figures 2.S1B and 2.S1C.
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Figure 2.2 | The Contribution of Non-Specific Binding to Nucleosome
Targeting In Vitro
(A) Representative EMSA showing the affinity of recombinant O, S, K, and M
proteins (bact. top panels and mamm. bottom panels) to LIN28B-DNA (left
50

panels) and LIN28B-nucleosome (right panels) in the presence of 40-fold molar
excess of specific competitor (“s” lanes) or non-specific competitor (“n” lanes) or
absence of competitor (“-“ lanes). Competition assays showing the specificity of
O, S, K, and M to their canonical DNA probes and to LIN28B DNA and
nucleosome under lower titration of competitor are shown in Figure 2.S2.
(B) DNase I footprinting showing the protection of LIN28B-DNA (left panels) and
LIN28B-nuc (right panels) in the absence (blue lines) or presence (red lines) of
O, S, K, and M. Electropherograms of 5′-6FAM end-labeled LIN28B (top strand)
oligonucleotides generated by DNase I digestion of DNA (0.006 U) and
nucleosomal DNA (0.06 U). Dashed boxes and stars represent specific and nonspecific sites protected by O, S, K, and M, respectively.
(C) A cartoon representation of the 162-bp LIN28B DNA (left) and nucleosome
(right) highlighting the binding sites of O, S, K, and M in vitro in blue, red, orange,
and green, respectively, as measured by DNase I footprinting. The protected
DNA sequences are indicated.
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Figure 2.3 | Oct4, Sox2, Klf4, and c-Myc Display a Range of Nucleosome
Targeting In Vivo
(A) Read density heatmaps (in color scales) showing the intensity of O, S, K, and
M ChIP-seq signal (blue) and MNase-seq (red) spanning ±1 kb from the center of
the O, S, K, and M peaks where each factor binds alone within 500-bp threshold.
The analyzed sequences were organized in rank order, from high to low number
ChIP-seq reads within the central 200 bp (double arrows). The number of
targeted sites is indicated.
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(B) As in (A), but showing where the OS, OK, and OM factors peaks are within
100 bp or less apart from each other. The full possible OSKM combinations are
shown in Figure 2.S3.
(C) The binding affinity of S, K, and M (1 nM) in the presence of Oct4 (0.3 nM) to
LIN28B nucleosomal DNA (lanes 4, 6, and 8, respectively) or absence of Oct4
(lanes 3, 5, and 7). The binding of Oct4 on its own (lane 2) and free LIN28B
nucleosomes (lane 1) are indicated. The histone content of the nucleosome
bound complexes is shown in Figure 2.S4.
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Figure 2.4 | Oct4, Sox2, and Klf4 Recognize Partial Motifs on Nucleosomes
(A–C) Same as in Figure 2.3A, but the sites were organized in a descending rank
order according to the MNase-seq tags within the central 200 bp. The
nucleosome-enriched sites were separated from the nucleosome-depleted sites
(dashed line) for each factor.
(D–F) Logo representations of de novo motifs identified in the O, S, and K
nucleosome-enriched targets (top) and nucleosome-depleted targets (bottom).
The motifs were aligned to canonical motifs (middle). The number of targets
analyzed and percentage of motif enrichments are indicated.
(G–I) Cartoon representations of the 3D structures of O (PDB-3L1P), S (PDB1GT0), and K (PDBs-2WBS and 2WBU) DBDs in complexes with DNA
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containing canonical motifs. Side and top views are shown for O and K, and
dashed curved arrows are shown to represent the extent of exposed DNA
surface (G and I). The 3D structure of the less distorted DNA (top) and
extensively distorted DNA (bottom) were superimposed on nucleosomal DNA
(PDB-3LZ0, gray) to display the extent Sox2-nucleosome binding compatibility by
measuring RMSD of the fit.
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Figure 2.5 | c-Myc Recognition of Degenerate E-Box on Nucleosome Is
Assisted by Binding with Co-Factors
(A–F) Same as shown in Figures 2.4A–2.4F, but for c-Myc alone and OM targets.
(C) The enrichment of an associated motif (HD) is measured within c-Myc alone
targets containing or depleted from nucleosomes. The data indicate that c-Myc is
driven to a degenerate E-box on nucleosomes, in part, by homeodomain factors
∗∗p < 0.001.
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Figure 2.6 | The Folding Extent of bHLH Basic Helix-1 on DNA AntiCorrelates with Targeting Centrally Degenerate E-Box Motifs on
Nucleosomes
(A–D) The folding trajectory of basic helix-1 of c-Myc upon DNA binding showing
the possible conformations of c-Myc:Max heterodimers (B and C) that are
compatible with nucleosome binding. See Figure 2.S6A for c-Myc Morph. The
initial DNA-free state (A) and the fully folded DNA-bound state (D), which is
incompatible with nucleosome binding, are indicated. The associated motifs for
each c-Myc:Max conformation are shown in the left. See Figure 2.S6B for Mitf
structure in complexes with E-box with variable central nucleotides.
(E–I) Cartoon representations of various bHLH reprogramming factors in
complexes with DNA containing their canonical motifs (right). The de novo motifs
identified for each factor from ChIP-seq data are indicated (left). The cyan and
pink arrows represent the position of the exposed nucleotides within the central
E-box motif not making base-contacts with the relative bHLH conformation. The
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central two nucleotides (CANNTG) are colored in purple in the DNA cartoon. The
color scheme of the bHLH along with leucine zipper (LZ) is shown at the bottom.
(J) Alignment of amino-acid sequences of the basic region of Ascl1, Olig2,
NeuroD, MyoD, Tal1, and c-Myc. The last basic residue at the C-terminal end is
highlighted in blue. See Figures 2.S6D and 2.S6E for MNase enrichment and
motif analysis of Asl1.
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2.8 Supplemental Figures
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Figure 2.S1 | Recombinant Oct4, Sox2, Klf4, and c-Myc Show Specific DNABinding Activities In Vitro, Related to Figure 2.1
(A) Schematic diagram showing the DNA-binding domains organization of the
full-length Oct4, Sox2, Klf4, c-Myc and Max (O, S, K, M and X) proteins. The
number of amino acids is indicated.
(B) Representative EMSAs showing the affinity of increasing amounts of
recombinant bacterial (bact.) and mammalian (mamm.) –expressed O, S, K, and
M proteins to Cy5-labeled DNA probes containing their respective canonical
binding sites. The concentrations used for each protein (nM) are indicated above
each lane. Lanes are numbered underneath each gel. Black arrows indicate the
migration of Free DNA and DNA-protein complexes. DNA sequences of the Cy5labeled probes are shown in the Extended Experimental Procedures.
(C) Same as in (B) but showing EMSAs with DNA probes containing non-specific
sequences for each protein.
(D) SDS-PAGE and coomassie staining showing the homogeneity of the
recombinant human histones (H2A, H2B, H3, and H4) purified from bacteria
under denaturing conditions (left panel) and then refolded to H2A/H2B dimers
and H3/H4 tetramers (middle-panel). EMSA (right panel) showing free Cy5labeled LIN28B DNA and Cy5-labeled LIN28B DNA assembled to nucleosomes
in vitro by salt gradient dilution with the refolded H2A/H2B dimers and H3/H4
tetramers. LIN28B DNA was generated by PCR using the primers shown in
Extended Experimental Procedures. DNA was visualized using EthidiumBromide staining (Et-Br) and Cy5 fluorescence (Cy5) as indicated underneath
each gel in the right panel. The sizes of protein standards in kDa and DNA
standards in bp are shown.
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Figure 2.S2 | Recombinant Oct4, Sox2, Klf4, and c-Myc Show a Range of
Specificity to Free DNA versus Nucleosomal DNA In Vitro, Related to Figure
2.2
(A) Representative EMSA showing the affinity of recombinant bact. O, S, K, M-X
and X proteins (1 nM) to Cy5-labeled probes (2 nM) containing canonical sites in
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the presence of 40 fold molar excess of specific non-labeled competitor (s) or
non-specific non-labeled competitor (n) or absence of competitor (-).
(B–E) Representative EMSAs showing the affinity of recombinant O, S, K, and M
proteins (bact. top panels and mamm. bottom panels) (1 nM) to Cy5-labeled
LIN28B free DNA (lanes 1–8) and Cy5-labeled LIN28B nucleosomal (nuc.) DNA
(lanes 9–16) (2 nM) in the presence of 5, 10 and 20-fold molar excess of nonlabeled specific competitor (s) (lanes 3–5 and 11–13) or non-labeled non-specific
competitor (n) (lanes 6—8 and 14—16) or absence of competitor (-) (lanes 2 and
10). Concentrations of competitors in nM are indicated above each lane. Lanes
are numbered underneath each gel. Full black arrow heads indicate free and TFbound LIN28B-DNA, and white arrow heads indicate free and TF-bound LIN28B
nucleosomal DNA. Brown boxes show Klf4-LIN28B-nucleosome complexes
under prolonged exposure.
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Figure 2.S3 | Oct4, Sox2, Klf4, and c-Myc Show a Range of Affinity and
Specificity to Nucleosomes In Vivo, Related to Figure 2.3
(A) The O, S, K, and M ChIP-seq peaks at 48 hr post induction in human
fibroblasts were called using different FDR thresholds to show the extent of nonspecific DNA binding for each factor in vivo. The plots are color coded as
indicated.
(B) Nucleosome enrichment as measured by MNase-seq in human fibroblasts
within regions bound by O, S, K, and/or M combinations at 48 hr post induction in
fibroblast.
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The bottom and top of the box represent the 25th and 75th percentile and the
middle band is the 50th percentile of the MNase-seq value; whisker ends
represent the min and max values. Outlier values are eliminated.
(C–M) Read density heatmaps (top panels) in red color scale (0—20) showing
the intensity of MNase-seq tags, spanning ± 1 kb from the center of the O, S, K,
and/or M peaks where the factors bind within 100 bp or less from each other. The
number of targeted sites is indicated above. Metaplots (bottom panels) showing
the average nucleosome enrichment (MNase-seq tags) within the same O, S, K,
and/or M sites shown above but separated into TSS-proximal (red) and TSSdistal groups (blue). Sites that were within 1 kb to the nearest TSS were
considered proximal, while sites that were more than 1 kb away from the nearest
TSS were considered distal.
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Figure 2.S4 | Oct4, Sox2, Klf4, and c-Myc Bind to Nucleosome Containing
H2A and H3 Histones, Related to Figure 2.3
Representative EMSAs showing the binding of Oct4 (1 nM) on its own and in
combination with Sox2, Klf4, and c-Myc-Max (3 nM) (left panels). The proteins
from EMSA were transferred onto a PVDF membrane (WEMSA) and blotted for
H3, H2B, Oct4, and/or Sox2, Klf4 and Myc as indicated (the three panels on the
right). Black arrow heads indicate the observed TF-nucleosome complexes.
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Figure 2.S5 | The Apparent Flexibility of Oct4, Sox2, Klf4, and c-Myc DBDs
Correlate with Their Nucleosome Binding Compatibility, Related to Figure
2.4
(A) DNase-I footprinting showing the protection of LIN28B-DNA in the absence
(blue lines) or presence (red lines) of Klf4. Electropherograms of 5′-6FAM endlabeled LIN28B oligonucleotides generated by DNase-I digestion of DNA (0.006
U) of the top-strand (top panel) or the bottom-strand (bottom panel). Dashed
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boxes represent specific sites protected by Klf4 and the corresponding sequence
is indicated underneath.
(B, C, and D) Cartoon representation showing the three dimensional structures of
O, S, and K free of DNA as determined by NMR. All the NMR-determined 3D
states are aligned and shown by transparent colors to indicate the measured
flexibility of the free DBDs. The PDB ids of each structure are indicated.
(E, F, and G) The gradual transition of O, S, and K DBDs from DNA-free to DNAbound was measured by morphing (Extended Experimental Procedures). Arrows
and color transparency indicate the extent of the apparent flexibility of each DBD.
The used color scheme is shown at the bottom.
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Figure 2.S6 | The HLH Factors Compatibility with Nucleosomes Correlates
with Central Degenerate E-Box Motif, Related to Figures 2.5 and 2.6
(A) Same as Figure 2.S5 (B, C, and D) for Myc-Max bHLH hetero dimer not
bound to DNA.
(B) Same as Figure 2.S5 (E, F, and G) for the transition of Myc-Max bHLH from
DNA-free to DNA-bound states.
(C) Pair-wise sequence alignment (left panel) of the basic region of Mitf and cMyc showing identical amino-acids (∗) and highly similar amino acids (:, .).
Cartoon representations of Mitf bHLH in complexes with DNA containing the
canonical E-box motif (middle panel) and centrally degenerate E-box (right
panel). The motifs bound and PDB ids are indicated above. The cyan and pink
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arrows represent the position of the exposed nucleotides within the central E-box
motif not making base-contacts with the relative bHLH conformation. The central
two nucleotides (CANNTG) are colored in purple in the DNA cartoon. The color
scheme of the bHLH along with leucine zipper (LZ) is shown at the bottom.
(D) Read density heatmaps (in color scales) showing the intensity of Ascl1 ChIPseq signal (blue) 48 hr post induction in MEFs and MNase-seq (red) in noninduced MEFs spanning ± 1 kb from the center of the Ascl1 peaks. The analyzed
sequences were organized in a descending rank order according to the MNaseseq tags within the central 200 bp (double arrows). The number of targeted sites
is indicated. The nucleosome enriched sites were separated from the
nucleosome depleted sites (dashed line).
(E) Logo representations of de novo motifs identified in Asl1 nucleosomeenriched targets (top) and nucleosome-depleted targets (bottom). The motifs
were aligned to canonical motifs (middle). The number of targets analyzed and
percentage of motif enrichments are indicated.

69

Figure 2.S7 | Nucleosome Binding Compatibility of Bipartite DBDs, Related
to Figure 2.6
(A) Cartoon representations of the 3-D crystal structures of the Pou domains
(blue) of Oct4 and Brn5 in complexes with DNA (red) containing canonical motifs.
Side and top views are shown and dashed curved arrows are shown to represent
the extent of exposed DNA surface. The PDB ids are indicated.
(B) Same as (A) for the Paired domains of Pax5 and Pax6.
(C) Cartoon representation (left panel) showing the three dimensional structures
of the bipartite paired (PRD and HD) domain of Pax8 free of DNA as determined
by NMR. All the NMR-determined 3D states are aligned and shown by
transparent colors to indicate the measured flexibility of the free DBD. The
gradual transition of the paired domain from DNA-free to DNA-bound was
measured by morphing (Extended Experimental Procedures). Color transparency
indicates the extent of the apparent flexibility. The motif recognized by the paired
domains is shown above. The color scheme is shown at the bottom.
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2.9 Supplemental Tables
Oct4

Sox2

Klf4

c-Myc

Apparent KD (nM)

bact. mamm. bact. mamm. bact. mamm. bact. mamm.

Total canonical

0.61

0.64

0.37

0.98

2.49

1.46

1.88

ND

Specific canonical

0.76

1.04

0.45

1.50

3.18

1.95

0.77

ND

Total LIN28B DNA

0.75

0.93

0.38

1.46

1.25

0.41

8.28

ND

Specific LIN28B DNA 0.92

2.05

0.68

3.83

2.26

1.12

6.25

ND

Total LIN28B nuc.

1.09

1.34

0.34

1.06

5.96

3.45

ND

ND

Specific LIN28B nuc. 1.17

1.84

0.39

1.43

7.21

13.97

ND

ND

Table 2.1 | Recombinant O, S, K, and M Show a Range of Affinities to
Nucleosomes
Apparent dissociation constants (KD) were derived from EMSA to represent the
relative affinities of bacterial (bact.) and mammalian (mamm.) O, S, K, and M to
their canonical sites, LIN28B-free DNA, and LIN28B nucleosomes (nuc.).
Apparent KD were derived from two separate binding curves representing two
experimental replicates, fitted to the experimental data within R2 values of ∼0.97,
and expressed in nM units. Apparent KD were quantified from the fractional
decrement of free DNA or nuc, designated as “total” binding, or from the first
bound-DNA/nuc complexes, representing “specific” binding. ND, not determined
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2.10 Materials and Methods

Protein Expression and Purification

The bacterial expression plasmids pET-28B-huOct4, pET-28B-huSox2,
pET-28B-huKlf4, and pET-28B-huMyc encode the human O, S, K, and M,
respectively, fused to an N-terminal 6X histidine tag. The O, S, K, and M cDNA
sequences were generated by PCR from the respective lentiviral constructs used
for generating human iPS cells (Hockemeyer et al., 2008), introducing a NotI and
EcoRI restriction sites for inserting into the pET-28B plasmid. The histidinetagged O, S, K, and M proteins were expressed in E. Coli Rosetta (DE3) pLysS
(Novagen # 70956-3). Transformed cells were grown at 37°C to a density of 0.5
at A600 nm and protein expression was induced by 0.5 mM IPTG for 4 hr for
Oct4, 2 hr for Sox2, and overnight for Klf4 and c-Myc at 30°C. The proteins were
purified over Hi-trap HP nickel-charged columns (GE healthcare # 17-5248-01)
under denaturing conditions. The purified proteins Oct4 and Sox2 were refolded
by initially dialyzing to 2 M Urea in 2 M increment gradients and then to 0 M Urea
using a desalting column (GE healthcare # 17-1408-01). The purified denatured
Klf4 was refolded by dialyzing to 2 M Urea in 2 M increment gradients and
refolded by diluting directly to 1 μM concentration in DNA binding buffer (10 mM
Tris-HCl pH 7.5, 1 mM MgCl2, 10 uM ZnCl2, 10 mM KCl, 1 mM DTT, 5%
glycerol,

0.5

mg/ml

BSA).

The

c-Myc:Max

heterodimer

complex

was

reconstituted as described previously (Farina et al., 2004). The recombinant
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human histones were expressed and purified as described previously (Tanaka et
al., 2004).
The mammalian expressed human O, S, K, and M recombinant proteins
were obtained from OriGene (Oct4 # TP311998, Sox2 # TP300757, Klf4 #
TP306691, c-Myc # TP301611). The DDK-tagged mammalian proteins were
expressed in HEK293 cells (human embryonic kidney cells) and purified under
native conditions using anti-DDK affinity column followed by conventional
chromatography steps.
Due to the presence of contaminants (Figure 2.1A), the mammalian
protein concentrations were calculated by quantifying the intensity of each of the
O,S,K,M bands running at the expected sizes in SDS-PAGE (without including
the contaminants) and comparing it with their respective bacterial counterparts;
the latter having been quantitated by direct protein measurements using
absorbance at 280 nM. To reduce error the band intensities were quantified
under variable concentrations.

Nucleosome Reconstitution

The 162-bp LIN28B DNA fragment was created by PCR with end-labeled
primers. The fluorescent-tagged DNA fragments were gel extracted and further
purified using ion-exchange liquid chromatography by MonoQ (GE Healthcare).
The nucleosomes were reconstituted by mixing purified human H2A/H2B dimers
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and H3/H4 tetramers with LIN28B-DNA at 1:1 molar ratio of histone
octamer:DNA using a salt-urea gradient.

The 162 bp LIN28B DNA fragment corresponds to the genomic location:

hg18-chr6:105,638,004-105,638,165
AGTGGTATTAACATATCCTCAGTGGTGAGTATTAACATGGAACTTACTCCAACAATACA
GATGCTGAATAAATGTAGTCTAAGTGAAGGAAGAAGGAAAGGTGGGAGCTGCCATCACT
CAGAATTGTCCAGCAGGGATTGTGCAAGCTTGTGAATAAAGACA
The DNA sequence was created by PCR with end-labeled primers (see
below for sequences). The 162 bp fluorescent-tagged DNA fragments were gel
extracted and further purified using ion-exchange liquid chromatography on a
Mono-Q column and 2 M salt step gradient. The nucleosomes were reconstituted
as described previously (Tanaka et al., 2004). Briefly, 10 μg of Cy5 or FAM end
labeled PCR fragment of LIN28B DNA was mixed with purified and refolded
H2A/H2B dimers and H3/H4 tetramers at a 1:1 DNA:Histone-octamer molar ratio
in 10 mM Tris-HCl pH8, 5 M Urea, 2 M NaCl, 1 mM EDTA, 0.1 mg/ml BSA. The
nucleosomes were assembled using salt-urea gradient by dialyzing against a
solution containing 2, 1.5, 1, 0.8, and then 0.6 M NaCl and 10 mM Tris–HCl pH
8.0, 5 M Urea, 1 mM EDTA, 10 mM 2-mercaptoethanol for 4 hr in each buffer at
4°C. The nucleosomes were then dialyzed against a no Urea buffer containing
0.6 M NaCl and 10 mM Tris–HCl pH 8.0, 1 mM EDTA, 1 mM 2-mercaptoethanol
and then the same buffer containing 0.1 M NaCl for 8 hr at 4°C. The
reconstituted nucleosomes were heat shifted by incubating at 37°C for 6 hr.
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DNA Binding Reactions

The end-labeled oligonucleotides containing specific or non-specific sites
(see below for sequences), LIN28B-DNA, and LIN28B-nucleosomes were
incubated with recombinant proteins in DNA-binding buffer (10 mM Tris-HCl
(pH7.5), 1 mM MgCl2, 10 μM ZnCl2, 1 mM DTT, 10 mM KCl, 0.5 mg/ml BSA, 5%
Glycerol) at room temperature for 60 min. Free and bound DNA were separated
on 4% non-denaturing polyacrylamide gels run in 0.5X Tris–borate–EDTA and
visualized using a PhosphorImager using Cy5 fluorescence setting (excitation at
633 nm and emission filter 670 BP 30) and high sensitivity setting. The apparent
dissociation constant (Kd) was calculated in two ways:

1.Total Kd was calculated to quantify the total affinity of each protein to DNA
accounting for both specific and non-specific binding by assuming that the
amount of nonspecific binding is linearly proportional to the concentration of
protein used. Total amount of DNA was quantified from Cy5 fluorescence of the
free DNA band at 0 nM protein concentration. The amount of free DNA at each
protein concentration was determined from the intensity of Cy5 fluorescence of
the free DNA bands using Multi-Gauge software (Fujifilm Science lab). The
fraction of bound DNA was calculated using the equation below:
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝐷𝑁𝐴-./0 = 1 −
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𝐷𝑁𝐴4566
𝐷𝑁𝐴7.789

Binding curves describing the fraction of bound DNA as a function of
protein concentration [TF] from two separate experiments were fitted to the data
using nonlinear regression in GraphPad Prism software (version 6.04 for
windows). The goodness of the fit was assessed using an R2 greater than 0.97.
The Kd for each protein was calculated using the equation below and fixing
Bmax to a maximum of 1where NS is the slope of nonspecific binding.

2.Specific Kd was calculated to quantify the specific affinity of each protein to
DNA not accounting for non-specific binding. The amount of free DNA and bound
DNA at each protein concentration was determined from the intensity of Cy5
fluorescence of the free DNA and the first DNA-TF complex bands using MultiGauge software (Fujifilm Science lab). The fraction of bound DNA was calculated
using the equation below:
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝐷𝑁𝐴-.:/0 =

𝐷𝑁𝐴-.:/0
𝐷𝑁𝐴4566 + 𝐷𝑁𝐴-.:/0

Binding curves describing the fraction of bound DNA as a function of
protein concentration [TF] from two separate experiments were fitted to the data
using nonlinear regression in GraphPad Prism software (version 6.04 for
windows). The goodness of the fit was assessed using an R2 greater than 0.97.
The Kd for each protein, which is determined as the protein concentration at halfmaximum DNA binding was calculated using the equation below and fixing Bmax
to a maximum of 1.
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For competition assays excessive amounts (from 5 to 40 fold) of nonlabeled probes containing specific and non-specific sites were added to the
binding reaction and incubated for 60 min at room temperature to reach
equilibrium. The binding reactions were loaded on the 4% EMSA gels as
described above. EMSA gels were run at 80 V at room temperature. As specific
competitors, the following DNA probes were used: FGF4 promoter for Oct4 and
Sox2, LEFTY1 promoter for Klf4, and CDKN2D promoter for c-Myc. As nonspecific competitors the following DNA probes were used: NS for Oct4 and Sox2,
NANOG promoter for Klf4 and c-Myc. See below for the DNA probes sequence.

DNase Footprinting

DNase footprinting reactions were carried out by incubating the 6-FAM
end labeled LIN28B free (50 ng) in the presence or absence of the purified TFs
or histone octamers with 0.006 (DNA or DNA+TFs) or 0.06 (nuc. or nuc.+TFs)
unit of DNase-I (Worthington) in 50 μl DNA-binding buffer (10 mM Tris-HCl
(pH7.5), 1 mM MgCl2, 10 μM ZnCl2, 1 mM DTT, 10 mM KCl, 0.5 mg/ml BSA, 5%
Glycerol) supplemented with additional 50 μl 10 mM MgCl2 and 5 mM CaCl2 at
25°C for 1 min. The reaction was stopped by adding 90 μl (200 mM NaCl, 30 mM
EDTA, 1% SDS) and chilling on ice for 10 min. One tenth of reaction volume (∼20
μl) of 3 M NaOAc (pH 5.2) was added to the reaction before the DNA fragments
were extracted with Phenol–chloroform extraction. The DNA fragments were
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further purified using MinElute PCR purification kit (QIAGEN) and eluted in 10 μl
dH2O. The digested DNA fragments were separated by capillary electrophoresis
as described previously (Zianni et al., 2006). Briefly, the digested DNA fragments
(5 μl) were added to 4.9 μl HiDi formide (Applied Biosciences) and 0.1 μl
GeneScan-500 LIZ size standards (Applied Biosciences). After denaturing at
95°C for 10 min, the samples were run on an ABI 96-capillary 3730XL
Sequencer, using G5 dye setting, running a genotyping module with an
increased injection time of 30 s and injection voltage of 3 kV. The generated
electropherograms were analyzed using the peak scanner software (Applied
Biosciences) and PeakStudio V 2.2.

Western Blotting After EMSA (WEMSA)

The EMSA was carried out as described above with 10-fold more protein
and nucleosomes and run on a 1.5 mm thick mini-gel cassette (life technologies
# NC2015) containing 5% polyacrylamide gel. To avoid Cy5 fluorescence
saturation, 90% of the nucleosome used in binding reaction was not labeled. The
gel was then visualized using Cy5 fluorescence as described above. To charge
the proteins, the gel was incubated for 2 hr in denaturing buffer (1% SDS, 375
mM Tris-HCl pH 7.5) at 20°C. The proteins were transferred to a 0.22 μm SequiBlot PVDF membrane (Bio-Rad) using NuPAGE transfer buffer (life technologies
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# NP0006), supplemented with 0.1% SDS and 20% methanol for 1 hr at 100
Volts at 4°C.
The proteins were fixed to the membrane by incubating in 10% Glacial
Acetic Acid for 15 min at room temperature. The membranes were blocked with
PBS-0.1% Tween containing 10% non-fat dry milk overnight at 4°C. The primary
antibody incubations with anti-human Oct4 antibody (0.5 μg/ml; Abcam #
ab19857), human Sox2 antibody (1 μg/ml; R&D systems # AF2018), human
KLF4 antibody (0.5 μg/ml; R&D systems # AF3640), human c-Myc antibody (1
μg/ml; R&D systems # AF3696), anti-human H3 (0.5 μg/ml; abcam # ab1791),
and anti-human H2B (0.8 μg/ml; abcam # ab1790) were performed for 2 hr at
room temperature. The secondary antibody incubations with goat anti-rabbit IgGHRP (1:5000 dilution; Santa Cruz # sc-2004) and donkey anti- goat IgG-HRP
(1:2000; Santa Cruz # sc-2020) were performed for 1 hr at room temperature.
Blots were visualized by using SuperSignal West Pico chemiluminescent
substrate (Thermo-Scientific # 34080) in Fujifilm LAS-4000 imaging system. The
membranes were stripped by incubating with Restore Western-Blot Plus
Stripping Buffer (Thermo-Scientifc # 46430) for 30 min at RT and re-blocked after
blotting with each antibody. The same membrane was serially blotted and
stripped with all antibodies shown.
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Genomic Data Analysis

The O, S, K, and M ChIP-seq aligned data along with the called peaks
(FDR-controlled at 0.005) were obtained from the GEO database (GSE36570)
(Soufi et al., 2012). The MNase-seq data (GSM543311) (Kelly et al., 2012) were
aligned to build version NCBI36/HG18 of the human genome and seven
replicates were pooled together generating 145,546,004.00 unique reads. The
MNase-seq reads were extended to 150 bp to cover one nucleosome and thus
resulting in 6.6 fold genome coverage.
To identify regions bound by single factors, we separated peaks if their
centers were at least 500 bp apart from each other. Sites bound by all possible
OSKM combinations were merged if their peak centers were within 100 bp or
less from each other. Regions spanning 1 kb upstream and downstream from the
center of the curated peaks were divided into 10 bp bins (n = 200). Tag counts
from O, S, K, and M ChIP-seq and MNase-seq were assigned to each
corresponding bin and used as a measure for enrichment. The curated genomic
locations were organized in ascending rank-order according to the tag counts
from the central 20 bins (200 bp) as described in the text. Sites were considered
to be nucleosome-depleted if their central 200 bp tag counts were smaller than
that of the average 200 bp flanking regions (ratio < 1).
bHLH factors ChIP-seq data were obtained from GEO with the accession
code GSE43916 for Ascl1 (Wapinski et al., 2013), GSM1167583 for Tal1,
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GSM1167584

for

Mitf

(Calero-Nieto

et

al.,

2014),

GSM1306365

and

GSM1306367 for Olig2 (Suva et al., 2014), GSM751036 for NeuroD (Tennant et
al., 2013), and GSE50415 for MyoD (MacQuarrie et al., 2013). MNase-seq data
for MEFs were obtained from GSM1004654 (Teif et al., 2012). The ChIP-seq and
MNase-seq data for the above factors were processed as described for OSKM in
human fibroblasts. The mouse sequencing data were aligned to the Mouse
genome built mm9, accordingly.

Motif Analysis

For de novo motif discovery, we used Discriminative DNA Motif Discovery
algorithm (DREME) (Bailey, 2011). We focused on motifs occurring at the central
200 bp of O, S, or K peaks, using central motif enrichment analysis (CentriMo)
(Bailey and Machanick, 2012). We quantified the occurrences of the first hits that
returned with the most statistical significance within the O, S, K, and M sites
using Find Individual Motif Occurrences (FIMO) (Grant et al., 2011). Motifs that
showed most central enrichment were considered. Moreover, the newly
discovered motifs were compared to the JASPAR and UniPROBE motif
databases using the Motif comparison tool (TOMTOM)(Gupta et al., 2007;
Mathelier et al., 2014; Newburger and Bulyk, 2009). The above tools are part
MEME-ChIP

suit

v.4.9.1

(Machanick

http://meme.nbcr.net.
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and

Bailey,

2011),

available

at

Molecular Modeling

We have modeled the macromolecular motions that take place during the
initial recognition of O, S, K, and M DBDs to their binding sites using the MORPH
server as described previously (Krebs and Gerstein, 2000). Briefly, we used the
DNA-free structures of O, S, K, and Myc:Max DBDs as the initial state and the
DNA-DBDs complexes structures as the final state (see below for PDB ids used).
Based on adiabatic mapping, the possible states accommodating the
conformational space between free and bound states were calculated within the
energy barriers constraints. By defining a set of hinges, the protein motion
describing the rigid-body rotation of a small part “core” in relation to a larger part
was directly linked protein flexibility. DNA flexibility was not accounted for in our
molecular dynamics. The DNA-free states of Oct4-POUS, Oct4-POUHD, Klf43ZFs, and c-Myc-bHLH were built based on their sequence homology (92%,
85%, 93%, and 89%) to the experimental NMR structures of Oct1-POUS, Oct1POUHD, Klf5-3ZFs and Max-bHLH, respectively (PDBs: 1POU, 1POG, 2EBT,
and 1R05) (Assa-Munt et al., 1993; Sauve et al., 2004) using Modeler program
(Sali and Blundell, 1993). The DNA-free structure of Sox2-HMG has been solved
using NMR and submitted to the protein databank under the PDB id 2LE4. The
structures of DNA in complex with Oct4-POU, Sox2-HMG, Klf4-2ZFs, Klf4-3ZFs
and Myc:Max-bHLH (PDBs: 1GT0, 2WBS, 2WBU, and 1NKP) were solved using
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X-ray crystallography (Esch et al., 2013; Nair and Burley, 2003; Remenyi et al.,
2003; Schuetz et al., 2011). The Sox2-HMG N46Q mutant was modeled based
on its sequence homology (94%) to hSRY-HMG mutant (PDB: 1J47) (Murphy et
al., 2001) as described above. The DNA bound to Sox2 wt or Sox2 N46Q mt was
superimposed on the nucleosomal DNA obtained from PDB-3LZ0 (Vasudevan et
al., 2010) using the super command from Pymol (Version 1.5.0.1 Schrödinger,
LLC) and the RMSD was calculated using the rms_curr command between the
phosphate backbone carbon atoms. The DNA accessible surface area (ASA)
exposed to solvent was calculated from free-DNA or bound to Oct4-POUS, Oct4
POUHD, Oct4-POUS-HD, Klf4-2ZFs, and Klf4-3ZFs from the corresponding
crystal structures using areaimol from the CCP4 package (Lee and Richards,
1971).
The X-ray crystal structures of Mitf (4ATK, 4ATI), NeuroD (2QL2), MyoD
(1MDY), and Tal1 (2YPB) were obtained from the RCSB protein data bank (El
Omari et al., 2013; Longo et al., 2008; Ma et al., 1994; Pogenberg et al., 2012).
The Ascl1 and Olig2 structures were obtained from the SWISS-Model server
based on their sequence homology to NeuroD (2QL2) (Kiefer et al., 2009; Kopp
and Schwede, 2006). The images used in the figures were ray-traced and
created using the PyMOL molecular graphics system (Version 1.5.0.1
Schrödinger, LLC).
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DNA Binding Sites

The DNA oligonucleotides used as binding sites (top and lower strands)
are shown below. The Cy5 5′-end-labeled oligonucleotides were obtained from
IDT (Integrated DNA Technologies). The double stranded probes were generated
by annealing the single strands using the following reaction: 1 nano-moles of
each strand (10 μl of 100 μM) were mixed in 50 μl final volume annealing buffer
(20 mM Tris-HCl pH7.6, 50 mM NaCl, 0.1 mM DTT, 1 mM EDTA). The reaction
was incubated at 70°C for 10 min, and slowly cooled at room temperature
overnight.
name_TF
FGF4
NANOG
NS
lEFTY
CDKN2D

Upper Strand
TTTAAGTATCCCATTAGCATCCAAACAAAGAGTTTTC
CTTACAGCTTCTTTTGCATTACAATGTCCATGGTGGA
CTGCAGGTGGGATTAACTGTGAATTCA
GAGCTCCCAGGAGGTCCCAGGGGTGTGACCTCTCT
AGGAGCCTGCAGCTGCCACGTGGGAAGGCCTGAGAGGACATAGT

PCR Primers

The DNA oligonucleotides used as primers for PCR to generate the
LIN28B sequence (162 bp) from human genomic DNA are shown. The chemical
modifications at the end of each oligonucleotide are also shown. All the DNA
oligonucleotides were obtained from IDT (Integrated DNA Technologies).
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Sequence
Name

Modifications
Services

Bases Sequence

and

lin28B- FWD 27

AGT GGT ATT AAC ATA TCC Standard Desalting
TCA GTG GTG

Cy5-lin28BFWD

27

/5Cy5/AGT GGT ATT AAC 5′ Cy5 HPLC Purification
ATA TCC TCA GTG GTG

6-FAMlin28B-FWD

27

/56-FAM/AGT GGT ATT AAC 5′
6-FAM
ATA TCC TCA GTG GTG
Desalting

lin28B-RVS

25

TGT CTT TAT TCA CAA GCT Standard Desalting
TGC ACA A

Cy5-lin28BRVS

25

/5Cy5/TGT CTT TAT TCA 5′ Cy5 HPLC Purification
CAA GCT TGC ACA A

6-FAMlin28B-RVS

25

/56-FAM/TGT CTT TAT TCA 5′
6-FAM
CAA GCT TGC ACA A
Desalting
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Standard

Standard

CHAPTER 3: STRUCTURAL FEATURES OF TRANSCRIPTION
FACTORS ASSOCIATING WITH NUCLEOSOME BINDING

3.1 Preface
The manuscript presented in this chapter was originally published online
July 11th, 2019 in Molecular Cell, Volume 75 (Fernandez Garcia et al., 2019). It
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publically-available with this dissertation at:
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3.2 Respective Contributions
The majority of the experiments and analyses presented in this chapter
were designed and performed by myself, under the guidance of Dr. Kenneth S.
Zaret. I carried out genomic data analysis with the guidance of Greg Donahue
from

Dr.

Zaret’s

lab,

recombinant

protein

purifications,

nucleosome

reconstitutions, EMSAs, DNase footprinting experiment, mid-stage and final data
processing of protein microarray, and 3D protein structure modeling. Oscar
Alberto purified CEBPb DBD and mutants under my supervision. Dr. Katharine N.
Schulz purified ZELDA and consulted on ZLD-binding experiments. Cedric D.
Moore. carried out protein microarray experiments and initial data processing
collected. Dr. Kenneth S. Zaret supervised personnel, data interpretation, and
writing the manuscript, while Dr. Melissa M. Harrison, Dr. Cedric Moore, Dr.
Heng Zhu and Dr. Dario Nicetto provided comments to the manuscripts. The
manuscript was written by me, with the assistance of Dr. Zaret.
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3.3 Abstract
Fate-changing transcription factors (TFs) scan chromatin to initiate new
genetic programs during cell differentiation and reprogramming. Yet the protein
structure domains that allow TFs to target nucleosomal DNA remain unexplored.
We screened diverse TFs for binding to nucleosomes containing motif-enriched
sequences targeted by pioneer factors in vivo. FOXA1, OCT4, ASCL1/E12a,
PU1, CEBPa, and ZELDA display a range of nucleosome binding affinities that
correlate with their cell reprogramming potential. We further screened 593 fulllength human TFs on protein microarrays against different nucleosome
sequences, followed by confirmation in solution, to distinguish among factors that
bound nucleosomes, such as the neuronal AP-2a/b/g, versus factors that only
bound free DNA. Structural comparisons of DNA binding domains revealed that
efficient nucleosome binders use short anchoring a-helices to bind DNA,
whereas weak nucleosome binders use unstructured regions and/or b-sheets.
Thus, specific modes of DNA interaction allow nucleosome scanning that confers
pioneer activity to transcription factors.
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3.4 Introduction
Diverse genomic studies have established that a subset of fate-changing
transcription factors (TFs) can target nucleosomal sequences in chromatin, and
hence act as pioneer TFs (Heinz et al., 2010; Iwafuchi-Doi and Zaret, 2014; Li et
al., 2018; Wapinski et al., 2013). However, the principles that predict whether a
given TF may target sites on nucleosomal DNA are not clear. DNA sequences
containing clusters of TF binding sites at active enhancers and promoters that
were considered to be “nucleosome-free regions” have been shown to harbor
histones variants H3.3 and H2A.Z (de Dieuleveult et al., 2016; Jin et al., 2009),
histone modifications such as H3K4me1/2, H3K27Ac (Calo and Wysocka, 2013),
and exposed or "fragile" nucleosomes (Iwafuchi-Doi et al., 2016; Mieczkowski et
al., 2016). Still, the presence of a nucleosome can be refractory to TF binding
and transcriptional activity (Blomquist et al., 1996; Taylor et al., 1991). In this
study, we investigate the intrinsic nucleosome-binding properties of diverse TFs
to identify features that enable nucleosome binding.
We focused on TFs that drive cell differentiation and reprogramming.
Analysis of the pioneer factor FOXA, a winged helix factor required for liver
development (Lee et al., 2005), revealed that FOXA1 can bind its target
sequence on nucleosomes and induce local nucleosomal accessibility in vitro
(Cirillo et al., 2002; Cirillo and Zaret, 1999a). In vivo, FOXA1 can displace linker
histone to promote local chromatin opening and allow cooperative binding of
other TFs (Iwafuchi-Doi et al., 2016). Similar to FOXA, the hematopoietic factors
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PU1 and CEBPa target compacted chromatin and induce chromatin accessibility,
while CEBPa binding to nucleosome-enriched regions is more dependent on
PU.1 and EBF1 (Heinz et al., 2010; van Oevelen et al., 2015). EBF1 has also
been shown to bind compacted chromatin and induce lineage-specific chromatin
accessibility (Boller et al., 2016; Li et al., 2018).
Genomic assessment of the ectopic OCT4, SOX2, KLF4 (OSK) targeted
sites and nucleosome occupancy by MNase-seq on pre-existing chromatin
showed that OSK target partial motifs on nucleosomal DNA that mirrors their
relative nucleosome affinity in vitro. By contrast, c-MYC bind nucleosomes poorly
and localizes at its nucleosomal targets via cooperative interaction with other
factors (Soufi et al., 2015b). Thus, TFs show a differential preference for
nucleosomes and a hierarchy by which they enable cell fate changes. Yet the
structural basis for nucleosome motif targeting, apart from the inherent
adaptability of the DNA binding domains (DBDs) (Soufi et al., 2015b), remains
unclear.
While there are over 2,000 predicted human TFs (Messina et al., 2004;
Vaquerizas et al., 2009), only a fraction has been tested for nucleosome binding
(Haswell and O'Shea, 1999; Hayes, 1992; Liu and Kraus, 2017; Perlmann,
1988). Recently, an assessment of TF DBDs interacting with nucleosomes,
based on SELEX enrichment of bound populations in vitro, revealed diverse
binding behaviors as revealed by the positions of motifs at different targeted
positions across the nucleosome (Zhu et al., 2018). However, the study did not
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provide a direct quantitative assessment of free DNA vs. nucleosome binding
and left open the question of how protein structure relates to nucleosome
binding. Transcription factors can exhibit slow on-rates to nucleosomes, allowing
time for thermal motions to elicit motif exposure, which can be compensated by
slow off-rates, resulting in nucleosome binding in the nanomolar range of
dissociation constant (kD)

as seen for free DNA (Cirillo and Zaret, 1999b;

Donovan et al., 2019)
Protein microarrays are a powerful tool for high-throughput assessment of
intermolecular interactions (Chen et al., 2008; Hu et al., 2009). However,
interactions determined by solid-state methods may not truly reflect interactions
under physiological conditions (Sun et al., 2013) and sequence-specific binding
needs to be confirmed in solution. To gain a broader view of how TFs target
nucleosomes, we used a high-throughput protein microarray that contained 593
unique full-length human TFs, after filtering for technical accessibility, followed by
validation in-solution of the most significant interactors. Using in vitro
reconstituted nucleosomes with three different endogenous sequences enriched
in TF motifs, we find that TFs bind with a range of nucleosome binding affinities
that positively correlate with TF reprogramming potential. Notably, we find that
strong nucleosome binding is associated with an anchoring a-helix that interacts
with no more than half of the DNA’s circumference, leaving the opposite side of
DNA free to engage in histone interactions. These findings improve our ability to
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predict transcription factors that can directly scan and bind nucleosomes and
thus act as pioneer factors.

3.5 Results
Recombinant

Nucleosomes

from

Endogenous

Nucleosomal

Sequences Targeted by Pioneer TFs
To establish conditions for a large scale study of TFs that can directly
interact with nucleosomes, we selected seven TFs (Table 1) suggested to have
pioneering activity on the basis of nucleosomal or closed chromatin targeting in
vivo, during fibroblast reprogramming to hepatocytes, neurons, or macrophages
(Heinz et al., 2010; van Oevelen et al., 2015; Wapinski et al., 2013). Pioneer TF
FOXA1 can drive the conversion of fibroblasts to hepatocytes and, during liver
development, directly interacts with nucleosome particle N1 within the ALB
enhancer to stimulate expression (Chaya et al., 2001; McPherson et al., 1993;
Sekiya and Suzuki, 2011). Therefore, FOXA1 was used as a positive control for
nucleosome binding on ALBN1 in vitro, assembled into 160 bp nucleosomes
containing motifs for FOXA1 and other liver TFs (Figure 3.1B, 3.1C).
ASCL1 and BRN2 drive reprogramming from fibroblasts to neurons
(Vierbuchen et al., 2010), with ASCL1 targeting closed fibroblast chromatin
(Wapinski et al., 2013). By integration of genomic datasets (Figure 3.1A) we
identified an ASCL1 and BRN2 nucleosomal target sequence at the neuron-gliaCAM-related cell adhesion molecule (NRCAM) locus (Figure 3.1D). The NRCAM
92

gene plays a role in neurite outgrowth and schizophrenia development (Honer et
al., 1997; Vawter et al., 1999). The NRCAM site was selected by consideration of
its high nucleosomal MNase-seq signal enrichment in fibroblasts before Ascl1
and Brn2 expression (Figure 3.1D, 3.S1A), ASCL1 and BRN2 targeting to the
site by ChIP-seq, the presence of respective DNA binding motifs (Figure 3.1D,
3.1E), its enrichment for enhancer associated marks H3K4me1, H3K27Ac,
DNase-hypersensitivity (Figure 3.1D), and gene expression associating with
neuronal function by gene ontology (Figure 3.S1A, 3.B).
Genomic and chromatin state analysis by MNase-seq of PU1, CEBPa,
and CEBPb targeting during B cell to macrophage reprogramming suggests that
hematopoietic TFs PU1 and CEBPa target nucleosome-enriched chromatin
(Barozzi et al., 2014; Heinz et al., 2010; van Oevelen et al., 2015), yet the prebound chromatin state was not evaluated. Comparison of fibroblast nucleosome
occupancy by MNase-seq signals and TFs ChIP-seq in macrophages (Figure
3.S1C-D) revealed CX3 chemokine receptor 1 (CX3CR1) locus as a candidate
nucleosomal targeted site (Figure 3.1F). CX3CR1-DNA shows enrichment for
H3K4me1, H3K27Ac and DNase-hypersensitivity in macrophages (Figure 3.1F)
and it contains the respective DNA binding motifs (Figure 3.1G). DNA fragments
of 160 bp of ALBN1-DNA, and 162 bp of NRCAM-DNA and CX3CR1-DNA were
PCR amplified, Cy5-end labeled (Figure 3.S1E), and prepared as free DNA and
nucleosomal templates by urea-salt step dialysis (Figure 3.S1F).
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At a low concentration of DNaseI, ALBN1, NRCAM, and CX3CR1
nucleosomes exhibited nearly complete resistance to cleavage, compared to free
DNA (Figure 3.1H-J). Using 20 fold more DNase-I on nucleosomes elicited a
markedly different cleavage pattern than seen on free DNA.

Each of the

nucleosomes revealed several interspersed ~10 bp cleavage repeat patterns,
indicative of different rotational frames that expose diverse DNA binding motifs
within 120 bp central core of the nucleosome populations (Figure 3.1H-J, bottom
panels). Our method of curating endogenous nucleosomal sites enriched for
pioneer factor binding in vivo appears robust for discovering DNA sequences that
make stable nucleosomes in vitro.

ASCL1 Heterodimerization with E12a Enhances DNA Binding and
Specificity
To establish conditions for a large-scale TF-nucleosome screen, we
purified full-length FOXA1, GATA4, HNF1a, ASCL1, BRN2, PU1, and CEBPa
from E. coli, validated their identity by predicted size and immunoblotting (Figure
3.2A, 3.S2A), and measured free DNA binding activity. Apparent dissociation
constants were determined by electromobility shift assays (EMSAs) with short
Cy5-DNA probes (Figure S2B-D) and quantified by two methods; total
dissociation constant (total KD), determined by decrement of free probe, and
specific dissociation constant (specific KD), determined by the appearance of
specific TF-complexes (Soufi et al., 2015b). As expected, all TFs but ASCL1
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displayed nanomolar dissociation constants for probes containing canonical DNA
binding motifs (Figure 3.S2C, Table 1), but not for probes lacking binding motifs
(Figure 3.S2D). We concluded that most of the purified full-length TFs were
highly active and bound DNA specifically.
ASCL1 homodimer DNA binding was not detectable within the nM range,
agreeing with previous studies estimating a high dissociation constant (KD) 140
μM (Figure 3.S2E-F) (Meierhan et al., 1995). Basic helix-loop-helix (bHLH) TFs
heterodimerize with other bHLHs (Longo et al., 2008; Powell and Jarman, 2008)
and interaction network analysis revealed the ubiquitously expressed E12a
(Tcf3) as an ASCL1 interacting partner (Figure 3.S2G) (Henke et al., 2009).
Therefore, we co-purified ASCL1/E12a heterodimers (Figure 3.2A), which formed
a DNA-bound complex that migrated faster than E12a homodimers (Figure S2E,
lanes 6, 11) and with a markedly increased DNA binding affinity of ~3.1 nM
(Figure 3.S2E,F, Table 3.1). We considered ASCL1/E12a heterodimers suitable
for further analysis.

Reprogramming TFs Interact with Nucleosomal Substrates with a
Nanomolar Range of Affinities
TFs bound to their respective 160 bp free DNAs of ALBN1-DNA, NRCAMDNA, CX3CR1 within the low nM range (Figure 3.2B-G, lanes 1-6). As expected,
the TFs show a higher affinity for the longer 160 bp DNA, compared to shorter
DNA probes (Table 3.1) due to increased non-specific DNA interactions with
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longer DNA templates. Thus, at low concentrations of TFs (0.1-1 nM), each of
the factors bound to the 160 bp DNA fragments in a single shifted band, while at
higher concentrations we detected additional shifted complexes with distinct
dissociation constants (Figure 3.2B-G, 3.S3A-B). The use of an EMSA assay
allowed us to make these distinctions, which could correspond to redundant
“periodic” TF binding to nucleosomes detected by SELEX (Zhu et al., 2018).
We then assessed binding of the TFs to the same sequences on
nucleosomes. FOXA1, GATA4, ASCL1/E12a, BRN2, HNF1a, and PU1 showed
high affinity for nucleosomes, with apparent KDs of 3.0 nM, 3.8 nM, 2.6 nM, 2.0
nM, 4.7 nM, 5.6 nM, respectively (Figure 3.2B-G lanes 7-12, Table 3.1).
Comparison of TFs by their KDDNA and KDNuc, including prior data on iPS
reprogramming factors OCT4, SOX2, KLF4, and c-MYC (Soufi et al., 2015b),
showed that nucleosome binding factors segregate among each other by a slight
difference in DNA affinity, with strong reprogrammers showing a slightly higher
DNA affinity (lower KD) compared to BRN2, KLF4, and HNF1a which are
suggested to have supporting roles in reprogramming (Figure 3.2H) (Chanda et
al., 2014; Raposo et al., 2015; Wapinski et al., 2013). CEBPa displayed the
lowest nucleosome affinity of the nucleosome-binding TFs, with a 5-fold higher
KD of 18 nM compared to the other TFs (Figure 3.2G lanes 7-12, Table 3.1). In
general, TF affinity for DNA was slightly higher than that for nucleosomes,
demonstrating that the presence of histone octamer can attenuate, but not inhibit,
DNA binding of the reprogramming pioneer TFs.
96

The isoforms CEBPa and CEBPb target the same DNA motif and share a
high degree of structural homology (Jakobsen et al., 2013; Nerlov, 2007).
Posttranslational modifications within the DBD of CEBPs can negatively regulate
DNA binding, with the few exceptions of positive DNA binding regulation by
sequential phosphorylation of CEBPb at residues T167 and S163, corresponding
to S184 and T188 in CEBPb LAP* isoforms (Li et al., 2007; Piwien-Pilipuk et al.,
2002; Tang et al., 2005). We generated phospho-mimic variants of CEBPb
(T167D) and (S163D, T167D) of the LAP isoform (Figure 3.S3E). CEBPb T167D
showed a weak increase of free DNA binding (Figure 3.2I, lanes 3,5) and no
discernable effect on nucleosome binding (Figure 3.2I, lanes 8,10). CEBPb
S163D, T167D showed no DNA binding or nucleosome binding enhancement
(Figure 3.2I, lanes 3,12,8,14). Our results show that engagement of histones with
DNA limit CEBPa/b binding to DNA and that post-translational modifications of
CEBPb at T167 or S163, T167 may not enhance nucleosome binding.

Nucleosomes Enhance Reprogramming TF Binding Specificity
TFs engage DNA through specific and non-specific DNA interactions
(Biggin, 2011). To measure the contribution of sequence specificity on TF binding
to DNA vs. nucleosomes, we carried out EMSA in the presence of increasing
amounts of short specific and non-specific double stranded DNA (dsDNA)
validated as competitors (Figure 3.S2C, D). An 80X molar excess of non-labeled
short dsDNA containing specific binding sites minimally displaced free DNA-TF
97

complexes for FOXA1, ASCL1/E12a, PU1, and C/EBPa (Figure 3.S3F, lanes
2,5), similar to competition with non-specific probes (Figure 3.S3F, lane 2,8);
while BRN2 exhibited specific competition. Strikingly, competition experiments on
nucleosomes, with a low 20X molar excess of specific competitor, completely
displaced all TF-nucleosome complexes (Figure 3.3A, B lanes 2,3). By contrast,
an 80X excess of non-specific competitor failed to displace them (Figure 3.3A, B
lanes 2,8). Moreover, specific ASCL1/E12a binding to nucleosomes occurs
without histone octamer dissociation, as determined by EMSA followed by
Western blotting with antibodies for core histones H2B and H3 (Figure 3.3C). It
appears that TFs generally engage in specific interactions with nucleosomes due
to decreased DNA availability by presence of histone octamers, while free DNA
is more accessible, allowing the TFs to engage in more non-specific interactions.
DNase footprinting reveals that ASCL1/E12a blocks cleavages on two of
its motifs on each of the NRCAM and CX3CR1 nucleosomes (Figure 3.3D, E,
middle panels, filled circles).

One of the ASCL1 motifs on the NRCAM

nucleosome is in the nucleosome center and was DNase-resistant, precluding
the ability to assess further protection by ASCL1/E12a. By contrast, the ALBN1
nucleosome lacks an ASCL motif and ASCL1/E12a gave no evidence of
protections (Figure 3.3F, middle panel). PU1 exhibited protections on one of its
two motifs on the NRCAM nucleosomes and protections on the single motifs of
each of the CX3CR1 and ALBN1 nucleosomes (Figure 3.3D-F, lower panels,
filled circles).

ASCL1/E12a and PU1 also show protections and enhanced
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DNase cleavages (Figure 3.3D-F, closed and open circles) at additional sites,
compared to the nucleosomes alone, suggesting that the TFs stabilize a
preferred rotational frame that exposes the target motif (Shim et al., 1998) or
induce local conformational changes in the nucleosomal DNA. The data indicate
that ASCL1/E12a and PU1 bind their motifs in multiple nucleosome sequences
contexts.

Zygotic Genome Activator Zelda Binds Nucleosomes Like Human Pioneer
Factors
We compared the ability of the Drosophila TF Zelda (ZLD) to bind
nucleosomes like the human TFs. ZLD reprograms the zygotic genome for
transcriptional activation during the maternal-to-zygotic transition (Foo et al.,
2014; Liang et al., 2008; Schulz et al., 2015; Sun et al., 2015) and binds in vitro
assembled nucleosomes from the bottleneck

locus (McDaniel, 2019).

Recombinant full-length ZLD binds a short dsDNA containing a canonical ZLDbinding motif (CAGGTAG), but not to dsDNA with mutated motif, in agreement
with previous studies (Figure 3.4A) (Hamm et al., 2015).
We identified fortuitous ZLD binding motifs (CAGGCAG) in the NRCAMDNA sequence (Figure 3.4B).

ZLD robustly bound both NRCAM-DNA and

NRCAM-NUC (Figure 3.4C), without histone octamer displacement (Figure 3.4E)
with a KDNuc of 1.8 nM (Figure 3.2H), comparable to strong reprogramming TFs.
Similar to the human reprogramming TFs we tested, EMSA competition
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experiments identified non-specific binding of ZLD to free DNA (Figure 3.4D left
panel). However, sequence-independent features also contributed to the binding
of ZLD to nucleosomes, as demonstrated by the requirement for 160X unlabeled
specific competitor to compete the ZLD-NUC complex as compared to 20X
competitor for the previously tested human TF-nucleosome complexes (Figure
3.4D, right panel). Thus, ZLD can directly engage nucleosomes, consistent with
chromatin targeting seen in vivo, and supports a comparable role of nucleosome
binding for reprogramming factors in multiple organisms.

Protein Array Screen for Nucleosome Binding TFs Identified TFAP-2 and
HMG Transcription Factors as Strong Nucleosome Binders
Having detailed the nucleosome binding of a subset of humanreprogramming factors and a well-studied insect TF, we were interested in more
generally identifying TFs with the fundamental feature of nucleosome binding. To
date only a small subset of the estimated 2,000 TFs in the human genome has
been tested for direct nucleosome binding (Kummerfeld and Teichmann, 2006;
Messina et al., 2004; Vaquerizas et al., 2009). We therefore screened human
full-length TFs, purified from yeast and printed on microarrays in duplicates, for
binding to Cy5-labeled ALBN1, NRCAM, CX3CR1 as free DNA and nucleosomes
(Figure 3.5A) (Hu et al., 2013). The three different templates have a fortuitous
occurrence of 116, 121, and 112 TF binding motifs, respectively, as determined
by TRANSFAC database, enabling us to assess many TFs binding to these
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natural nucleosome sequences (Table 3.S1) (Matys et al., 2006). Moreover, the
occurrence of multiple rotational positions on the nucleosomes provide a myriad
of accessible motifs (Figure 3.1H-J). Cy5 fluorescence of probed protein
microarrays, incubated with Cy5-labeled ALBN1, NRCAM, CX3CR1 DNAs or
nucleosomes, was measured and positive protein-nucleic acid signals were
processed (Figure 3.S4A) by protein auto-fluorescence subtraction (Figure
3.S4B), minimal protein amount per spot cutoff (Figure 3.S4C,D), background
normalization (Figure 3.S4E), and determination of positive versus negative
signal thresholds (Figure 3.S4F). Protein microarrays contained 1,755 nuclear
proteins spotted, which after the cutoffs resulted in 1,592 proteins. Finally, out of
1,755 proteins, 593 TFs showed a fluorescent intensity after probing for free DNA
and nucleosomes that passed the positive/negative signal threshold; we
considered these proteins to be experimentally accessible (Table 3.S2).
The protein microarray screen provisionally identified 326 TFs that interact
with both DNA and nucleosomes, 104 that interact with DNA-only, and 163 that
interact with nucleosomes-only. Protein microarray screening with Cy5 NRCAM
free DNA and nucleosomes identified TFAP2a as a possible nucleosome binding
TF (Figure 3.5B). AP2 TFs are crucial for neuronal crest development and
regulate the fragile X mental retardation-1 gene (Schorle et al., 1996; Zhang et
al., 1996). Validation of TFAP2a-nucleosome interaction with an in-solution
EMSA showed that TFAP2a binds DNA and nucleosomes comparable to
ASCL1/E12a (Figure 3.5C).
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To further validate interactions detected from the screen, we purified 81
more of the proteins. Surprisingly, 57 of the proteins exhibited no free DNA or
nucleosome binding by EMSA, including 9 transcription factors that scored as
"nucleosome only binders" on the arrays. Twenty-four full-length human TFs
resulted in detectable DNA binding by EMSA on one of the ALBN1, NRCAM, or
CX3CR1 free DNA and nucleosome sequences that contained motifs for each
respective TF located within the central domain of the nucleosomes (Figure
3.S5). TF-nucleosome binding was tested at 3X, 6X, or 9X nM higher
concentration of TF compared to TF-DNA concentrations (Figure 3.S6A).
Quantification of the free DNA and nucleosome bound fraction by EMSA
revealed that 11 of the 24 TFs bound to DNA and nucleosomes, 13 to DNA only,
and none to nucleosomes only (Figure 3.5D, 3.S6B-E). Thus, the nucleosomeonly interactors by protein microarrays could not be confirmed in solution.
Furthermore, the DNA only TFs, IRF3 and CREM1, lacked nucleosome binding
in multiple nucleosome sequences contexts harboring their target motifs (Figure
3.S6F-G). The IRF3 DBD is a modified version of the helix-turn-helix (HTH) motif
that includes a four-stranded antiparallel β-sheet (De Ioannes et al., 2011). Our
results showed that lack of nucleosomes binding is not sequence context
dependent.
Clustering of TFs by bound fraction, quantified from EMSAs, identified TFs
as strong DNA and nucleosome binders (cluster 1), low DNA binders (cluster 2),
and high DNA binders with low nucleosome affinity (cluster 3) (Figure 3.5D).
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Cluster 1 TFs with high nucleosome binding affinity also display high DNA affinity
(Figure 3.5D). This included TFAP-2 isoforms TFAP-2β and TFAP-2γ which also
showed strong nucleosome binding similar to reprogramming TFs, as quantified
by EMSA (Figure 3.5D). In addition, we also observed that in solution, members
of the high mobility group superclass HMGA1, HMGN1, HMGN5, and SOX5
show high affinity to nucleosomes (Figure 3.S6D, lane 10, 3.S6E, lanes 8, 12,
and 16). Thus, we were able to identify the TFAP-2 and HMG families of TFs as
nucleosome binding factors.
In contrast, sorting TFs by the nucleosome bound fraction revealed a
more heterogeneous DNA binding preference, with IRF3, T-Box factors TBX20
and Brachyury (T), and the TALE-MEINOX TF PKNOX displaying high DNA
binding but undetectable nucleosome binding, regardless of a higher 9X fold TF
concentration on nucleosomes compared to DNA (Figure 3.5E, 3.S6B) and the
presence of DNA binding motifs (Figure 3.S5). We conclude that high DNA
affinity does not necessarily translate to nucleosome binding. Thus, nucleosome
binding TFs are also strong DNA binders and yet nucleosome binding is not an
obligate feature of TFs with high DNA affinity.

Common Structural Features Associated with Pioneer TFs programming
TFs
To identify structural commonalities among strong relative to weak
nucleosome binders, we compared the 3D structures of the above tested
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transcription factors’ DBDs. TFs were classified into strong nucleosome binders
(group I) and weak nucleosome binders (group II). Group I TFs, validated in
solution, exclusively include structural DBD superclasses characterized by ahelical folds (Wingender et al., 2015), including basic helix-loop-helix (bHLH),
helix-turn-helix (HTH), homeodomains (HD), and zinc fingers (ZnF) (Figure 3.6A).
ZLD is a C2H2-ZnF TF that could fit within group I, even though its structure is not
known. Two main types of DNA anchoring modes are observed; a scissor-like
binding mode by dimers of bHLH TFs, and the HTH module characteristic of
HMG TFs such as SOXs, homeodomain TFs OCT4, BRN2, and ETS TFs PU1.
Although structurally different, we observed that strong nucleosome binders
anchor DNA through a short recognition a-helix (Figure 3.6A). TALE-PBC class
TFs such as PBX adopt a DNA binding arrangement with a kink in the
recognition helix, resulting in a truncated recognition helix similar to group I short
recognition a-helix (Figure 3.6D). This is in agreement with in vivo data
suggesting PBX1 has pioneer activity (Berkes et al., 2004). Therefore, structural
comparison of PBX1 with group I strong nucleosome binders predicts strong
nucleosome binding potential.
Group II TFs include weak nucleosome binders, which we further
subdivided into groups IIA and IIB. Similar to group I TFs, group IIA TFs MYOG,
CREM, and previously tested weak nucleosome binder USF1 (Adams and
Workman, 1995) display a scissor-like arrangement, but contain an extended
recognition a-helix that protrudes past the diameter of the DNA helix (Figure
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3.6B). This suggest that a scissor-like recognition mode with an extended
anchoring a-helix results in weak nucleosome binding (Soufi et al., 2015b) and
would include bZIP TFs such as cMYC, MYOG, and CEBP.
Group IIB weak nucleosome binders TFs Brachyury and TBX20,
homologous to the TBX1 DBD, lack a recognition a-helix and instead use short
helical twist or unstructured regions (Figure 3.6C). These factors are members of
the immunoglobulin superclass characterized by a b-sheet core structure,
hypervariable loops, and DNA recognition through unstructured regions (Bork et
al., 1994; Wingender et al., 2015). Interestingly, group IIB TFs have been
previously shown to engage in a multitude of cooperative interactions with
homeodomain TFs binding partners resembling group I strong nucleosome
binders, such as PITX2 and NKX2 (Naiche and Kelly, 2005), and thus appear
more dependent on direct nucleosome binders for their genetic activity.

3.6 Discussion
It has been well established that the presence of nucleosomes can impair
DNA binding of many transcription factors and DNA repair enzymes (SchildPoulter et al., 1996; Taylor, 1991). We have addressed how lineage-specific TFs
engage nucleosomes to initiate regulatory events in silent chromatin during
development and cell programming. We previously showed that the pioneer TFs
FOXA and OSK are able to target nucleosomes in vivo and comparably interact
with nucleosomes in vitro (Cirillo et al., 1998; Iwafuchi-Doi et al., 2016; Soufi et
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al., 2015b). Here we show that TFs that drive reprogramming toward hepatic,
neuronal, macrophage lineages and the maternal-to-zygotic transition can
directly interact with nucleosomes. Additionally, we identify TFs with previously
unreported nucleosome binding ability. Given that nucleosome binding is the
defining characteristic of pioneer factors, our study defines the DNA binding
domain characteristics that endow pioneer activity.
Using nucleosomes assembled with endogenous sequences, we show
that ASCL1 heterodimerization with E12a markedly increases ASCL1 DNA and
nucleosome binding affinity (Figure 3.S2E,F). E12a is ubiquitously expressed in
fibroblasts,

suggesting

that,

during

neuronal

reprogramming,

ASCL1

heterodimerizes with ubiquitously expressed fibroblast TFs to target neuron
specific regulatory elements in nucleosome enriched chromatin. This agrees with
previous findings, where tethering of ASCL1 to E12a results in increased
transcriptional activity (Henke et al., 2009). Additionally, we find that BRN2 also
directly interacts with nucleosomes (Figure 3.2F). This is in agreement with in
vivo chromatin targeting of these factors during neuronal reprogramming where
ASCL1 and BRN2 engage chromatin (Wapinski et al., 2013).
PU1 is a strong nucleosome binder, while CEBPa shows a weaker
nucleosome affinity (Figure 3.2H). During B cell reprogramming, knockdown of
PU1 results in a decreased CEBPa binding to pre-existing and de novo
enhancers, suggesting that in the absence of PU1, CEBPa targeting to closed
chromatin might be driven by cooperative interactions (van Oevelen et al., 2015).
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Comparison among reprogramming TFs show a range of DNA and nucleosome
binding affinities that correlate with TF reprogramming potential and chromatin
targeting strength, suggesting that the intrinsic nucleosome binding preferences
of these TFs contributes to the hierarchy driving cellular reprogramming.
By utilizing protein microarrays as a discovery tool, we identified the
TFAP-2 family as a family of pioneer TFs. By contrast, TBX20 and Brachyury of
the T-BOX family lack detectable nucleosome binding, even while possessing
high DNA affinity to sequences containing specific motifs. Nucleosome-only
binders, suggested by protein microarrays, could not be validated in solution,
probably due to aberrant protein folding or unnatural domain exposure in a solidstate environment. We note that our nucleosome binding results with full-length
proteins agree partially but not entirely with Zhu et. al., who mostly studied DBDs
in a SELEX assay. Regardless, both studies find that high DNA affinity does not
necessarily result in nucleosome binding, which presents a different model than
where TFs would engage nucleosomal sites simply by displacing the octamer.
Interestingly, sequence alignment of HMGN proteins and SOX2, SOX5,
and SOX9 revealed a high degree of conservation between the SOX group B
homology domain, with unknown function (Weina, 2014), and the C-term of the
HMGN nucleosome binding domain (NBD) (Figure 3.S6H). C-term truncation of
the HMGN1 NBD greatly impairs chromatin binding (Ueda et al., 2008),
suggesting that SOX homology group B, outside of the SOX DBD, is required for
the nucleosome binding and chromatin targeting ability of SOX TFs.
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Pioneer TFs contain diverse DBD structures (Figure 3.6A), suggesting
diverse modes of DNA targeting in chromatin. For example, FOXA has been
suggested to compete with linker histone, due to its resemblance with H1 DBD
(Clark, 1993; Iwafuchi-Doi et al., 2016), while OCT4 has been suggested to
initially interact with chromatin using either of its POU or homeodomain DNA
binding modules (Soufi et al., 2015b). We find that DNA recognition via a short
scissor-like module or a HTH module is compatible with nucleosome binding
(Figure 3.6A). Recent studies in agreement with our findings showed that Reb1,
a yeast HTH factor, displays slower dissociation rates from nucleosomes,
compared to free DNA, without histone octamer eviction (Donovan et al., 2019).
More recently additional HTH TFs, such as Isl1, have been proposed play a
pioneering role in cardiomyocyte reprogramming (Gao et al., 2019).
In contrast, we predict that TFs of the immunoglobulin superclass, lacking
an a-helix recognition helix, such as T-Box factors, would need cooperative
interactions for nucleosome binding (Figure 3.6C). In agreement with our
findings, the TBOX factor Tpit binding to closed target sites in vivo is restricted
and mainly driven by the pioneer TF PAX7 (Mayran et al., 2018). Furthermore,
TP53, an immunoglobulin fold TF, was shown to bind nucleosomes at their
edges, at histone-free DNA (Yu and Buck, 2019). Similarly, BZLF1, a bZIP TF
similar to group IIB, showed minimal nucleosome binding at high TF
concentrations (Schaeffner et al., 2019).
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Our study reveals that nucleosome binding positively correlates with
reprogramming potential and suggests a hierarchical model where pioneer TFs
work

as

trailblazers

for

epigenome

regulators

and

modifiers

during

reprogramming. Furthermore, we reveal commonalities and structural length
limitations among the DNA binding modes of pioneer TFs, compared to nonpioneer TFs. Our study provides insight into how diverse groups of TFs engage
in nucleosomal interactions via common structural features. Further studies of
the domains of pioneer factors that modulate nucleosomal interactions will unveil
how other factors are enabled to bind closed, silent chromatin and initiate cell
fate changes.

109

3.7 Main Figures
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Figure 3.1 | Endogenous TF-Nucleosomal Targets Assemble into Stable
Nucleosomes In Vitro
(A) Schematic diagram showing genomic data processing for the identification of
TFs nucleosomal targets.
(B-G) ChIP-seq profile for reprogramming TFs at identified nucleosomal targets
and 3D representation of the DNA sequences used for nucleosome assembly
containing TFs canonical motifs indicated (yellow). (B) FOXA1, GATA4 and
HNF1a ChIP-seq (red) in liver and MNase-seq profile (green) in fibroblasts
across the ALBN1 enhancer within the displayed genomic location. (C) 3D
representation of the 160 bp- ALBN1-DNA. (D) ASCL1 and BRN2 ChIP-seq
(red) at 48 hr induction in fibroblast and MNase-seq profile in fibroblasts near the
NRCAM gene. (E) 162 bp NRCAM-DNA. (F) PU1, CEBPa, and CEBPb ChIP-seq
in macrophages and MNase-seq profile in fibroblasts near the CX3CR1 gene.
(G) 162 bp- CX3CR1-DNA.
(H-J) DNase-I footprinting showing the protection of (H) ALBN1-DNA, (I)
NRCAM-DNA, (J) CX3CR1-DNA before and after nucleosome reconstitution in
vitro. Electropherograms generated by digesting 5’-6 FAM end-labeled free DNA
(top panel) and nucleosomes with low DNaseI (middle panel) and high DNaseI
(bottom panel). Concentrations of DNase-I indicated. Dashed lines indicate
central histone octamer protection within nucleosomes.
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Figure 3.2 | Reprogramming TFs bind Nucleosomes with Nanomolar
Affinity
(A) Recombinant purified full-length TFs analyzed by SDS-PAGE and Coomassie
staining. The factors are grouped by reprogramming to iHEP (induced
hepatocytes), iN (induced neurons), and iMAC (induced macrophages).
Recombinant single purification of ASCL1, E12a, and co-purification of
ASCL1/E12a (right panel).
(B-G) Representative EMSA showing the affinity of increasing amounts of TFs
(B) FOXA1, (C) PU1, (D) ASCL1/E12a, (E) GATA4, (F) BRN2 and (G) CEBPa
to Cy5-labelled DNA (lanes 1-6) and nucleosome (lanes 7-12). Black arrowheads
indicate TF-DNA complexes. White arrowheads indicate TF-nucleosome
complexes.
(H) 2D plot of TFs dissociation constants for DNA (x-axis) and nucleosomes (yaxis).
(I) Representative EMSA showing the affinity of CEBPb WT, mutants T167D and
S163D, T167D to CX3CR1-DNA and nucleosomes.
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Figure 3.3 | TFs Bind Nucleosomes with Specificity
(A-B)Representative EMSA of competition assays showing the affinity of
recombinant (A) FOXA1, ASCL1/E12a and PU1 to ALBN1-NUC, NRCAM-NUC,
and CX3CR1-NUC in the presence of 20-, 40- and 80-fold molar excess of
specific competitor ( “s” lanes) or non-specific competitor (“ns” lanes) or absence
of competitor (“-“ lanes). (B) Same as (A) for BRN2 and CEBPa.
(C) Representative WEMSA showing the binding of ASCL1/E12a to NRCAMNUC. ASCL1/E12a :Nuc complex from EMSA were transferred onto a PVDF
membrane (WEMSA) and blotted for H3, H2B, ASCL1 as indicated (the three
panels on the right). White arrow heads indicate the observed TF-nucleosome
complexes.
(D-F) DNase-I footprinting electropherograms of 5’-6 FAM-labeled (D) NRCAMNUC, (E) CX3CR1-NUC, and (F) ALBN1-NUC in absence (top) or presence of
ASCL1/E12a (middle) or PU1 (bottom) end-labeled free DNA (top strand). 3D
DNA representation (red) with each TF motif (yellow)..Filled circles, protections;
open circles, enhancements. "deg. motif" = degenerate motif for PU1.
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Figure 3.4 | ZnF TF Zelda Bind to Nucleosomes
(A) Representative EMSA of ZLD showing affinity to short dsDNA probes a
containing canonical ZLD-binding motif ( “s” lanes) or mutated motif ( “ns” lanes).
(B) Graphical representation of ZLD motifs (yellow) identified on NRCAM-DNA
sequence.
(C) Representative EMSA showing the affinity of increasing amounts of
recombinant ZLD to Cy5- NRCAM-DNA (lanes 1-5) and nucleosome (lanes 610).
(D) Quantification competed fraction of ZLD:DNA (left panel) or ZLD:nucleosome
(right panel) complexes by addition of molar excess of specific competitor ( “s”
lanes), non-specific competitor (“ns” lanes) or absence of competitor (“-“ lanes).
Molar excess listed.
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(E) Representative WEMSA of ZLD :Nuc complex from EMSA transferred onto a
PVDF membrane (WEMSA) and blotted for H3, H2B as indicated (the two panels
on the right). White arrow heads indicate the observed TF-nucleosome
complexes.
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Figure 3.5 | Systematic Assessment of Nucleosome Binding of Human TFs
with Protein Microarrays
(A) Graphical scheme used to identify nucleosome interacting human TF using
DNA and nucleosome probes binding to protein microarrays.
(B) Cy5 fluorescence of TAP2-a on protein microarray printed spot in duplicate in
absence (“-“) or hybridized with NRCAM-DNA or NRCAM-NUC.
(C) Representative EMSA comparing the affinity of ASCL1/E12a with TFAP-2a
to NRCAM-DNA or NRCAM-NUC. Black arrow heads indicate TF-DNA
complexes. White arrow heads indicate the TF-nucleosome complexes.
(D-E). Heatmap representations of TFs bound fractions to DNA (left) and
nucleosome (right) by quantification from EMSA. (D) Clustered heatmap showing
strong DNA and nucleosome binders (red-cluster 1), low DNA binders and
(yellow-cluster 2), high DNA binders with low nucleosome affinity (blue-cluster 3)
(E) Heatmap sorted on TF nucleosome bound fraction. TFs concentrations used
on Figure 3.S6A.

119

120

Figure 3.6 | Strong Nucleosome Binding TFs Recognize DNA with Short
Recognition a-Helixes
(A) Group I pioneer TFs DBDs crystal structures of FOXA3 (pdb 1VTN) (Clark,
1993), OCT4 (pdb 3L1P) (Esch et al., 2013), PU1 (pdb 1PUE) (Kodandapani et
al., 1996), KLF4 (pdb 2WBS) (Schuetz et al., 2011) and, GATA3 (pdb 4HC9)
(Chen et al., 2012). ASCL1 (SMR P50553).
(B) Group IIA TFs with scissor-like DBDs crystal structures and extended
recognition a-helixes of cMYC/MAX (pdb 1NKP) (Nair and Burley, 2003), CEBPa
(pdb 1NWQ) (Miller et al., 2003), USF (pdb 1AN4) (Ferre-D'Amare et al., 1994),
MYOG (SMR P15173), and CREM (SMR Q03060).
(C) Group IIB TFs with immunoglobulin-like fold DBDs crystal structures of TBX1
(pdb 4A04) (El Omari et al., 2012), Brachyury (pdb 1XBR) (Muller and Herrmann,
1997), NF-kB p50 subunit (pdb 1SVC) (Muller et al., 1995) and, GAL4 (pbd
3COQ) (Hong et al., 2008).
(D) TALE-PBC PBX1 (pdb 1PUF) (LaRonde-LeBlanc and Wolberger, 2003) and
UBX (pbd 4UUS) (Foos et al., 2015) crystal structures showing scissor-like
binding in dimer form with HOX TFs showing kink in recognition a-helixes (blue
arrow).
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3.8 Supplemental Figures
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Figure 3.S1 | Reprogramming TFs Target MNase Enriched Target Sites
Associated with cell identity Genes. Related to Figure 3.1.
(A-B) Genomic data integration for ASCL1 and BRN2 nucleosomal target site
identification. (A) Venn diagram of TFs ChIP-seq peaks association with
upregulated/downregulated nearest genes and their nucleosome occupancy as
determine by MNase-seq tag enrichment or depletion at 48 hr ASCL1, BRN2 and
MYT1L ectopic expression in fibroblast. (B) Gene ontology analysis of nearest
genes associated with TFs ChIP-seq peaks in 48 hr ASCL1, BRN2 and MYT1L
ectopic expression in fibroblast.
(C-D) Venn diagram of PU1, CEBPa and, CEBPb ChIP-seq peaks association
with upregulated/downregulated nearest genes in macrophages and nucleosome
occupancy of fibroblast determine by MNase-seq tag enrichment at expected
target sites according to macrophage PU1, CEBPa and, CEBPb ChIP-seq
targeting. (D) Gene ontology analysis of nearest genes associated with for PU1,
CEBPa and, CEBPb ChIP-seq peaks in macrophages.
(E) Schematic diagram showing 3’ end enzymatic Cy5 labeling of DNA with
Klenow-exo
(F) Nucleosome reconstitution of ALBN1-NUC, CX3CR1-NUC and NRCAM-NUC
(white arrows) compared to free DNA (black arrows).

123

124

Figure 3.S2 | Recombinant Purified Full-Length TFs Bind Their Canonical
Motifs on Short dsDNA. Related to Figure 3.2.
(A) TFs identity verification by Western blot analysis.
(B) Cy5 detection of labeled short double stranded DNA containing canonical
binding motifs for reprogramming TFs. Base pair length of each DNA shown at
the bottom.
(C-D) TFs binding curves showing the affinity of E. coli. expressed full-length TFs
to Cy5 labelled DNA probes containing or lacking TFs respective canonical
binding sites, (C) specific DNA and (D) non-specific respectively. TFs were
titrated at 0, 0.1, 0.3, 1, 3 and 9 nM concentrations with 1 nM DNA. DNA
sequences of the Cy5-labelled probes are in the star methods and equations for
total and specific dissociation constants ( KdTotal , KdSpecific are described in (Soufi
et al., 2015b).
(E) Representative EMSA showing the affinity of increasing amounts of purified
ASCL1, ASCL1/E12a and, E12a homodimers proteins to Cy5- MCK-DNA
containing an ASCL1 E-box binding motif.
(F) Binding curves or ASCL1, ASCL1/E12a and, E12a to Cy5-MCK DNA based
on (E).
(G) ASCL1 STRING functional association network of protein-protein
interactions.
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Figure 3.S3 | Recombinant Purified Full-Length TFs Bind with Specificity to
DNA and Nucleosomes. Related to Figures 3.2 and 3.3.
(A-D) TFs binding curves related to EMSAs fraction bound quantification of
Figures 3.2B-G showing the affinity of TFs to Cy5-160bp-DNA (left panels) or
Cy5-160bp-NUC (right panels). TFs were titrated on 1 nM DNA or NUC.
(E) Recombinant purified full-length CEBPb WT and, CEBPb-T163, CEBPbS163D, T167D phosphomimetic mutants analyzed by SDS-PAGE and
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coomassie staining. The TFs bands run at the expected sizes when compared to
the sizes of protein standards. All proteins in the same gel.
(F) FOXA1, ASCL1/E12a, PU1, BRN2, CEBPa binding to ALBN1-DNA, NRCAMDNA and CX3CR1-DNA in the presence of 20-, 40- and 80-fold molar excess of
specific competitor ( “s” lanes) or non-specific competitor (“ns” lanes) or absence
of competitor (“-” lanes).
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Figure 3.S4 | Pipeline for Protein Microarray Data Processing. Related to
Figure 3.5.
(A) Schematic diagram showing protein microarray data processing for the
identification novel nucleosome binding TFs.
(B) Representative protein microarray chip showing printed proteins autofluorescence on chip edge.
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(C) Representative protein microarray zoom showing relative printed protein
amounts per spots differences by fluorescence detection with primary anti-GSTTag antibody and Cy5-conjugated secondary antibody.
(D) Removal of proteins with low concentration per spot to yield positive signal.
Scatter plot showing protein amounts of all protein spots in all experiments (left
panel), and scatter plot showing proteins removed from the analysis due to low
estimated concentration (right panel).
(E) Representative protein microarrays probed with Cy5 labeled ALBN1, NRCAM
and CX3CR1 DNA or NUC showing the difference in background intensity.
(F) Examples of spots duplicates showing the range of fluorescence intensities
(shown above each spot) detected when probed with Cy5 labeled ALBN1,
NRCAM and CX3CR1 DNA or NUC. Threshold for a positive hit (binding) and
negative hit (not binding) was determined to be F-B of 80 (black arrow).
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Figure 3.S5 | 3D Representation of DNA Sequences Showing Positioning of
TFs Binding Motifs of Tested Factors. Related to Figure 3.5.
For each TF tested by EMSA (see Figure 3.5D) the DNA and nucleosome
sequence which the TF was tested for bindings is shown, consensus motif for the
factor, motif sequence within the tested DNA sequence, strand location of the
motif, and 3D representation of tested sequences showing TF motif (yellow)
localization within the sequence are shown.
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Figure 3.S6 | HMG TFs Interact with Nucleosomes. Related to Figures 3.5
and 3.6.
(A) Heatmap representation of TFs DNA bound fraction showing tested TFs (nM)
concentration on DNA and nucleosomes. Concentrations were determined
experimentally.
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(B-E) Representative EMSA of identified microarray hits for nucleosome
interaction with (B) NRCAM-DNA, (C,E) CX3CR1-DNA and, (C) ALBN1-DNA
(black arrows) or nucleosome (white arrows). (E) Representative EMSA showing
DNA and nucleosome binding of HMG TFs.
(F-G) EMSA of DNA only binders (F) IRF3 (G) CREM1 to ALBN1 and CX3CR1
DNA and nucleosomes containing TFs binding motifs.
(H) Sequence alignment of SOX2, SOX5, SOX9 with HMGN1, HMGN2, HMGN5
TFs showing high conservation between SOX group B homology domain and
HMGN C-term nucleosome binding domain.
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3.9 Tables
Apparent
KD
FOXA1 GATA4 HNF1A ASCL1/E12a E12a BRN2 PU1 CEBPaZLD
(nM)
Total canonical 1.3
2.4
2.7
3.1
ND 1.2
4.5 ND
Specific
canonical

0.9

2.1

2.5

3.0

31.4 4.9

3.0

7.5

-

Total DNA

0.3

0.5

1.1

0.7

-

0.7

0.6

4.6

0.4

Specific DNA

0.4

0.5

1.7

0.9

-

2.3

0.7

5.3

0.6

Total nuc

2.5

1.6

3.5

1.6

-

1.4

4.9

13

1.3

Specific nuc

3.0

3.8

4.7

2.6

-

2.0

5.6

18

1.8

Table 3.1 | Recombinant TF Dissociation Constants
Apparent dissociation constants (KD) were derived from quantified EMSA bands
to represent the relative affinities of TFs to their canonical sites or respective free
DNA and nucleosomes (nuc). Apparent KDs were derived from two separate
binding curves, each representing two experimental replicates, and fitted to the
experimental data within R2 values of 0.8-0.99, expressed in nM units. Apparent
KDs were quantified from the fractional decrement of free DNA or nuc, designated
as “total” binding, or from the first bound-DNA/nuc complexes, representing
“specific” binding. ND, not determined. “-“ not measured (Figure 3.S2C, 3.S3AD).
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3.10 Supplemental Tables
Table 3.S1 | Fortuitous Motif Occurrence in DNA Sequences by Motif Scan.
Related to Figure 3.5. (see accompanying online spreadsheet)
Each of the ALBN1-DNA, NRCAM-DNA and CX3CR1-DNA sequences were
scanned with PROMO (Messeguer et al., 2002) for identification of putative TFs
binding sites (TFBS) defined by TRANSFAC databased and used as weight
matrices for TFBS prediction.
Table 3.S2 | Protein Microarray Data. Related to Figure 3.5. (see
accompanying online spreadsheet)
Unprocessed and processed protein microarray data containing the 1,755
proteins name, identifier lists and their respective (F-B)+Cy5 signals for in each
experiment, 1,592 proteins after data processing and 593 positive hits TFs in at
least one experiment.
Table 3.S3 | Short DNA oligonucleotides containing TFs binding sites used
as unlabeled competitors. Related to Figure 3.3 (see accompanying online
spreadsheet)
Oligonucleotide DNA sequences used as dsDNA containing TFs binding sites in
EMSA competition experiments as specific or non-specific competitors.
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3.11 Key Resources
REAGENT or RESOURCE
Antibodies
anti-mouse ASCL1
anti-human H2B
anti-human H3
Cy5-dCTP
Klenow Fragment (3ÅL→5ÅL exo-)
Bacterial and Virus Strains
6HIS_pRSF_TEV
FUW-TetO-Gata4
pCMW-SPORT6-Hnf1
Tet-O-FUW-Ascl1
pBABE-E12-cTAP
pET-28b-FoxA1
pET-28b-Gata4
pET-28b-Hnf1a
pET-28b-Ascl1
pET-28b-Tcf3
pRSFDUET1-Ascl1+Tcf3
pET-28d-Brn2
pET-28b-Spi1
pET-28b-Cebpa
pET-28b-Cebpb
pET-28b-Cebpb-T167D
pET-28b-Cebpb- S163D,T167D
Chemicals, Peptides, and Recombinant Proteins
His6x-FOXA1
His6x-GATA4
His6x-HNF1a
His6x-ASCL1
His6x-E12a
His6x-ASCL1/E12a
GST-His6x-BRN2
His6x-PU1
His6x-CEBPa
His6x-CEBPb WT
His6x-CEBPb T167D
His6x-CEBPb S163D,T167D
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SOURCE

IDENTIFIER

Abcam
Abcam
Abcam
GE
Healthcare
Life
Sciences
New England Biolabs

ab74065
ab1790
ab1791
PA55021

Gifft
from
Ronen
Marmorstein lab
Buganim et al., 2012
Dharmacon mammalian
gene collection
Vierbuchen et al., 2010
Yang et al., 2009
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Gift from Marius Wernig
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab

6HIS_pRSF_TEV

Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab
Zaret Lab

His6x-FOXA1
His6x-GATA4
His6x-HNF1a
His6x-ASCL1
His6x-E12a
His6x-ASCL1/E12a,
GST-His6x-BRN2
His6x-PU1

M0212S

Addgene 41084
MMM1013-202761012
Addgene 27150
Addgene 20916
pET-28b-FoxA1
pET-28b-Gata4
pET-28b-Hnf1a
pET-28b-Ascl1
pET-28b-Tcf3
pRSFDUET1-Ascl1+Tcf3
pET-28d-Brn2
pET-28b-Spi1
pET-28b-Cebpa
pET-28b-Cebpb
pET-28b-Cebpb-T167D
pET-28b-CebpbS163D,T167D

His6x-CEBPa
His6x-CEBPb WT
His6x-CEBPb T167D
His6x-CEBPb
S163D,T167D

GST-MYOG
GST-TBX20
GST-NHLH2

Hu et al., 2013
Hu et al., 2013
Hu et al., 2013

GST-MYOG
GST-TBX20
GST-NHLH2

GST-CREM1
GST-IRF3
GST-RBPJ
GST-HMGN1
GST-HMGN5
GST-HMGA1

Hu et al., 2013
Hu et al., 2013
Hu et al., 2013
Hu et al., 2013
Hu et al., 2013
Hu et al., 2013

GST-CREM1
GST-IRF3
GST-RBPJ
GST-HMGN1
GST-HMGN5
GST-HMGA1

GST-SOX5
Critical Commercial Assays
MinElute PCR purification kit
Quick change II XL Site-Directed mutagenesis
Kit
Deposited Data
ASCL1 and BRN2 ChIP-seq
PU1, CEBPa and CEBPb ChIP-seq
FOXA1 and HNF1a ChIP-seq
GATA4 ChIP-seq
Fibroblast MNase-seq
FOXA3-DBD:DNA co-crystal structure
OCT4-DBD:DNA co-crystal structure

Hu et al., 2013

GST-SOX5

QIAGEN
Agilent

28004
200521

Vierbuchen et al., 2013
Heinz et al., 2010
Faure et al., 2012
Zheng et al., 2013
Teif et al., 2012
Clark et al., 1993
Esch et al., 2013

GEO GSE43916
GSE21512
E-MTAB-941
GSE49132
GSE40910
RCSB PDB 1VTN
RCSB PDB 3L1P

PU1-DBD:DNA co-crystal structure
KLF4-DBD:DNA co-crystal structure
GATA3-DBD:DNA co-crystal structure
ASCL1
cMYC/MAX-DBD:DNA co-crystal structure

Kodandapani et al., 1996
Schuetz et al., 2011
Chen et al., 2012
SWISS-MODEL
Nair and Burley, 2003

RCSB PDB 1PUE
RCSB PDB 2WBS
RCSB PDB 4HC9
SMR P50553
RCSB PDB 1NKP

CEBPa-DBD:DNA co-crystal structure
USF-DBD:DNA co-crystal structure

RCSB PDB 1NWQ
RCSB PDB 1AN4

UBX-DBD:DNA co-crystal structure
Raw gel images

Miller et al., 2003
Ferre-D'Amare et al.,
1994
SWISS-MODEL
SWISS-MODEL
El Omari et al., 2012
Muller and Herrmann,
1997
Muller et al., 1995
Hong et al., 2008
LaRonde-LeBlanc
and
Wolberger, 2003
Foos et al., 2015
Mendeley

Experimental Models: Cell Lines
Rosetta (DE3)pLysS Competent Cells

Novagen

Novagen # 70956-3

MYOG
CREM
TBX1-DBD:DNA co-crystal structure
Brachyury-DBD:DNA co-crystal structure
NF-kB p50-DBD:DNA co-crystal structure
GAL4-DBD:DNA co-crystal structure
PBX1-DBD:DNA co-crystal structure
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SMR P15173
SMR Q03060
RCSB PDB 4A04
RCSB PDB 1XBR
RCSB PDB 1SVC
RCSB PDB 3COQ
RCSB PDB 1PUF
RCSB PDB 4UUS
https://doi.org/10.17632/5
dnznn9kwt.1

Experimental Models: Organisms/Strains
Oligonucleotides
Table S3
Recombinant DNA
GATCCTGTCTCCTGCTCTGTCAGCAGGGCA
CTGTACTTGCTGATACCAGGGAATGTTTGTT
CTTAAATACCATCATTCCGGACGTGTTTGCC
TTGGCCAGTTTTCCATGTACATGCAGAAAGA
AGTTTGGACTGATCAATACAGTCCTCTGCCT
TGGATC

Zaret Lab

160 bp ALBN1-DNA

GATCCATTACTTCTGAAACAGATGACTCCCA
GCAGCTGCTGCCTGTGGCCCACAGGGCTTC
CTGCCCTGCATGACAGCTGCACATCACATC
CTGTGGTCATACTACTTCAGCCGCTTCTACG
GCCAGATACAAAAGTGGGTGGGGAACATAG
GCAAGGGATC

Zaret Lab

162 bp NRCAM-DNA

GATCCGCAGGGCCTCTCGGCTGCTGATCTT
CAGCTGGTTGCTGAGAGTTGCAGCATTGCT
GAGTCTTAGCAATGGATACTTCCCGATTCCC
CTCACAAAAATAGGTCAGTCTGTCTGGCTAG
TTCTGTACTTGCAGACACAGGGCATGTGGG
GTTCCGGATC

Zaret Lab

162 bp CX3CR1-DNA

Thermo Fisher
Thermo Fisher Scientific
Cloud

Cat no. 4440915
https://www.thermofisher.
com/us/en/home/lifescience/sequencing/frag
ment-analysis/fragmentanalysisfundamentals/fragmentanalysis-software-dataanalysis.html
https://pymol.org/2/
https://www.graphpad.co
m/scientificsoftware/prism/
http://alggen.lsi.upc.es/cgi
bin/promo_v3/promo/pro
moinit.cgi?dirDB=TF_8.3
http://mdc.custhelp.com/a
pp/products/detail/p/129/~
/version-7
https://www.rstudio.com/
https://imagej.net/
https://swissmodel.expas
y.org/

Software and Algorithms
Gene Mapper v4.1
Peak Scanner module

Pymol
PRISM 7

Schrodinger
GraphPad

PROMO

Messeguer et al., 2002

GenePix Pro 7

Molecular Devices, LLC.

R studio
Fiji is Just ImageJ (Fiji) version 2.0.0-rc/1.51f
SWISS-MODEL

Bienert et al., 2017
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Other
Human TF Protein microarrays

Hu et al., 2013
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3.11 Materials and Methods

Experimental model and subject details

Escherichia coli bacterial strain Rosetta (DE3)pLysS Competent Cells
were used for recombinant protein expression.

Genomic Data Analysis

The ASCL1 and BRN2 ChIP-seq were obtained from GEO GSE43916
(Vierbuchen et al., 2013); PU1, CEBPa and CEBPb from GSE21512 (Heinz et
al., 2010); FOXA1 and HNF1a from

E-MTAB-941 (Faure et al., 2012); and

GATA4 from GSE49132 (Zheng et al., 2013). ChIP-seq and MNase-seq data
GSE40910 (Teif et al., 2012) were aligned to build version NCBI37/mm9 of the
mouse genome. The MNase-seq reads were extended to 150 bp to cover one
nucleosome.

Protein Expression and Purification

The bacterial expression plasmids: pET-28b-FoxA1, pET-28b-Gata4, pET28b-Hnf1a,

pET-28b-Hnf4a,

pET-28b-Ascl1,
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pET-28b-Tcf3,

pRSFDUET1-

Ascl1+Tcf3, pET-28d-Brn2, pET-28b-Spi1, pET-28b-Cebpa, pET-28b-Cebpb
encode

the

mouse

FOXA1,

GATA4,

HNF1a,

HNF4a,

ASCL1,

E12a,

ASCL1+E12a, BRN2, PU1, CEBPa, and CEBPb proteins respectively, fused to
an N-terminal 6X histidine tag. BRN2 was expressed fused to a N-terminal 6X
histidine tag followed by a GST-tag. pRSFDUET1 contained 6X his tagged Ascl1
in MCS1 between restriction sites BamH1 and HindIII and untagged E12a (tcf3
gene) in MCS2 between restriction sites NdeI and XhoI. Plasmid containing TFs
cDNA were obtained as follow; FUW-TetO-Gata4 (Addgene plasmid #41084)
(Buganim et al., 2012b), pCMW-SPORT6-Hnf1a from Dharmacon mammalian
gene collection (MMM1013-202761012), pGCDNsam-Hnf4a (Addgene plasmid #
33002) (Sekiya and Suzuki, 2011), Tet-O-FUW-Ascl1 (Addgene plasmid #
27150) (Vierbuchen et al., 2010), pBABE-E12-cTAP (Addgene plasmid #
20916)(Yang et al., 2009), pET28d-mBrn2 was a gift from Marius Wernig, LZRS
PU.1 WT (Addgene plasmid #34835) (Anderson et al., 2002), CEBPalpha NGFR
(Addgene plasmid #44627) (Del Real and Rothenberg, 2013), pcDNA 3.1 ()mouse C/EBP beta (LAP) was a gift from Peter Johnson (Addgene plasmid #
12557). TF cDNA sequences were generated by PCR from the respective
constructs, introducing restriction sites; NdeI and HindII for FoxA1, Hnf1a, Hnf4a;
NdeI and XhoI for Gata4, Spi1, Cebpa, Cebpb, Ascl1; XbaI and XhoI for Brn2 for
insertion into their respective plasmid. pET-28b-Cebpb-T167D and pET-28bCebpb-S163D,T167D plasmids were generated from pET-28b-Cebpb plasmid
with Quick change II XL Site-Directed mutagenesis Kit (Agilent).
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The histidine-tagged proteins were expressed in E. Coli Rosetta (DE3)
pLysS (Novagen # 70956-3). Transformed cells were grown at 37 °C to a density
of 0.5-0.7 at an absorbance of 600 nm and protein expression was induced with;
1 mM IPTG at 37 °C for 4 hr with a 30 min delay addition of 20 mg/mL rifampicin
for FOXA1; 1 mM IPTG at 16 °C for 16 hr for ASCL1, BRN2 and PU1; 1 mM
IPTG at 37 °C for 4 hr for HNF1a, HNF4a, CEBPb; 2 mM IPTG at 37 °C for 4 hr
GATA4 and CEBPa. ZLD was purified as previously described (Harrison et al.,
2010; McDaniel, 2019)
The proteins were purified over Hi-trap HP nickel-charged columns (GE
healthcare #17-5248-01) or with Ni-NTA resin under denaturing conditions (20
mM Tris-HCl pH 8.0, 0.5M NaCl, 6M Urea) with 5 mM imidazole and 20-300 mM
single step imidazole changes follow by 4M and 2M urea step dialysis. The
recombinant human full length histones H2A, H2B, H3, and H4 were expressed
and purified as described previously (Tanaka et al., 2004). Histone expression
plasmids were a gift from Shelley Berger. Protein concentrations were calculated
by quantifying the intensity of each of the protein bands running at the expected
sizes in SDS-PAGE fitted to a BSA standard curve. To reduce error, the band
intensities were quantified at various concentrations.
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Cy5 DNA Labeling of Short Canonical-DNA Binding Sites

The DNA oligonucleotides used as binding sites are shown in Table S3.
The expected binding sites are highlighted in red. The short oligonucleotide
fragments were labeled with Cy5-dCTP (GE Healthcare Life Sciences) by endrepair with Klenow fragment DNA polymeraase (3ÅL→5ÅL exo-) (NEB) as
follows. Cy5 5’-end-labelled double stranded probes were generated by
annealing complementary single strand DNA probes to give rise to a two
nucleotide 3’ overhang (with the last annealed nucleotide being a G) using the
following reaction: 1 nanomoles of each ssDNA strand (10 μl of 100 μM) were
mixed in 50 μl final volume annealing buffer (20 mM Tris-HCl pH7.5, 50 mM
NaCl, 0.1 mM DTT, 1 mM EDTA). The reaction was incubated at 70 ºC for 10
min, and slowly cooled at room temperature overnight. Cy5-DNA labeling
reactions were carried out at final concentrations of 1.26 μM dsDNA, 4 μM Cy5dCTP and 0.5 U/uL Klenow fragment in the presence of excess 4 mM dATP, 4
mM dTTP, and 4 mM dGTP in NEB buffer 2 (50 mM NaCl, 10 mM Tris-HCl, 10
mM MgCl2, 1 mM DTT). The reaction was incubated at 37 oC for 1 hr. After Cy5
labeling, the probe was purified using Illustra MicroSpin G-25 columns (GE
Healthcare Life Sciences).
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Nucleosome Preparation

The 160 bp ALBN1-DNA fragment containing BamH1 flanking sequences
corresponds to the genomic location: mm9 chr5:90879148-90879300
GATCCTGTCTCCTGCTCTGTCAGCAGGGCACTGTACTTGCTGATACCAGGGAATGTTTG
TTCTTAAATACCATCATTCCGGACGTGTTTGCCTTGGCCAGTTTTCCATGTACATGCAG
AAAGAAGTTTGGACTGATCAATACAGTCCTCTGCCTTGGATC
The 162 bp NRCAM-DNA fragment containing BamH1 flanking sequences
corresponds to the genomic location: mm9 chr12:45445284-45445450
GATCCATTACTTCTGAAACAGATGACTCCCAGCAGCTGCTGCCTGTGGCCCACAGGGCT
TCCTGCCCTGCATGACAGCTGCACATCACATCCTGTGGTCATACTACTTCAGCCGCTTC
TACGGCCAGATACAAAAGTGGGTGGGGAACATAGGCAAGGGATC
The 162 bp CX3CR1-DNA containing BamH1 flanking sequences fragment
corresponds to the genomic location: mm9 chr9:119946611-119946762
GATCCGCAGGGCCTCTCGGCTGCTGATCTTCAGCTGGTTGCTGAGAGTTGCAGCATTGC
TGAGTCTTAGCAATGGATACTTCCCGATTCCCCTCACAAAAATAGGTCAGTCTGTCTGG
CTAGTTCTGTACTTGCAGACACAGGGCATGTGGGGTTCCGGATC
The DNA sequences were created by PCR of genomic mouse DNA with
EcoRI-BamHI and BamH1-XbaI restriction sites into pUC19 plasmid to generate
pUC19-EB-NRCAM-BX, pUC19-EB-ALBN1-BX, and pUC19-EB-CX3CR1-BX.
Plasmid were amplified in E.coli, purified, and digested with BamHI to release
fragments. DNA sequences were purified by agarose gel electroelution,
phenol:chloroform extraction, and ethanol precipitation followed by Cy5
enzymatic labeling as described above and purified with QIAquick PCR
purification kit (Qiagen 28106)
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The nucleosomes were reconstituted by dialysis as described previously
(Tanaka et al., 2004). Briefly, 10 μg of Cy5 end labelled DNA sequences were
mixed with purified and refolded H2A/H2B dimers and H3/H4 tetramers at a 1:1
DNA:histone-octamer molar ratio in 10 mM Tris-HCl pH 8.0, 4 M Urea, 2 M NaCl,
0.1 mg/ml BSA. The nucleosomes were assembled by salt-urea step dialysis
against buffers containing 1.5, 1, 0.8, and then 0.6 M NaCl with 10 mM Tris–HCl
pH 8.0, 5 M Urea, 1 mM EDTA, 10 mM 2-b mercaptoethanol for 2-4 hr at 4 °C.
The nucleosomes were then dialyzed against a no urea buffer containing 0.6 M
NaCl and 10 mM Tris–HCl pH 8.0, 1 mM EDTA, 1 mM 2-b mercaptoethanol and
then the same buffer containing 0.1 M NaCl for 6 hrs at 4 °C. The reconstituted
nucleosomes were then heat shifted by incubating at 42 °C for 2 hr, and further
purified with a 10-30% glycerol gradient in 50 mM Tris pH 7.5, 1 mM EDTA and
0.03 mg/mL BSA at 35,000 rpm for 18 hr at 4 °C. Gradients were fractionated
and nucleosome-containing factions were pooled and concentrated.

DNA and Nucleosome Binding Reactions

The end-labelled oligonucleotides containing specific or non-specific sites
(see above for sequences), free DNA sequence and nucleosomes were
incubated with recombinant proteins in DNA-binding buffer (10 mM Tris-HCl
pH7.5, 1 mM MgCl2, 10 μM ZnCl2, 1 mM DTT, 50 mM KCl, 3 mg/ml BSA, 5%
Glycerol) at room temperature for 30 min. Free and bound DNA were separated
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on 4% non-denaturing polyacrylamide gels run in 0.5X Tris–borate–EDTA. Gels
were visualized using with an Amersham Typhoon RGB Biomolecular Imager
using Cy5 fluorescence setting (excitation at 633 nm and emission filter 670 BP
30) and a high sensitivity setting. The apparent dissociation constant (Kd) were
calculated as previously described (Soufi et al., 2015b). For competition assays
excessive amounts (from 20 to 80 fold) of non-labelled probes containing specific
and non-specific sites were added to the binding reaction and incubated for an
additional 30 min at room temperature to reach equilibrium. The binding
reactions were loaded on the 4% EMSA gels as described above. EMSA gels
were run at 90 volts at room temperature.

Western Blotting After EMSA (WEMSA)

EMSAs were carried out as described above with 10-fold more protein
and nucleosomes run on a 1.5 mm thick mini-gel cassette (life technologies #
NC2015) containing 5% non-denaturing polyacrylamide gels run in 0.5X Tris–
borate–EDTA. To avoid Cy5 fluorescence saturation, 90% of the nucleosomes
used in binding reactions was not labelled. The gel was then visualized using
Cy5 fluorescence as described above. Western blot was done as described
previously (Soufi et al., 2015b). Primary antibody incubations with anti-mouse
ASCL1 antibody (1:1000; Abcam # ab74065), anti-human H3 (0.5 μg/ml; abcam
# ab1791), and anti-human H2B (0.8 μg/ml; abcam # ab1790) were performed
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for 2 hr at room temperature. The secondary antibody incubations with goat antirabbit IgG-HRP (1:5000 dilution; Santa Cruz # sc-2004) and donkey anti- goat
IgGHRP (1:2000; Santa Cruz # sc-2020) were performed for 1 hr at room
temperature.

Blots

were

visualized

by

using

SuperSignal

West

Pico

chemiluminescent substrate (Thermo-Scientific # 34080) in Fujifilm LAS-4000
imaging system. The membranes were stripped by incubating with Restore
Western-Blot Plus Stripping Buffer (Thermo- Scientifc # 46430) for 30 min at RT
and re-blocked after blotting with each antibody. The same membrane was
serially blotted and stripped with all antibodies shown.

DNase Footprinting on Free DNA and Nucleosomes

DNase footprinting reactions were carried out as previously described
(Soufi et al., 2015b). In brief, 6-FAM end labeled free DNA or nucleosomes (50
ng) were incubated in the presence or absence or the purified ASCL1/E12a (60
nM) and PU1 (100 nM) for 45 min at room temperature in a total volume of 50 μl
in DNA-binding buffer (10 mM Tris-HCl pH 7.5, 1 mM MgCl2, 10 μM ZnCl2, 1 mM
DTT, 50 mM KCl, 3 mg/ml BSA, 5% glycerol). The binding reactions were then
supplemented with an additional 50 μl of 10 mM MgCl2 and 5 mM CaCl2 at room
temperature for 1 min (total 100 μl). Binding reactions were treated with DNase-I
(Worthington) by addition of 3 μl of DNase-I yielding a final concentration of 9x105

U/ μl for free DNA or 1.8x10-3 U/ μl
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for nucleosomes

for 1 min at room

temperature. The reactions were stopped by adding 90 μl of 200 mM NaCl, 30
mM EDTA,1%SDS buffer immediately followed by phenol extraction. One tenth
of reaction volume (20 μl) of 3 M NaOAc (pH 5.2) was added to the reaction
before the DNA fragments were extracted with saturated phenol. The DNA
fragments were further purified using MinElute PCR purification kit (QIAGEN)
and eluted in 10 μl of EB buffer. The digested DNA fragments were separated by
capillary electrophoresis. Briefly, the DNA fragments (5 μl) were added to 4.9 ml
HiDi formamide (Applied Biosciences) and 0.1 ml GeneScan-500 LIZ size
standards (Applied Biosciences). After denaturing at 95 oC for 10 min, the
samples were run on an ABI 96-capillary 3730XL Sequencer, using G5 dye
setting, running a genotyping module with an increased injection time of 30 s and
injection voltage of 3 kV. The generated electropherograms were analyzed using
the Gene mapper V4.1 (Applied Biosciences) and Peak Scanner module
(Thermo Fisher Scientific Cloud).

Protein Microarrays

Full length human proteins were purified as GST fusion proteins from
yeast

using

a

high-throughput protein

purification protocol

as

described

previously (Zhu et al., 2001). Purified human proteins predicted to bind DNA
were arrayed in a 384-well format and printed on FAST slides (Whatman,
Germany) in duplicate, as described previously (Hu et al., 2009). To estimate
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protein amount printed per spot, prepared chips were incubated with anti-GST
antibody conjugated with Cy5 binding targeting the printed proteins GST-tags.
The protein microarrays were probed without (- control) or with Cy5-labeled
ALBN1, NRCAM, CX3CR1 DNA or NUC using a similar protocol described
previously (Hu et al., 2009). In brief, a protein chip was blocked for 3 hr at 4 oC
with 3% BSA in 25 mM HEPES pH 8.0, 50 mM KGlu, 8 mM MgCl2, 3 mM DTT,
10% glycerol, 0.1% triton x-100 buffer and then incubated with Cy5-labeled
ALBN1, NRCAM, CX3CR1 DNA or NUC at a final concentration of 20 nM in 80
μL of binding buffer (10 mM Tris-HCl pH 8.0, 1 mM MgCl2, 10 μM ZnCl2, 1 mM
DTT, 50 mM KCl, 3 mg/ml BSA, 5% Glycerol) overnight at 4 oC. The chip was
washed once with TBST (0.1% triton x-100) for 5 min at 4 oC, rinsed with water
and spun dry. The slides were finally scanned with a GenePix 4000B scanner
(Molecular Devices, Sunnyvale, CA) and the binding signals were acquired by
aligning an array list over the chip, foreground and background signals for each
protein spot were then extracted by the using the GenePix Pro 7 software, and
fluorescence minus background (F-B) signals were obtained for each spots.

3D Structural Model Assemblies

MYOG, CREM, and ASCL1/E12a structural models (SMR P15173, SMR
Q03060, SMR P50553) were constructed based on SWISS-MODEL sequence
alignment (Bienert et al., 2017) with MYOD (pdb 1MDY) showing 74.2% DBD
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sequence identity, CREB1 (pdb 1DH3) showing 76.3% DBD sequence identity
with CREM1, and NEUROD1 of the NEUROD1/E12a (pdb 2QL2) showing
42.86% DBD sequence identity with ASCL1. Structural models assemblies were
aligned to published crystal structures of MYOD, CREB1, and NEUROD1/ E12a
using Pymol.

EMSA Processing

For image processing, we used ImageJ version 2.0.0-rc/1.51f.

Before

displaying, the images were corrected for brightness and contrast; a linear range
was maintained.

Dissociation Constant Analysis

Apparent KDs were derived from two separate binding curves, each
representing two experimental replicates as described by (Soufi et al., 2015b).
Experimental data was fitted to non-linear regressions “One site – Specific
binding”, “One site – Total” or Specific binding with Hill slope” with a Bmax less
than 1 constrain within R2 values of 0.8-0.99, expressed in nM units using
GraphPad Prism 7 software.
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Protein Microarray Analysis

To quantify the signal intensity for each spot, the signal intensities were
calculated as the fluorescent median intensity minus its local background median
intensity (F-B) followed by averaging of printed duplicate spots F-B (Table
S2)(Hu et al., 2009). F-B signals were further processed to minimize artifacts
(Figure 3.S4A). Auto-fluorescent edging (Figure 3.S4B) was corrected by
subtraction of the F-B signal of microarrays incubated with binding buffer (F-B)-ctrl
from the F-B signal of microarrays incubated with Cy5-labeled samples (F-B)+Cy5.
Heterogeneity in printed protein amounts per spot (Figure 3.S4C) was
considered by estimating relative protein levels per spot amount using chips
incubated with anti-GST antibody conjugated to Cy5 (F-B)GST, a (F-B)GST < 170
signal cutoff was assigned (Figure 3.S4D). The cutoff removed proteins spots
with below threshold levels amounts to yield significant binding events from our
analysis. To eliminate artifacts resulting from uneven washing and drying of the
chips after incubation with Cy5 probes (Figure 3.S4E), we performed a withinchip normalization by the median normalization method. Known chromatin
modifiers were removed from our analysis. Finally, to identify proteins that bind
to DNA or nucleosomes, an intensity cutoff value of (F-B)+Cy5 equal to 80 was
assigned (Figure 3.S4F), where spots producing a signal greater than the cuttoff
were identified as “positive hits”.
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Heatmap Representation of DNA and Nucleosome Binding by Transcription
Factors

Heatmaps in Figure 3.5D, E were generated by first quantifying the TFs
total bound fraction from EMSAs as described in the methods section “DNA and
Nucleosome Binding Reactions” and in (Soufi et al., 2015a). Total bound fraction
for each TF was measured for their respective free DNA and nucleosome
template shown in Figure 3.S5, at the concentrations shown in Figure 3.S6A. Kmeans clustering of the TF total bound fraction for free DNA and nucleosomes
was done with R studio software and the pheatmap package. We defined a K
means clustering function with an optimal number of 6 cluster centers (k); no Z
score normalization was applied to the data. Cluster number was further
simplified by manually regrouping of highly similar clusters resulting in three
clusters.
Data and Software Availability

All the original unprocessed gel images in this manuscript have been
deposited

with

Mendeley

and

https://doi.org/10.17632/5dnznn9kwt.1.
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can

be

accessed

with

CHAPTER 4: PERSPECTIVES AND FUTURE DIRECTIONS

4.1 Summary of Major Conclusions and Implications
Early work on FOXA1 interactions with

chromatin in vivo and in vitro

defined pioneer TFs by their ability to directly associate with nucleosomes and
induce local changes in chromatin accessibility, to allow competence for gene
expression at the initial stages of cell differentiation (Cirillo et al., 1998; IwafuchiDoi and Zaret, 2014; McPherson et al., 1993; Zaret and Carroll, 2011). The
subsequent identification of FOXA1 as a direct reprogramming TF (Huang et al.,
2011; Huang et al., 2014) then raised questions about the potential pioneering
activity of other reprogramming TFs and the role of TF nucleosome binding
during cell reprograming.
Our lab previously demonstrated that OCT4, SOX2, and KLF4 (OSK) can
access closed chromatin during the initial days of fibroblast to iPSCs
reprogramming (Soufi et al., 2012). Furthermore, OSK was found to directly
interact with nucleosomes and target nucleosomes-enriched sites in vivo, while
cMYC target sites are mainly nucleosome-depleted (Figure 2.4,5). We therefore
showed that in vivo OSKM chromatin targeting tendencies are mirrored by the
TFs ability to directly interact with nucleosomes in vitro (Figure 2.1). Thus, we
established the identity of OSK but not M as pioneer TFs (Chapter 2). Based on
these findings, we propose that the inherent ability of these factors to target
chromatin is determined by their intrinsic ability to recognize partial motifs on
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nucleosomes and by the structural adaptability of the TFs DBD (Soufi et al.,
2015b).
Studies correlating TF binding co-occurrence with chromatin accessibility
in vivo suggest a hierarchical model of TF-mediated genome re-activation during
reprogramming where early expressed developmental TF are also sufficient for
reprogramming,
reprogramming

such
TFs

as

OSK.

preferentially

These
access

early

developmental

compacted

and

chromatin,

now

induce

chromatin opening and subsequently recruit factors with weak nucleosome
binding activity (Mall et al., 2017; Soufi et al., 2012; Soufi et al., 2015b; Wapinski
et al., 2013). The reprogramming hierarchical model places TF nucleosome
binding ability and thus pioneering activity as a determinant of a TF
reprogramming potential. Nonetheless, what dictates the preference of OSK to
closed chromatin remains unknown. The studies presented in Chapter 2 and 3
were based on mono-nucleosomes substrates. Therefore, we suggest that a
more complex chromatin structure allows a higher level of nucleosome
interactions and provides multiple binding sites for TFs that could increase the
nucleosome affinity of these factors in chromatin. Therefore, a more complex
substrate such as chromatin could explain the preferential targeting of these TFs
to closed chromatin.
Following our findings of OSKM pioneer activity in vivo and in vitro during
iPSC reprogramming, I extended our analysis to include TFs driving the direct
cell reprogramming of fibroblast to neurons, hepatocytes, macrophages and B
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cells (Chapter 3). We purified 9 cell reprogramming TFs under denatured
conditions and measured their apparent dissociation constant on short dsDNA
containing the respective TFs motif to validate specific DNA binding of the TFs
compared to non-specific DNA (Figure 3.S2C-D). We showed that each TF is
able to specifically interact with their respective motif by EMSA, competition
experiments and DNase I footprinting (Figure 3.3). Additionally, by estimation of
the percent of fraction bound by the TF to free DNA at 1 nM we estimate that
90% of the purified FOXA1, PU1 and ASCL1/E12aa are properly folded since a
1:1 molar ratio of TF:DNA shows almost complete saturation of binding to the
free DNA probe (Figure 3.2B-D). We estimate GATA4 and BRN2 to be 75%
folded by this method (Figure 3.2E-F). Still, more quantitative experiments such
as isothermal titration calorimetry can be done to determine the stoichiometric
ratio of TF:DNA binding in order to accurately quantify the percentage of folded
TF. Assessment of the nucleosome binding of these cell reprogramming TFs
revealed these factors display a range of nucleosome binding affinities that
correlate with the reprogramming strength of TFs (Fernandez Garcia et al.,
2019). Moreover, by DNase I footprinting experiments, we observe that upon TF
binding, nucleosomes become DNase I protected at TF binding sites but also
show enhancement of DNase I sensitivity at other regions (Figure 3.3).
Therefore, suggesting that TF binding to nucleosomes can induce allosteric
conformational changes in the histone octamer that lead to changes in
nucleosomes rotational positioning.
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Transcription factors cannot be functionally understood without knowledge
of the DNA sequences that they bind. Therefore, many efforts have been made
to understand the DNA binding preferences of TFs resulting in the creation of TF
motif databases such as JASPAR, TRANSFAC, UNiPROBE, and CIS-BP that
use TFs ontology and structural databases (Jolma et al., 2013; Mathelier et al.,
2014; Matys et al., 2006; Yin et al., 2017). Still, nucleosome-TFs studies have
been mainly restricted to low-throughput analyses due to the requirement of
specific DNA sequences for TFs binding. Moreover, the complexity of TFs posttranslational modifications, TF dimerization, and TF binding partners, all of which
contribute to TF stability and DNA binding, have made it challenging to screen for
sequence–specific nucleosome binders and to determine the underlying features
that permit or inhibit nucleosome binding. This study precisely addressed this
gap in our knowledge.
Using protein microarray technology, we screened 593 TFs for
nucleosome binding on sequence specific DNA and identified factors with
previously unreported pioneer activity, including the AP2 TF family (Figure 3.5C).
In solution validation, of sequence specific nucleosome-TF interactions identified
from the protein microarray screen, showed that while nucleosome binding TFs
typically have a high DNA binding affinity this does not equate to nucleosome
binding activity (Figure 3.5D). Based on these findings and earlier work on
pioneer FOXA1 (Cirillo et al., 2002) we suggest that DNA curvature induced by
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association with the histone octamer or with histones themselves plays a role
facilitating TFs-nucleosome binding interactions.
TFs are classified by their DBDs into 10 structural superclasses that
represent the topology of the TFs DBD. The 3 largest superclasses, zinccoordinating, helix-turn-helix, and basic domain, account for 90% of all human
TFs. Following in size are the superclasses containing b-sheet structures
including the immunoglobulin fold DBDs, and the b-hairpin exposed superclasses
(Lambert et al., 2018; Wingender et al., 2015). My comparison between strong
and weak nucleosome binders revealed that strong nucleosome binding factors
engage DNA through a short anchoring a-helix while weak TFs engage DNA
through an extended anchoring a-helix (Figure 3.6A,B). A long anchoring a-helix
that extends past the diameter of the DNA can be incompatible with nucleosome
structure and cause steric hindrance to the association of the histone octamer
with DNA. It has now become evident that pioneer TFs fall within superclasses
with a- helical structures (Figure 3.6).
We also identified a second group of weak nucleosome binders that
contains DBDs mainly composed of b-sheets and that interact with DNA through
short helical twists or unstructured loops. This group of non-pioneer TFs include
TFs of the immunoglobulin-like superclass family. Therefore, this group of nonpioneer TFs are part of the b-sheet containing TF superclasses (Figure 3.6C).
Not surprisingly, these TFs which include p63 and TBX5, have been shown to be
insufficient for direct cell reprogramming protocols versus. For example, p63 is
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insufficient for keratinocyte reprogramming and requires pioneer TFs AP2 or
KLF4 (Li et al., 2019; Lin-Shiao et al., 2019). Additionally, reprogramming into
cardiomyocytes with MEF2A and TBX5 is also insufficient for reprogramming and
requires pioneer TF GATA4 (Ieda, 2013; Ieda et al., 2010). MEF2A is classified
as a MADS-box TF which contains a DBD structure mainly composed of a-helical
structures exposed by b-sheet scaffold (Santelli and Richmond, 2000; Wu et al.,
2010). Comparison of these factors with non-pioneer TBX20 (Figure 3.5D),
suggests that b-sheet-containing DBDs are insufficient for nucleosome binding
and thus cell reprogramming.
Structural comparison of weak versus strong nucleosome binders
revealed key structural differences between pioneer and non-pioneer factors.
Identification of such features revealed DNA binding modes associated with
nucleosome binding strength and reprogramming dominance (Fernandez Garcia
et al., 2019).

The findings from my thesis work provide strong evidence to

suggest that the intrinsic nucleosome binding preferences of pioneer TFs
contribute to their hierarchy of cellular reprogramming (Fernandez Garcia et al.,
2019). Furthermore, the work presented here gives insight into how such a
diverse group of TFs from multiple structural superclasses engage in
nucleosomal interactions via common structural features.
My thesis works provides a knowledge base that allows prediction of the
TFs with pioneer and reprogramming potential based on their TFs DBD
structures. Such knowledge may be used to improve the generation of induced
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reprogrammed hematopoietic stem and progenitor cells (iHSPCs), since efficient
generation of Induced HSPCs from somatic cells has yet to be developed (Ebina
and Rossi, 2015). Runx3 has been proposed to initiate chromatin accessibility
during memory cytotoxic T lymphocyte differentiation (Wang et al., 2018), yet
RUNX is insufficient for reprogramming protocol toward hematopoietic lineages
and reprogramming (Ebina and Rossi, 2015). Current RUNX-based strategies for
iHSPCs reprogramming using RUNX, from closely related lymphoid progenitors,
require the use of at least 7 TFs for efficient reprogramming (Wang et al., 2018).
RUNX DBD adopts an immunoglobulin fold conformation (Tahirov et al., 2001)
and can therefore be predicted as a non-pioneer TF. We speculate that RUNX
inability to efficiently reprogram cells is due to structural similarities with nonpioneer TFs. DBD-based prediction of pioneer TFs will instruct the informed
selection of better reprogramming TFs cocktails for the reprogramming of cells
yet to be produced.

4.2 Future directions
Advancement in structural biology techniques, growth in the number of
nucleosome structures, and proteomic based mass-spectrometry has allowed
the analysis of nucleosome-protein complexes with higher resolution and has
provided new insight the landscape of the nucleosome interactome (Kale et al.,
2019). These advancements have revealed the principles of nucleosome
recognition and the effect of histone and DNA post translational modifications on
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nucleosome recognition by epigenetic factors (Bartke et al., 2010; Dann et al.,
2017; Makowski et al., 2018; Nguyen et al., 2014). However, these studies
mainly provided understanding of non-specific nucleosome binding proteins by
relaying on nucleosomes assembled with DNA sequences shown to restrict TFs
nucleosome binding, due to high rigidity (Appendix B) (Takizawa et al., 2018).
Currently, there is no published structure of full-length sequence-specific TFs
bound to nucleosomes, which therefore limits our understanding on the
nucleosome recognition mode of full-length, sequence-specific factors.
The development of nucleosome libraries assembled with diverse DNA
sequences bypassed the limitations of TF DNA sequence specificity (Zhu et al.,
2018). The study revealed distinct nucleosome interacting behaviors of TF DBDs
based on sequence-specific DNA motif analysis. Still, further experiments need
to be done for the validation of such nucleosome interacting behaviors. Structural
manipulation of the DNA anchoring a-helix of pioneer TFs DBDs followed by
nucleosome affinity assays will determine the role of the proposed secondary
structures in dictating nucleosome interacting behaviors (Chapter 3). Conversely,
it would be interesting to determine whether non-pioneer TFs can acquire
pioneering activity and reprogramming activity by substitution of DNA-anchoring
loops with an anchoring a-helix.
Different mechanisms have been suggested for the action of pioneer TFs
to induce local chromatin changes in DNA accessibility.

For example,

comparison of FOXA with histone 1 (H1) showed that the FOXA DBD contains a
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winged-helix domain resembling H1 (Clark, 1993). This extends to other FOX
family TFs such as FOXE1 and FOXO1, which also interact with nucleosome
through a winged-helix domain (Hatta and Cirillo, 2007). Interestingly, H1 and
FOX TFs execute opposing functions – H1 compacts nucleosomes while FOXA
induces DNA chromatin accessibility (Cirillo et al., 2002; Osipova et al., 1980).
These differences are potentially dictated by accessory domains outside of the
DBD since both H1 and FOXA1 interact near the nucleosome dyad (Chaya et al.,
2001; McPherson et al., 1993; Sekiya et al., 2009). For instance, H1 is known to
interact with linker DNA while FOXA is not (Allan et al., 1986; Thomas, 1999).
Nonetheless, structural similarities between FOXA and H1 suggest FOXAdisplacement of H1 may play a role in the pioneer function of FOXA1 (IwafuchiDoi et al., 2016).
Our lab has also shown that FOXA1 contain a highly conserved C-terminal
a-helix that establishes direct histone contacts with the histone octamer (Cirillo et
al., 2002). Deletion of FOXA a-helix in the C-term (FOXA1Da-helix) inhibits
FOXA1 chromatin accessibility activity in nucleosomes arrays in vitro (Cirillo et
al., 2002). Therefore, the presence of FOXA C-term-a-helix suggests the
existence of external DBD domains that mediate nucleosome binding and the
chromatin opening activity of pioneer TFs. Interestingly, preliminary experiments
measuring dissociation constants of FOXA1Da-helix showed it retain nucleosome
affinity similar to FOXA1 WT (Appendix C, Figure C3). Additional experiments on
FOXA1-DBD fragment showed that the FOXA DBD alone is sufficient for
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nucleosome binding, albeit with a lower affinity (Cirillo et al., 2002). Preliminary
work from our lab indicates that a FOXADa-helix mutants triggers an increase in
chromatin compaction at FOXA1 target sites in undifferentiated mouse
embryonic endoderm (manuscript submitted). These results indicate that
domains outside of FOXA1-DBD are needed for chromatin opening (Appendix
C). Similarly, studies of the pioneer TF EBF1 have also shown EBF1 promotes
chromatin accessibility of B-cell specific genes (Boller et al., 2016; Li et al.,
2018). Detailed analysis of EBF1 DC-term mutants showed a decrease in
chromatin accessibility and limited the co-occupancy of secondary TFs at these
genomic regions (Boller et al., 2016). Therefore, EBF1 C-term confers chromatin
opening ability. These results show that nucleosome binding ability can be
uncoupled from the chromatin opening activity of pioneer TFs. Based on these
findings we suggest that accessory domains external to TFs DBDs mediate the
establishment

of

TF-histone

interaction

and

disruption

of

nucleosome-

nucleosome histone contacts to induce local chromatin accessibility.
As discussed in Chapter 3, through my thesis work I identified previously
unreported pioneer TFs and confirmed the pioneering activity of proposed
reprogramming TFs that direct reprogramming toward three different cell types
(Fernandez Garcia et al., 2019). Identification of pioneer TFs form diverse
structural families now place us in position to determine whether these factors
also interact with histones and which domains are involved in these interactions.
Studies comparing pioneer TFs specific nucleosome binding with non-specific
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nucleosome binding proteins will determine whether TFs also establish similar
histone-nucleosome interactions through association of the histone acidic patch
(Figure 1.4) or through distinct interactions (McGinty and Tan, 2016). Detailed
structural studies in TF-histone interactions will aid in the elucidation of the
similar or differential mechanisms by which pioneer TFs interact with
nucleosomes and will determine whether nucleosome binding by TFs stabilize or
destabilize nucleosome structures to induce chromatin accessibility. Future
research on pioneer TF mechanisms of nucleosome binding will elucidate the
initial steps silent chromatin targeting by TFs and will unveil the mechanisms by
which cells reactivate developmentally silenced gene networks.
At a higher level of DNA compaction our lab has shown that OSK cannot
access highly compacted chromatin that is enriched for H3K9me3, thus revealing
the sensitivity of these pioneer TFs to highly compacted chromatin subtype
(Becker et al., 2017; Soufi et al., 2012). As the chromatin sensitivity of these
pioneer factors limits their ability to induce activation of late reprogramming
genes resulting in incomplete activation of new cell fate regulatory networks
(Becker et al., 2017; Soufi et al., 2012). Knowledge of the histone marks, DNA
modifications, and chromatin-specific interacting proteins that influence pioneer
TFs chromatin sensitivity may be used to enhance cellular reprogramming.
These gaps in knowledge can be addressed by the use of DNA-barcoded mononucleosome libraries of chemically-modified histones, histone variants and
methylated DNA (Dann et al., 2017; Nguyen et al., 2014). Such libraries would be
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generated with native DNA sequences specific to TF of interest (Figure 3.1) in
order to profile the biochemical susceptibility of a pioneer TF to diverse types of
sequence-specific nucleosomes.
In addition, we have shown that although some reprogramming TFs can
associate with closed chromatin, not all TFs have nucleosome binding activity
(Chapter 2). c-MYC was shown to have weak nucleosome binding and a minority
of cMYC target sites within nucleosome-enriched chromatin in vivo are also
enriched for Oct4 and Sox2 binding sites (Soufi et al., 2015b). Therefore, we
suggest that cMYC associates with chromatin through cooperative interactions
with pioneer TFs. Similarly, CEBPA has been associated with the induction of
chromatin accessibility during B-cell reprogramming, although we showed that
CEBPA displays the weakest nucleosome binding affinity of the TFs tested in
Chapter 3. Furthermore, a majority of CEBP target sites have shown to be
dependent on PU1 (van Oevelen et al., 2015). Therefore, future studies should
also address the role of cooperative binding of non-pioneering TFs at closed
chromatin in inducing chromatin accessibility during reprogramming.
The question of which reprogramming TFs can directly induce chromatin
opening in an ATP-independent mechanism, and whether chromatin opening
activity is limited by nucleosome affinity can be directly tested in vitro by high
precision mapping techniques such as DNAse footprinting using compacted
chromatin arrays. Our lab has shown that FOXA1 and GATA4 can bind
nucleosomes. GATA4 showed a lower nucleosome affinity and decreased
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chromatin opening compared to FOXA1 on H1 compacted arrays (Cirillo and
Zaret, 1999a). DNAse footprinting experiments of in vitro reconstituted chromatin
can therefore elucidate the dependence of chromatin opening activity on
nucleosome binding affinities of the newly identified pioneer TFs. Furthermore,
coupling

of

these

experiments

with

newly

developed

DNA-sequencing

technologies, in vitro, will provide further details and mapping of the ATPindependent mechanism by which pioneer TFs induce chromatin opening.

4.3 Final Remarks
Just about over 10 years ago the explosion and refinement of highthroughput genome-wide technologies have highlighted the importance of
chromatin compaction and 3D genome folding in the establishment of cell
identity. Discoveries of genome wide changes in chromatin accessibility during
cell differentiation shifted the perception of transcription factors as merely static
DNA binding proteins into proteins that target nucleosomes and lead to local
structural perturbations. Now, thanks to the extensive identification and validation
of pioneer TFs in addition to FOXA, after much skepticism pioneer TFs have now
become widely accepted as mediators of chromatin accessibility. Therefore,
pioneer TFs nucleosome and chromatin binding preference should be
incorporated into the functional analysis of TFs in order to understand how TFs
regulate gene expression in the nucleus, a highly compacted and tightly
regulated environment.
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APPENDIX A: ENZYMATIC 3’ DNA LABELING WITH CY5
FLUOROPHORE

This appendix provides a detailed overview of the enzymatic 3’ DNA
labeling with Cy5 fluorophore protocol used in Chapters 2 and 3. The protocol
has been robustly used by other labs, including Doris Wagner and Shelly
Berger’s labs. The protocol was developed and optimized by myself with
guidance from Dr. Zaret.

I. Objective
Label DNA at the 3’ end with Cy5 fluorophore for EMSA experiments and
for Cy5 fluorescence detection.

II. Reagents and Kits
Reagents

Cy5-dCTP [1mM]
Unlabeled dATP [100 mM]
Unlabeled dTTP [100 mM]
Unlabeled dGTP [100 mM
Klenow fragment (-exo)
Purification column illustra MicroSpin G-25 columns (GE healthcare)
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Note: If using DNA longer than ~150 bp DNA, cleanup can be done with Qiagen
PCR Purification Kit.
DNA Sequences

Double stranded DNA (dsDNA) should be longer than 32 bps otherwise the
purification (removal of unincorporated dNTPs) by size exclusion will not be
efficient as the size difference between dNTP and DNA will be minimal.
Designed oligonucleotides should contain sticky ends of at least 2 bp on each
side, the last of which will be labeled with a Cy5 labeled C. This protocol works
for both annealed ssDNA (top strand) and ssDNA (bottom strand) or dsDNA
fragments.

Buffers
10X Annealing Buffer: 200 mM Tris, pH 7.6; 500 mM NaCl; 1 mM DTT; 10 mM
EDTA

III. Protocol
Note: Skip to Step 2 if starting from dsDNA (Cy5 labeling reaction).
1. Anneal complementary strands of ssDNA:
a. Prepare annealing reaction:
10 uL ssDNA (top) 100 µM stock
10 uL ssDNA (bottom) 100 µM stock
5 uL 10X annealing buffer
25 uL ddH2O
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b. Heat the reaction at 70˚C for 10 min. on a heat block. Turn the heat
block off and let the sample gradually cool down in the heat block
overnight.
c. Determine the DNA concentration on a Nanodrop.
2. Labeling reaction:
a. Prepare 5X dNTP mix:
Stock
100 mM dATP
100 mM dTTP
100 mM dGTP

Final Concentration
20 mM
20 mM
20 mM

1 mM Cy5-dCTP

20 µM

b. Prepare reaction:
Stock
1
3
3
3

Final Concentration
1

dsDNA (50 ug)
10X NEB Buffer #2
C

5X dNTP Mix
a

[1.260 µM ] final concentration
1X
1X (4mM dATP, dTTP, dGTP, 0.004 mM Cy5dCTP)

Klenow Fragment (-exo) 5
0.5 U/µL
U/uL l
4
ddH2O
Subtract everything from total volume
c
2
Total volume
Adjust to DNA final conc.
Calculate how much DNA you want to label: 50 ug 160 bp DNA
2

Then calculate the total volume needed to have 50 ug DNA with a final

concentration of 1.26 µM. Do not exceed 10 µL if DNA < 150 bp. Do not
exceed the maximum loading volume if using G-25 spin columns since
this will decrease the purification efficiency. Additionally, if more DNA is
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desired make sure to keep the ratio of DNA:Cy5-dCTP the same
otherwise efficiency of labeling can be compromised.
3

Calculate how much 10X buffer, 5X dNTP mix and Klenow you need to

add to have 1X, 1X and 0.5 U/uL final concentrations.
4

Subtract the volume of DNA, buffer, dNTPs, and Klenow from the total

to get the volume of H2O to add.

c. Incubate at 37˚C for 1 hr in a water bath.
3. DNA purification
a. DNA < 150 bp: proceed as per the illustra MicroSpin G-25 column
manufacturer protocol, with a few modifications:
i.

Load the sample into the column and add an additional 10 µL
ddH2O for a final volume of 20 µL.

ii.

Spin at 2,800 RPM for 1.5 min.

iii.

To verify purity of the sample run on a 10 % Acrylamide, 0.5X TBE
gel (non-denaturant). Make a ~1:60 dilution of your sample and
load 10 µL of the dilution + 2 µL 30% sucrose. Additionally, run one
lane with 2 µL 6X DNA loading dye just to have an estimate of
how far off your sample has run. Run the gel in 0.5X TBE at 90 V
for ~ 1.5 hr. Scan the gel in a fluorimeter scanner with Cy5
detection. Note: be sure to use sucrose when loading your sample,
as DNA loading dye will obscure the Cy5 signal.

b. DNA ≥ 150 bp: purify using Qiagen PCR Purification Kit.
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i.

Note: Do not load more than 10 µg DNA per column otherwise purification
yields will be lower.

ii.

Elute 10 µg in 50 µL EB buffer.
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APPENDIX B: WIDOM 601 DNA SEQUENCE AS A TEMPLATE FOR
TF-NUCLEOSOME INTERACTIONS

This appendix contains unpublished analyses which test FOXA1
nucleosome binding affinity for Widom 601 asymmetric nucleosomes containing
or lacking FOXA1 binding sites at multiple nucleosome rotational phasing
positions. Experimental design, reagents, experiments, and analysis was done
by me.

I. Objective
The goal of the experiments presented here is to determine the viability of
using a synthetic DNA sequence, such as the Widom 601 asymmetric DNA, as a
universal and modifiable template for nucleosome assembly. Such a template will
be useful for testing the binding affinities of multiple transcription factors on
nucleosomes containing binding sites at various rotational positions. The Widom
601 sequence has been the standard for in vitro nucleosome biochemical assays
due to its exceptional histone octamer affinity and favorable DNA bending and
distortion, both of which allows stable nucleosome assembly in vitro (Vasudevan,
J. Mol. Bio, 2010; Chua et al., NAR, 2012; Lowary & Widom, J. Mol. Bio, 1998).
The 601 sequence is extensively used for nucleosome structural analyses
(Makde et al., 2010) nucleosome interaction assessment ( Lone, et al, PLOS
Gentics, 2013), and nucleosome mechanics (Chua et al.,NAR, 2012) and
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disassembly studies (Gansen et al. PNAS 2009). Therefore, we did preliminary
work testing FOXA1 binding to 601 nucleosomes constraining or lacking a FOXA
binding site at multiple rotational positions.
II. Reagents
DNA Sequences
601 asymetric-162 bp

5’ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACGCG
GGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’

601-eG (D)
5’ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAAGAAT
GTTTGTTCTTAGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’

601-eG (D-1)
5’ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAGAATG
TTTGTTCTTACGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’

601-eG (D-5): 5 bp shift causes a shift of 34° degrees.
5’ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTGAATGTTTG
TTCTTAAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’

601-TA mut at superhelical location -0.5, 1.5

5’ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTGGAAACGCG
GGGGACAGCGCGGGCGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’

601-eG (D)-TA mut at superhelical location -0.5, 1.5

5’ATCGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTGGAAAGAAT
GTTTGTTCTTAGGGCGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGG
CACCGGGATTCTGAT-3’
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Purified Proteins
Mouse FOXA1 full-length

III. Assessment of FOXA1-specific binding at multiple rotational positions
on 601 nucleosomes
Goal
To compare FOXA1 binding to Widom 601 free DNA and Widom 601
nucleosomes with our without a single FOXA1 binding motif and determine
whether different rotational phasing inhibits or allows FOXA1 binding to
nucleosomes.

Approach
pUC19-601 plasmid (gift from Karolyn Luger) was used as a template for
mutagenesis of the FOXA eG binding site at positions near the 601 nucleosome
dyad (D), 1 bp away from the dyad towards the DNA super helix (SH) 1.5, or 5 bp
away from dyad toward SH 1.5 (Figure B1B). The FOXA1 eG site in the dyad is
considered assessible. From the dyad, a 1 bp shift of the eG site in the
nucleosome causes a 34° rotation and a 5 bp shift causes it to be inaccessible to
FOXA1, as shown by molecular modeling (Figure B1C). The eG site orientation
was placed so that wing 2 of the FOXA1-DBD structure is closest to the dyad,
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similar to the orientation that FOXA1 adopts on the alb1- N1 nucleosomes
(Figure B1D).
PCR with Cy5 labeled primers was performed to generate 162-bp of 601,
601-eG (D), 601-eG (D-1), and 601-eG(D-5) DNAs. The sequences were then
assembled into nucleosomes by urea-salt gradient dilution with purified
recombinant, full-length human histones. FOXA1 free DNA and nucleosome
binding was determined by Electromobility Shift Assay (EMSA).
Results
FOXA1 binds with higher affinity to 601 DNA containing the eG site at
positions D, D-1 and D-5 (Figure B2A). In contrast, FOXA1 shows minimal
binding to all 601 nucleosomes containing or lacking the eG site (Figure B2B).

IV. Assessing FOXA1 binding to less rigid 601 nucleosomes
Goal
To make flexible 601 nucleosomes that are less rigid and more closely
resemble natural nucleosome structures to allow FOXA1 binding.

Approach
Widom 601 nucleosomes have been characterized as very rigid
nucleosomes compared to nucleosomes assembled with the 5S DNA sequence
or with the albN1 enhancer. Therefore, to generate a more natural and flexible
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nucleosome I mutated the H3/H4 TA steps super helical locations -0.5 and 1.5
closest to the dyad (Figure B3A,B). H3/4 TA steps serve as histone-DNA
interaction points. These two TA steps were mutated to GC in order to increase
nucleosome flexibility near dyad.

Results
Mutagenesis of 601 H3/4 TA steps near the dyad and eG site did not
affect FOXA1 specific binding to 601 free DNA. EMSA of FOXA1 to 601-eG (D)
TA mut nucleosomes showed minimal FOXA1 nucleosome binding enhancement
compared to 601-eG(D) nucleosomes (Figures B2B-C) and nucleosome
saturation could only be observed at 90 nM FOXA1 concentrations.

V. Conclusions
Here I have shown that the Widom 601 asymmetric DNA can be used to
test TF-specific binding with the insertion of TF target site and that mutagenesis
of 601 does not disrupt nucleosome assembly. Nonetheless, 601 nucleosomes
showed to be too rigid and inhibited FOXA1 nucleosome binding ability,
regardless of the DNA binding motif orientation within the nucleosome structure.
These conclusions are in agreement with a recent publication comparing the
albN1 nucleosomes to 601 nucleosomes by cryo-EM (Takizawa et al., 2018).

196

VI. Figures

Figure B1 | Design of 601-eG nucleosomes.
(A) Schematic diagram showing plasmid generation to DNA purification workflow
of Cy5-601 DNA sequences and FOXA1 eG binding site insertion.
(B) 3D representation of the 601 DNA sequences used for nucleosome assembly
containing FOXA1 eG binding site (yellow) and DNA nucleotide sequence of
FOXA1 with highlighted FOXA1 specific contacts (green and red) and DNase
protected nucleotides shown by McPherson et al 1993, Cell.
(C) Modeled crystal structure of 601 nucleosomes (pdb 3LZ0) with docked
FOXA3 DBD (pdb IVNT) by alignment of FOXA3 eG containing DNA from crystal
structure with 601 DNA at eG site insertion positions shown in (B).
(D) AlbN1-DNA sequence with MNase and DNAase I cleavages in liver nuclei. Arrows
indicate sites of enhanced MNase cleavage in liver nuclei; large arrows represent the
strongest cleavages that define the real nucleosome boundaries. Sequences contained
within the N1site (red box) which were inserted into 601 (B) show the orientation of the
FOXA3 secondary structural folds with respect to the dyad. Bars indicate areas
protected from cleavage by DNAase I in liver nuclei, and dots indicate positions of
enhanced liver-specific cleavage by DNAase I. (Liu et al., 1991, McPherson et al 1993,
Cell)
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Figure B2 | The Widom 601 nucleosomes fail to Recapitulate FOXA1
nucleosome binding regardless of TF binding motif rotational positing.
(A) Representative EMSA showing the affinity of increasing amounts of FOXA1
WT to 160 bp 601 free DNAs. Black arrowheads indicate free DNA and
DNA:FOXA1 complexes.
(B) Representative EMSA showing the affinity of increasing amounts of FOXA1
WT to 160 bp 601 free DNAs and nucleosomes. Black arrowheads indicate free
DNA and DNA:FOXA1 complexes; white arrow indicate nucleosomes and
nuc:FOXA1 complexes.
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Figure B3 | Mutagenesis of 601 H3/4 TA steps does not enhance FOXA1
nucleosome binding.
(A) 601 nucleotide sequence showing the dyad position (F) and highlighted H3/4 TA
steps (orange).
(B) Crystal structure of 601 nucleosomes (pdb 3LZ0) showing H3/4 TA steps (orange
base pairs) and mutated super helical locations (SHL) -0.5 and 1.5.
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APPENDIX C: FOXA1 CHROMATIN OPENING-DEFICIENT MUTANTS
BINDING TO NUCLEOSOMES

This appendix contains unpublished analyses which measure FOXA1 WT
and FOXA1 C-terminal mutant affinity to albN1 DNA and nucleosome. While
FOXA1 double mutant protein expression plasmids and FOXA1 purifications
were done by Naomi Takenaka, I generated the single FOXA1 mutant plasmids
for protein expression, EMSA experiments, dissociation curve analysis, and
histone octamer pulldown assays.

I. Objective
Unpublished work from our lab have shown that FOXA1 contains two
highly conserved lysines, K270 and K414, that interact with the nucleosome core
histone octamer by FOXA1–core histone octamer crosslinking followed by mass
spectrometry (in revision; Iwafuchi-Doi et al, Nature Genetics). mFOXA1 residues
K270 and K414 reside within the C-terminus of FOXA1. K270 is located in close
proximity to the FOXA1 DBD and within highly conserved EKQ (269-271)
residues while residue K414 resides within the FOXA1 C-terminal a-helix
structure (In revision; Iwafuchi-Doi et al, Mol Cell, 2019). Deletion of the FOXA1
C-term a-helix was shown to decrease DNA accessibility at FOXA1 bound sites
in vivo observed by ATAq-seq experiments, while in in vitro experiments it
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causes chromatin opening inhibition and loss of FOXA1 histone interactions (In
revision; Iwafuchi-Doi et al, Nature Genetics). Therefore, to determine the role of
the K270 and K414 residues to FOXA1 nucleosome binding I measured free and
DNA affinity of FOXA1 C-term mutants to 160 bp albN1 DNA and nucleosomes.

II. Reagents
DNA Sequences
See section 3.11 Key Resource Table -160 bp ALBN1-DNA
Purified Proteins
FOXA1 WT
FOXA1 DBD aa168-268,
FOXA1 eDBD aa144-294
FOXA1 eDBD aa144-294: EKQ (269-271) AAA
FOXA1 (A415P, A419P)
FOXA1 DF413-Q421
FOXA1 EQK (269-271) AAA
FOXA1 EQK (269-271) AAA + (A415P, A419P)
FOXA1 EQK (269-271) AAA + D413-421

III. FOXA1 chromatin opening-deficient mutants binding to short dsDNA

Goal
To compare the ability of WT and chromatin opening deficient FOXA1
mutants to specifically bind to short dsDNA.
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Approach
FOXA1 WT and mutant plasmids were generated and recombinant
proteins were purified (Figures C1A-C) from E. coli under denaturing conditions
as described above. Purified recombinant proteins where tested and validated for
specific and non-specific DNA binding to short ds-DNA containing or lacking the
FOXA1 eG site by EMSA (Figure C1D).

Results
FOXA1 chromatin opening deficient mutants bind short dsDNA DNA with
specificity and similar affinity compared to WT.

IV. FOXA1 chromatin opening-deficient mutants bind to 160 bp albN1 free
DNA and nucleosomes
Goal
Determine whether FOXA1 K270 or K414, are required for FOXA1
nucleosome binding ability.
Approach
Electromobility shift assays (EMSA) were used to determine the apparent
dissociation constants of WT and mutant FOXA1 to 160 bp albN1 free DNA and
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nucleosomes (Figure C2A-F). Dissociation constants were quantified by two
methods: total dissociation constant (total KD), determined by decrement of free
probe, and specific dissociation constant (specific KD), determined by the
appearance of specific TF-complexes (Soufi et al., 2015b) (Figures C3A-C).
Results
FOXA1 mutants bind 160 bp albN1 DNA and nucleosomes with similar
affinities within the low nanomolar range of 1-2.5 nM for nucleosomes compared
to WT, albeit with less affinity for nucleosomes compared to DNA, as was also
seen for FOXA1 WT.

V. FOXA1 EKQ (269-271) residues contribute to FOXA1 interactions with
the histone octamer

Goal
Determine FOXA1 EKQ (269-271) amino acid contribution to FOXA1histone octamer interaction.

Approach
Constructs of FOXA1 truncations containing either the DBD lacking
residues EKQ 269-271, an extended DBD (eDBD), or eDBD with EKQ (269-271)
AAA mutation were generated (Figure C4A). These plasmids were then used for
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protein expression and purification from E. coli under denatured conditions
(Figure C4B). Purified recombinant proteins where initially tested and validated
for specific and non-specific DNA binding to short dsDNA containing or lacking
the FOXA1 eG site (Figure C4C). Histone octamer pulldown assays are
described in Cirillo et al., 2002, Mol Cell (Figure C4C). Initially we compared
histone interaction of FOXA1 full-length WT with FOXA1 full-length EKQ (269271) AAA mutant followed by comparison of FOXA1 DBD lacking residues EKQ
269-271 and extended DBD (eDBD).
Results
FOXA1 eDBD, short DBD, and eDBD-AAAmut show similar affinities for
short dsDNA containing a FOXA eG binding site (Figure C4C). We show that fulllength FOXA1 is able to interact with histone octamers, in agreement with
previous published experiments (Cirillo et al., 2002), but AAA substitution of EKQ
residues in full-length FOXA1 causes a partial decrease in FOXA1-histone
octamer interaction (Figure C4E). Further truncation of FOXA1 eDBD fragment
which removes adjacent amino acids, including the EQK residues, greatly inhibits
FOXA1 DBD fragment interactions with histone octamers (Figure C4F).

VI. Conclusions
Here we show that purified FOXA1 WT and chromatin opening-deficient
mutants bind nucleosomes with similar affinities. Nonetheless mutation of
residues EQK, adjacent to FOXA1 DBD, limit histone octamer interaction of
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FOXA1. Previous work from our lab has shown that FOXA1 DBD fragment is
sufficient for nucleosome binding but show decrease affinity compared to fulllength FOXA1 (Cirillo et al., 2002). Moreover the DBD alone is insufficient for
FOXA1 chromatin opening ability (Cirillo et al., 2002). Therefore, comparison of
histone octamer interaction by pull down assay between FOXA1 eDBD (includes
EQK) and short DBD fragments (exclude EQK), show that truncation of adjacent
amino acids such as EQK result in inhibition of FOXA1-DBD interaction with
histone octamers in vitro. These experiments provide evidence that FOXA1
nucleosome binding and chromatin opening functions can be uncoupled and that
domains outside of the DBD might play a role mediating FOXA1 histone
interactions.
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VII. Figures
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Figure C1 | FOXA1 WT and mutants bind short dsDNA with specificity
(A) Amino acid sequence of FOXA1, highlighting the predicted α-helix and
conserved region III (CR III) in red.
(B) Representation of FOXA1 WT, truncations, mutants and deletions displaying
FOXA1 DNA binding domain (DBD), K270 and K414.
(C) Purified recombinant, full-length FOXA1 and mutants were analyzed by SDSPAGE and Coomassie staining. The TFs bands run at the expected sizes when
compared to the protein standards. All proteins were run on the same gel.
(D) Representative EMSA showing the affinity of increasing amounts of FOXA1
WT and mutants to specific, short dsDNA Cy5-eG and non-specific short, dsDNA
Cy5-lefty. Black arrowheads indicate free DNA and DNA:FOXA1 complexes.
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Figure C2 | Mutation of FOXA1 K270 or C-term αHelix does not inhibit
nucleosome binding.
(A-F) Representative EMSAs showing the affinity of increasing amounts of
FOXA1 WT and mutants to (A-C) Cy5- albN1 DNA and (D-F) nucleosomes.
Black arrowheads indicate free DNA and DNA:FOXA1 complexes, white
arrowheads indicate nucleosomes and nuc:FOXA1 complexes.
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Figure C3 | Purified recombinant, full-Length FOXA1 WT and mutants bind
free DNA and nucleosomes with similar nucleosome binding affinities.
(A) FOXA1 binding curves related to EMSAs fraction bound quantification of
Figures B2-A,F showing the dissociation constants of FOXA1 mutants to Cy5160bp-albN1 DNA (blue) or to Cy5-160bp-albN1-NUC (orange). Proteins were
titrated on 1 nM DNA or NUC.
(B) FOXA1 WT and mutant binding curves of total fraction bound to free DNA
(left) and nuc (right) in a single graph for comparison.
(C) Same as B, but binding curves of specific fraction bound to free DNA (left)
and nuc (right).
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Figure C4 | FOXA1 residue K270 contributes to FOXA1 histone octamer
interaction.
(A) Representation of FOXA1 DNA binding domain (DBD) truncations aa 168268, extended DBD 144-294 (eDBD), which includes K270 and mutants eDBD,
and 144-294 with EKQ (269-271) AAA triple alanine mutant.
(B) Purified recombinant FOXA1 DBD, eDBD, and eDBD EKQ (269-271) AAA
truncations analyzed by SDS-PAGE and Coomassie staining. The TFs bands run
at the expected sizes when compared to the protein standards. All proteins were
run on the same gel.
(C) Representation of Sepharose-conjugated FOXA1 pull down with purified
recombinant histone octamers.
(D) Histone octamer pulldown assays with FoxA1 full-length (FL) protein and
FoxA1 FL-AAA mutant bound to sepharose beads to assess binding to histone
octamers.
(E) Representative EMSA showing the affinity of increasing amounts of FOXA1
DBD, eDBD, and eDBD-AAA to specific “s” short dsDNA Cy5-eG and nonspecific “ns” short dsDNA Cy5- lefty. Black arrowheads indicate free DNA.
(F) Same as E but with eDBD and DBD.
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